TW200813158A - Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device - Google Patents
Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device Download PDFInfo
- Publication number
- TW200813158A TW200813158A TW096124476A TW96124476A TW200813158A TW 200813158 A TW200813158 A TW 200813158A TW 096124476 A TW096124476 A TW 096124476A TW 96124476 A TW96124476 A TW 96124476A TW 200813158 A TW200813158 A TW 200813158A
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- group
- crystal alignment
- component
- acid
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 315
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 150
- 150000001875 compounds Chemical class 0.000 claims abstract description 131
- 229920005575 poly(amic acid) Polymers 0.000 claims abstract description 45
- 150000002391 heterocyclic compounds Chemical class 0.000 claims abstract description 26
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 14
- -1 oxocyclobutane Chemical compound 0.000 claims description 156
- 239000002253 acid Substances 0.000 claims description 115
- 150000004985 diamines Chemical class 0.000 claims description 103
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 91
- 229910052799 carbon Inorganic materials 0.000 claims description 91
- 125000000217 alkyl group Chemical group 0.000 claims description 76
- 125000004432 carbon atom Chemical group C* 0.000 claims description 61
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 55
- 150000001412 amines Chemical class 0.000 claims description 53
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims description 52
- 108010026466 polyproline Proteins 0.000 claims description 37
- 239000001257 hydrogen Substances 0.000 claims description 35
- 229910052739 hydrogen Inorganic materials 0.000 claims description 35
- 125000006158 tetracarboxylic acid group Chemical group 0.000 claims description 35
- 239000000758 substrate Substances 0.000 claims description 33
- 150000002466 imines Chemical class 0.000 claims description 32
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 31
- 125000000623 heterocyclic group Chemical group 0.000 claims description 30
- 229920000656 polylysine Polymers 0.000 claims description 30
- 108010039918 Polylysine Proteins 0.000 claims description 28
- 125000003118 aryl group Chemical group 0.000 claims description 22
- NIDNOXCRFUCAKQ-UHFFFAOYSA-N bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical class C1C2C=CC1C(C(=O)O)C2C(O)=O NIDNOXCRFUCAKQ-UHFFFAOYSA-N 0.000 claims description 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 20
- 125000003545 alkoxy group Chemical group 0.000 claims description 19
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 17
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 15
- 239000001301 oxygen Substances 0.000 claims description 15
- 229910052760 oxygen Inorganic materials 0.000 claims description 15
- 239000004593 Epoxy Substances 0.000 claims description 14
- 229910052707 ruthenium Inorganic materials 0.000 claims description 14
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 11
- 125000002723 alicyclic group Chemical group 0.000 claims description 10
- 125000002947 alkylene group Chemical group 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 9
- 229910052797 bismuth Inorganic materials 0.000 claims description 8
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 8
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 239000011737 fluorine Substances 0.000 claims description 7
- 229910052731 fluorine Inorganic materials 0.000 claims description 7
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 6
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 5
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 5
- 101100452593 Caenorhabditis elegans ina-1 gene Proteins 0.000 claims description 4
- 229910052684 Cerium Inorganic materials 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 4
- 150000002923 oximes Chemical class 0.000 claims description 4
- 239000004575 stone Substances 0.000 claims description 4
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 150000008064 anhydrides Chemical class 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- 229910052734 helium Inorganic materials 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- 150000004060 quinone imines Chemical class 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- MFAWEYJGIGIYFH-UHFFFAOYSA-N 2-[4-(trimethoxymethyl)dodecoxymethyl]oxirane Chemical compound C(C1CO1)OCCCC(C(OC)(OC)OC)CCCCCCCC MFAWEYJGIGIYFH-UHFFFAOYSA-N 0.000 claims description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 2
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 2
- 238000001354 calcination Methods 0.000 claims 2
- PIFBMJMXJMZZRG-UHFFFAOYSA-N 2,2,4,6,6-pentamethyl-1,5-dihydropyrimidine Chemical compound CC1=NC(C)(C)NC(C)(C)C1 PIFBMJMXJMZZRG-UHFFFAOYSA-N 0.000 claims 1
- FAUAZXVRLVIARB-UHFFFAOYSA-N 4-[[4-[bis(oxiran-2-ylmethyl)amino]phenyl]methyl]-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC(CC=2C=CC(=CC=2)N(CC2OC2)CC2OC2)=CC=1)CC1CO1 FAUAZXVRLVIARB-UHFFFAOYSA-N 0.000 claims 1
- 241000219307 Atriplex rosea Species 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- 235000006040 Prunus persica var persica Nutrition 0.000 claims 1
- 240000006413 Prunus persica var. persica Species 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 238000004299 exfoliation Methods 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- PQIOSYKVBBWRRI-UHFFFAOYSA-N methylphosphonyl difluoride Chemical group CP(F)(F)=O PQIOSYKVBBWRRI-UHFFFAOYSA-N 0.000 claims 1
- 150000002924 oxiranes Chemical class 0.000 claims 1
- 125000002345 steroid group Chemical group 0.000 claims 1
- IBBLKSWSCDAPIF-UHFFFAOYSA-N thiopyran Chemical compound S1C=CC=C=C1 IBBLKSWSCDAPIF-UHFFFAOYSA-N 0.000 claims 1
- 229920000642 polymer Polymers 0.000 abstract description 20
- 230000007774 longterm Effects 0.000 abstract description 7
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 64
- 239000010408 film Substances 0.000 description 63
- 239000000243 solution Substances 0.000 description 48
- 230000015572 biosynthetic process Effects 0.000 description 45
- 238000003786 synthesis reaction Methods 0.000 description 44
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 41
- 239000000203 mixture Substances 0.000 description 40
- 238000000034 method Methods 0.000 description 34
- 239000002904 solvent Substances 0.000 description 31
- 239000002585 base Substances 0.000 description 28
- 150000002500 ions Chemical class 0.000 description 25
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 23
- 125000001424 substituent group Chemical group 0.000 description 22
- 239000012046 mixed solvent Substances 0.000 description 21
- 239000003607 modifier Substances 0.000 description 18
- 229920000768 polyamine Polymers 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- 229910000071 diazene Inorganic materials 0.000 description 16
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 14
- 239000001294 propane Substances 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 11
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 108010094020 polyglycine Proteins 0.000 description 11
- 229920000232 polyglycine polymer Polymers 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000000654 additive Substances 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 9
- 229920000954 Polyglycolide Polymers 0.000 description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 8
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 8
- 239000004633 polyglycolic acid Substances 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 150000002431 hydrogen Chemical class 0.000 description 7
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical group C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 7
- 150000003431 steroids Chemical group 0.000 description 7
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 125000006159 dianhydride group Chemical group 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 5
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical group N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 5
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 5
- JAYXSROKFZAHRQ-UHFFFAOYSA-N n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC=CC=1)CC1CO1 JAYXSROKFZAHRQ-UHFFFAOYSA-N 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 230000000704 physical effect Effects 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 125000003944 tolyl group Chemical group 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229920000037 Polyproline Polymers 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 4
- 239000012024 dehydrating agents Substances 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 4
- 239000004584 polyacrylic acid Substances 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 4
- 125000003396 thiol group Chemical class [H]S* 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 3
- KUBDPQJOLOUJRM-UHFFFAOYSA-N 2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol Chemical compound ClCC1CO1.C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 KUBDPQJOLOUJRM-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical group N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000007822 coupling agent Substances 0.000 description 3
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 3
- 125000000466 oxiranyl group Chemical group 0.000 description 3
- 239000003495 polar organic solvent Substances 0.000 description 3
- 229920000647 polyepoxide Polymers 0.000 description 3
- VOVUARRWDCVURC-UHFFFAOYSA-N thiirane Chemical compound C1CS1 VOVUARRWDCVURC-UHFFFAOYSA-N 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 239000002966 varnish Substances 0.000 description 3
- 229910052727 yttrium Inorganic materials 0.000 description 3
- FIDRAVVQGKNYQK-UHFFFAOYSA-N 1,2,3,4-tetrahydrotriazine Chemical compound C1NNNC=C1 FIDRAVVQGKNYQK-UHFFFAOYSA-N 0.000 description 2
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 2
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 2
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 2
- CPXAVMWHYAGLNU-UHFFFAOYSA-N 2-(2-decoxypropoxy)propan-1-ol Chemical compound CCCCCCCCCCOC(C)COC(C)CO CPXAVMWHYAGLNU-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- OJGMBLNIHDZDGS-UHFFFAOYSA-N N-Ethylaniline Chemical compound CCNC1=CC=CC=C1 OJGMBLNIHDZDGS-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 125000003302 alkenyloxy group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N anhydrous diethylene glycol Natural products OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 2
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 2
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229930004069 diterpene Natural products 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 150000003222 pyridines Chemical group 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- RRBGTUQJDFBWNN-MUGJNUQGSA-N (2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-2,6-diaminohexanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoic acid Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O RRBGTUQJDFBWNN-MUGJNUQGSA-N 0.000 description 1
- KNDQHSIWLOJIGP-UMRXKNAASA-N (3ar,4s,7r,7as)-rel-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione Chemical compound O=C1OC(=O)[C@@H]2[C@H]1[C@]1([H])C=C[C@@]2([H])C1 KNDQHSIWLOJIGP-UMRXKNAASA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- CWZQYRJRRHYJOI-UHFFFAOYSA-N 1,1,1-trimethoxydecane Chemical compound CCCCCCCCCC(OC)(OC)OC CWZQYRJRRHYJOI-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- LORRLQMLLQLPSJ-UHFFFAOYSA-N 1,3,5-trithiane Chemical compound C1SCSCS1 LORRLQMLLQLPSJ-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DQVRVXRIKVWXQH-UHFFFAOYSA-N 1,8-bis(oxiran-2-yl)-4,6-bis(oxiran-2-ylmethyl)octane-3,5-diol Chemical compound C1OC1CC(C(O)C(CCC1OC1)CC1OC1)C(O)CCC1CO1 DQVRVXRIKVWXQH-UHFFFAOYSA-N 0.000 description 1
- ANFXTILBDGTSEG-UHFFFAOYSA-N 1-methyl-4,5-dihydroimidazole Chemical compound CN1CCN=C1 ANFXTILBDGTSEG-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- RQZUWSJHFBOFPI-UHFFFAOYSA-N 2-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COCC1CO1 RQZUWSJHFBOFPI-UHFFFAOYSA-N 0.000 description 1
- SKIIKRJAQOSWFT-UHFFFAOYSA-N 2-[3-[1-(2,2-difluoroethyl)piperidin-4-yl]oxy-4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound FC(CN1CCC(CC1)OC1=NN(C=C1C=1C=NC(=NC=1)NC1CC2=CC=CC=C2C1)CC(=O)N1CC2=C(CC1)NN=N2)F SKIIKRJAQOSWFT-UHFFFAOYSA-N 0.000 description 1
- ZDNUPMSZKVCETJ-UHFFFAOYSA-N 2-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=C(C=2OCCN=2)C=C1 ZDNUPMSZKVCETJ-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- BEFWKRMPVGUNOB-UHFFFAOYSA-N 2-chloro-3-methyloxirene Chemical compound CC1=C(Cl)O1 BEFWKRMPVGUNOB-UHFFFAOYSA-N 0.000 description 1
- ODXYTQJKEFUIRN-UHFFFAOYSA-N 3-[(diethoxyamino)-ethoxyamino]propan-1-amine Chemical compound NCCCN(N(OCC)OCC)OCC ODXYTQJKEFUIRN-UHFFFAOYSA-N 0.000 description 1
- 229940018563 3-aminophenol Drugs 0.000 description 1
- AOCFYLGZVCPZML-UHFFFAOYSA-N 3-benzyl-1h-imidazole-2-thione Chemical compound S=C1NC=CN1CC1=CC=CC=C1 AOCFYLGZVCPZML-UHFFFAOYSA-N 0.000 description 1
- GXEPXBHZRCFMMC-UHFFFAOYSA-N 3-benzylbenzene-1,2-diamine Chemical compound NC1=CC=CC(CC=2C=CC=CC=2)=C1N GXEPXBHZRCFMMC-UHFFFAOYSA-N 0.000 description 1
- 125000004829 3-ethylpropylene group Chemical group [H]C([H])([H])C([H])([H])C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- IBOFVQJTBBUKMU-UHFFFAOYSA-N 4,4'-methylene-bis-(2-chloroaniline) Chemical compound C1=C(Cl)C(N)=CC=C1CC1=CC=C(N)C(Cl)=C1 IBOFVQJTBBUKMU-UHFFFAOYSA-N 0.000 description 1
- GNPSQUCXOBDIDY-UHFFFAOYSA-N 4-(trimethoxymethyl)dodecane Chemical compound C(CCCCCCC)C(C(OC)(OC)OC)CCC GNPSQUCXOBDIDY-UHFFFAOYSA-N 0.000 description 1
- CXXSQMDHHYTRKY-UHFFFAOYSA-N 4-amino-2,3,5-tris(oxiran-2-ylmethyl)phenol Chemical compound C1=C(O)C(CC2OC2)=C(CC2OC2)C(N)=C1CC1CO1 CXXSQMDHHYTRKY-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 1
- DBTPMQIQJZFVAB-UHFFFAOYSA-N 4-phenyl-4,5-dihydro-1,3-oxazole Chemical compound C1OC=NC1C1=CC=CC=C1 DBTPMQIQJZFVAB-UHFFFAOYSA-N 0.000 description 1
- DPMGLJUMNRDNMX-UHFFFAOYSA-N 4-tert-butyl-2-[2-(4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl)propan-2-yl]-4,5-dihydro-1,3-oxazole Chemical compound CC(C)(C)C1COC(C(C)(C)C=2OCC(N=2)C(C)(C)C)=N1 DPMGLJUMNRDNMX-UHFFFAOYSA-N 0.000 description 1
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 1
- TYOXIFXYEIILLY-UHFFFAOYSA-N 5-methyl-2-phenyl-1h-imidazole Chemical compound N1C(C)=CN=C1C1=CC=CC=C1 TYOXIFXYEIILLY-UHFFFAOYSA-N 0.000 description 1
- YXALYBMHAYZKAP-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]heptan-4-ylmethyl 7-oxabicyclo[4.1.0]heptane-4-carboxylate Chemical compound C1CC2OC2CC1C(=O)OCC1CC2OC2CC1 YXALYBMHAYZKAP-UHFFFAOYSA-N 0.000 description 1
- 241000193006 Aphrodita Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- CUEVCRFQRQFRTA-UHFFFAOYSA-N C(C1CO1)OCCCC(C(OCC)(OCC)CCCCCCCCCC)CCCCCCCC Chemical compound C(C1CO1)OCCCC(C(OCC)(OCC)CCCCCCCCCC)CCCCCCCC CUEVCRFQRQFRTA-UHFFFAOYSA-N 0.000 description 1
- DLPJEOLFKCEWJM-UHFFFAOYSA-N C(C1CO1)OCCCC(CCCCCCCCC)(OCCCCCCCCCC)CCCCCCCCCC Chemical compound C(C1CO1)OCCCC(CCCCCCCCC)(OCCCCCCCCCC)CCCCCCCCCC DLPJEOLFKCEWJM-UHFFFAOYSA-N 0.000 description 1
- ZCTISQOKAOLVCD-UHFFFAOYSA-N COC(C(OC)(OC)OC)(CCCCCCCC)CCC.SCC=C Chemical compound COC(C(OC)(OC)OC)(CCCCCCCC)CCC.SCC=C ZCTISQOKAOLVCD-UHFFFAOYSA-N 0.000 description 1
- KSSJBGNOJJETTC-UHFFFAOYSA-N COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC Chemical compound COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC KSSJBGNOJJETTC-UHFFFAOYSA-N 0.000 description 1
- 229920013683 Celanese Polymers 0.000 description 1
- PQIRIBDHYAWKDJ-UHFFFAOYSA-N ClCCCC(CCCCCCCCC)OCCCCCCCCCCCCC Chemical compound ClCCCC(CCCCCCCCC)OCCCCCCCCCCCCC PQIRIBDHYAWKDJ-UHFFFAOYSA-N 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 102100028630 Cytoskeleton-associated protein 2 Human genes 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical group OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 101000766848 Homo sapiens Cytoskeleton-associated protein 2 Proteins 0.000 description 1
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 1
- 241000502522 Luscinia megarhynchos Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- XJDCHDFUMGSEHD-UHFFFAOYSA-N NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCCC(C(OC)(OC)OC)CCCCCCCC XJDCHDFUMGSEHD-UHFFFAOYSA-N 0.000 description 1
- NSLCUJWUWZQKPT-UHFFFAOYSA-N N[NH3+].[O-]C(=O)C1=CC=CC2=CC=CC=C12 Chemical class N[NH3+].[O-]C(=O)C1=CC=CC2=CC=CC=C12 NSLCUJWUWZQKPT-UHFFFAOYSA-N 0.000 description 1
- 239000004988 Nematic liquid crystal Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- FQYUMYWMJTYZTK-UHFFFAOYSA-N Phenyl glycidyl ether Chemical compound C1OC1COC1=CC=CC=C1 FQYUMYWMJTYZTK-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- KVIXPDSTVUISDR-UHFFFAOYSA-N SC(C(=O)N)S.NN Chemical compound SC(C(=O)N)S.NN KVIXPDSTVUISDR-UHFFFAOYSA-N 0.000 description 1
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical compound C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005089 alkenylaminocarbonyl group Chemical group 0.000 description 1
- 125000005090 alkenylcarbonyl group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000005095 alkynylaminocarbonyl group Chemical group 0.000 description 1
- 125000005133 alkynyloxy group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- YJXGADCZMLHGLV-UHFFFAOYSA-N aniline;pyridine Chemical group C1=CC=NC=C1.NC1=CC=CC=C1 YJXGADCZMLHGLV-UHFFFAOYSA-N 0.000 description 1
- 150000001448 anilines Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 125000005100 aryl amino carbonyl group Chemical group 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical group C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 description 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003426 co-catalyst Substances 0.000 description 1
- 235000020057 cognac Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000002993 cycloalkylene group Chemical group 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- ZWAJLVLEBYIOTI-UHFFFAOYSA-N cyclohexene oxide Chemical compound C1CCCC2OC21 ZWAJLVLEBYIOTI-UHFFFAOYSA-N 0.000 description 1
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohexene oxide Natural products O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 1
- HHNHBFLGXIUXCM-GFCCVEGCSA-N cyclohexylbenzene Chemical compound [CH]1CCCC[C@@H]1C1=CC=CC=C1 HHNHBFLGXIUXCM-GFCCVEGCSA-N 0.000 description 1
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 1
- OCDXZFSOHJRGIL-UHFFFAOYSA-N cyclohexyloxycyclohexane Chemical group C1CCCCC1OC1CCCCC1 OCDXZFSOHJRGIL-UHFFFAOYSA-N 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical group C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- PZBQKYMKJRPBDB-UHFFFAOYSA-N decanoate;decylazanium Chemical compound CCCCCCCCCC[NH3+].CCCCCCCCCC([O-])=O PZBQKYMKJRPBDB-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000006612 decyloxy group Chemical group 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000004427 diamine group Chemical group 0.000 description 1
- BEQZMQXCOWIHRY-UHFFFAOYSA-H dibismuth;trisulfate Chemical compound [Bi+3].[Bi+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O BEQZMQXCOWIHRY-UHFFFAOYSA-H 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
- WOERBKLLTSWFBY-UHFFFAOYSA-M dihydrogen phosphate;tetramethylazanium Chemical compound C[N+](C)(C)C.OP(O)([O-])=O WOERBKLLTSWFBY-UHFFFAOYSA-M 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical compound C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000005685 electric field effect Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RBBXSUBZFUWCAV-UHFFFAOYSA-N ethenyl hydrogen sulfite Chemical compound OS(=O)OC=C RBBXSUBZFUWCAV-UHFFFAOYSA-N 0.000 description 1
- 150000003947 ethylamines Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- ANSXAPJVJOKRDJ-UHFFFAOYSA-N furo[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1=C2C(=O)OC(=O)C2=CC2=C1C(=O)OC2=O ANSXAPJVJOKRDJ-UHFFFAOYSA-N 0.000 description 1
- 108700039708 galantide Proteins 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 1
- MSTLSCNJAHAQNU-UHFFFAOYSA-N heptylcyclohexane Chemical compound CCCCCCCC1CCCCC1 MSTLSCNJAHAQNU-UHFFFAOYSA-N 0.000 description 1
- PGFXOWRDDHCDTE-UHFFFAOYSA-N hexafluoropropylene oxide Chemical compound FC(F)(F)C1(F)OC1(F)F PGFXOWRDDHCDTE-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000006289 hydroxybenzyl group Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- 150000002537 isoquinolines Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- CWLKGDAVCFYWJK-UHFFFAOYSA-N m-Aminophenol Natural products NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- NZGGUIFHFVGRKD-UHFFFAOYSA-N n,n,2-tribromo-3,4-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CC1=C(Br)C(N(Br)Br)=CC=C1CC1CO1 NZGGUIFHFVGRKD-UHFFFAOYSA-N 0.000 description 1
- FXJADUPVIYKCMH-UHFFFAOYSA-N n,n-bis(sulfanyl)aniline Chemical compound SN(S)C1=CC=CC=C1 FXJADUPVIYKCMH-UHFFFAOYSA-N 0.000 description 1
- JJWRKQIITDNSSJ-UHFFFAOYSA-N n,n-didecylaniline Chemical compound CCCCCCCCCCN(CCCCCCCCCC)C1=CC=CC=C1 JJWRKQIITDNSSJ-UHFFFAOYSA-N 0.000 description 1
- YWWNNLPSZSEZNZ-UHFFFAOYSA-N n,n-dimethyldecan-1-amine Chemical compound CCCCCCCCCCN(C)C YWWNNLPSZSEZNZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- XJINZNWPEQMMBV-UHFFFAOYSA-N n-methylhexan-1-amine Chemical compound CCCCCCNC XJINZNWPEQMMBV-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 150000005209 naphthoic acids Chemical class 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- 239000010955 niobium Substances 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- AFEQENGXSMURHA-UHFFFAOYSA-N oxiran-2-ylmethanamine Chemical compound NCC1CO1 AFEQENGXSMURHA-UHFFFAOYSA-N 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- MTZWHHIREPJPTG-UHFFFAOYSA-N phorone Chemical compound CC(C)=CC(=O)C=C(C)C MTZWHHIREPJPTG-UHFFFAOYSA-N 0.000 description 1
- 229930193351 phorone Natural products 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000007517 polishing process Methods 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 150000004032 porphyrins Chemical group 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- ZTILHLWDFSMCLZ-UHFFFAOYSA-N prop-2-enylhydrazine Chemical compound NNCC=C ZTILHLWDFSMCLZ-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000009537 qingyi Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003248 quinolines Chemical group 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 102220054046 rs138638048 Human genes 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
- 108010061115 tetralysine Proteins 0.000 description 1
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical group C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nonlinear Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Liquid Crystal (AREA)
Abstract
Description
200813158 24843pif , 九、發明說明: 【發明所屬之技術領域】 本發明是關於一種液晶配向劑、由該液晶配向劑所形 成之液晶配向膜、以及具備該液晶配向膜之液晶顯示元 件,上述液晶配向劑是將選自聚醯胺酸及該聚醯胺酸的衍 生物中的至少1個聚合物、與烯基取代納迪克酸醯亞胺 (nadimide )(即,内_5_降冰片烯_2,3_二曱醯亞胺 r ( Endo_5-norbornene_l 3-dicarboximide ))化合物以及具有 特定雜環結構的雜環化合物中的至少丨種加以紐合面成之 改良劑溶解於溶劑中而形成。 【先前技術】 液晶顯示元件,目前使用於以筆記型電腦及桌上型電 腦,顯不器為代表之、攝影機的視野取景器、投影型顯示 态等各種液晶顯示裝置中,最近亦逐漸應用於電視。進而, 亦用於光列印機頭、光傅立葉轉換元件、光閥(light vdve) 等與光電子學有關的元件。 I 1液晶顯示元件通常具有:(1)對向配置之一對基板、(2) 於刚述一對基板各自相對面的一面或兩面上所形成之電 極、/3)於丽述一對基板各自的相對面上所形成之液晶配 向膜、以及(4)於前述一對基板間所形成之液晶層。 作為先前的液晶顯示元件,其主流是使用向列液晶 (nematic liquid crystal)之顯示元件,目前正在將(1)進 行90度扭轉之TN (Twisted Nematic,扭轉向列型)型液 晶頭示元件、(2)通常進行18〇度以上扭轉之stn (Super 6 200813158 24843pif[Technical Field] The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film formed of the liquid crystal alignment agent, and a liquid crystal display element including the liquid crystal alignment film, wherein the liquid crystal alignment The agent is at least one polymer selected from the group consisting of polylysine and a derivative of the polyaminic acid, and an alkenyl group substituted with nadimide (ie, inner _5_norbornene _ At least an anthracene of a compound having a specific heterocyclic structure and a heterocyclic compound having a specific heterocyclic structure are formed by dissolving a modifier in a solvent in a solvent. [Prior Art] The liquid crystal display device is currently used in various liquid crystal display devices such as a notebook computer and a desktop computer, a display device, a viewfinder of a camera, and a projection display state. TV. Furthermore, it is also used in optoelectronics related components such as optical printer heads, optical Fourier transform elements, and light vdve. The I 1 liquid crystal display element generally has: (1) one pair of substrates disposed opposite to each other, (2) electrodes formed on one or both surfaces of opposite surfaces of the pair of substrates, and/or a pair of substrates a liquid crystal alignment film formed on each of the opposing faces, and (4) a liquid crystal layer formed between the pair of substrates. As a conventional liquid crystal display element, the mainstream is a display element using a nematic liquid crystal, and (1) a TN (Twisted Nematic) type liquid crystal head element which is twisted at 90 degrees, (2) usually perform a twist of 18 degrees or more (Super 6 200813158 24843pif
Twisted Nematic ’超扭轉向列型)型液晶顯示元件、(3) 使用/π膜%曰日體之所謂丁FT ( Thin Film Transistor,薄膜電 晶體)型液晶顯示元件實用化。這些液晶顯示元件,可適 當地看見圖像之視角較窄,具有以下缺點:當從斜方向看 時壳度及對比度下降以及產生半色調中的亮度反轉。A Twisted Nematic 'super-twisted type liquid crystal display element', and (3) a so-called FT (Thin Film Transistor) type liquid crystal display element using a /π film %曰. These liquid crystal display elements can appropriately see that the angle of view of the image is narrow, and have the following drawbacks: when the oblique direction is viewed, the shellness and contrast are lowered and the brightness inversion in the halftone is generated.
近年來’藉由(1 )使用光學補償膜之TN— TFT型液 晶顯不兀件、(2 )使用垂直配向及光學補償膜之VA f ( ^^腦1 Ali§nment,垂直配向)型液晶顯示元件、(3) 將垂直配向與突起構造物技術併用之MVA (Mulii D〇main Vertical Alignment,多域垂直配向)型液晶顯示元件、或 者⑷橫向電場效應方式之IPS (In_piane 8以她_, 共平面切換)型液晶顯示元件、(5) ECB (Electrically Controlled Birefringence,電場控制雙折射效應)型液晶顯 示元件、(6)光學補償彎曲(0pticallyC〇mpensatedBend 或者 Optically self—Compensated Birefringence (光學自補 償雙折射);OCB)型液晶顯示元件等技術對該視角的問 ί 題進行改良,且將經改良的技術實用化或者對其進行研究。 液晶顯示元件的技術發展,並不是僅藉由這些驅動方 式及元件結構的改良’而且亦豬由液晶顯示元件所使用的 構成部件的改良而達成。於液晶顯示元件所使用之構成部 件中,尤其是液晶配向膜,是與液晶顯示元件的顯示品質 相關的重要因素之一,伴隨液晶顯示元件的高品質化液晶 配向膜的作用變得愈發重要。 液晶配向膜是由液晶配向劑而製備。目前,主要使用 7 200813158 24843pif ^所谓液晶配向劑’是指將聚醯胺酸或者可溶性聚醯亞胺 於有機溶劑之溶液。藉由將如此之溶液塗佈於基板上 膜進行加熱等方法’將其成膜而形成聚醯亞胺系配向 究|^者亦對除聚酿胺酸以外的各種液晶配向劑進行了研 但就耐熱性、耐化學藥品性(耐液晶性)、塗佈性、液 工向丨生、電氣特性、光學特性、顯示特性等方面而言, 成乎未實用化。In recent years, '(1) TN-TFT type liquid crystal display using optical compensation film, (2) VA f (^^ brain 1 Ali§nment, vertical alignment) type liquid crystal using vertical alignment and optical compensation film Display element, (3) MVA (Mulii D〇 main Vertical Alignment) type liquid crystal display element using vertical alignment and protrusion structure technology, or (4) IPS of transverse electric field effect mode (In_piane 8 by her_, Coplanar switching type liquid crystal display element, (5) ECB (Electrically Controlled Birefringence) type liquid crystal display element, (6) optically compensated bending (0ptically C〇mpensated Bend or Optically self-Compensated Birefringence) Techniques such as refracting; OCB) type liquid crystal display elements improve the problem of the viewing angle, and the improved technique is put to practical use or research. The technical development of the liquid crystal display element is not only achieved by the improvement of these driving modes and element structures, but also by the improvement of the components used for the liquid crystal display element. Among the constituent members used for the liquid crystal display element, in particular, the liquid crystal alignment film is one of the important factors related to the display quality of the liquid crystal display element, and the role of the liquid crystal display element in improving the quality of the liquid crystal alignment film becomes more and more important. . The liquid crystal alignment film is prepared from a liquid crystal alignment agent. At present, the main use of 7 200813158 24843pif ^liquid crystal alignment agent 'refers to a solution of poly-proline or soluble polyimine in an organic solvent. By applying such a solution to a film on a substrate and heating it, a method of forming a film to form a polyimine-based alignment method has also been studied for various liquid crystal alignment agents other than poly-aramidic acid. It has not been put into practical use in terms of heat resistance, chemical resistance (liquid crystal resistance), coating properties, liquid-phase growth, electrical properties, optical properties, display properties, and the like.
要失作為用以提高液晶顯示元件顯示品質的液晶配向膜所 巾貞期^要特性,可舉A離子密度。絲子密度低,則於 常的二^加給液晶的電壓下降,結果造成亮度下降、對正 初期S’顯不造成f響。另外,存在以下問題:例如即使 期可土雖子控度較咼’但經高溫加速試驗後的離子密度(長 」#性)亦會下降。 決前述問題之嘗試,最近業者提出有若干方法。 個以上取已A I ^^用以形成液晶配向膜的物性不同的二 參照專合而包含之聚_酸組合物(例如 分、鱼、jn:包含包含聚酿胺酸及聚醯胺的聚合物成 =劑之清漆組合物(例如參照專利文獻3)。 酸胺、有t3物性不同的三個以上聚醯胺酸及聚 狀清·合物(例如參照翻文獻4)。 子材料有’包含南分子材料之清漆組合物,該高分 胺酸(:二冓的二胺化合物而合成之聚醯 8 200813158 Ζ464^ρΐΤ (5)已知有,於聚醯亞胺及聚醯胺酸清漆中添加低分 子環氧樹脂之技術(例如參照專利文獻6)。 另外,業者提出有幾種謀求解決以下課題之技術:該 課題包含藉由於聚醯胺酸中添加添加劑而改善液晶顯示元 件的性能。作為如此之技術,例如可舉出:包含聚醯胺酸 及具有嗓嘻(oxazine )結構或。惡吐蛛(〇xazine)結構的硬 化促進劑之液晶配向劑(例如參照專利文獻7)、包含聚醯 胺酸及烯基取代納迪克酸醯亞胺化合物之液晶配向劑(例 如參照專利文獻8及9 )、以及包含聚醯胺酸及含環氧基化 合物之液晶配向劑(例如參照專利文獻1〇及η)。 ”另外,業者亦提出有以下若干技術,這些技術是謀求 %决ig藉由於光配向用化合物中添加添加劑而改善液晶 顯示元件的性能之課題。作為如此之技術,例如可i出: 包含二色性分子及具有二酿亞胺基作為自由基聚合性基的 化合物之光配向用組合物(例如參照專利文獻12)。The characteristics of the liquid crystal alignment film to improve the display quality of the liquid crystal display element are as follows. When the filament density is low, the voltage applied to the liquid crystal is lowered in the normal temperature, and as a result, the brightness is lowered, and the initial S' is not caused to f-sound. In addition, there is a problem that, for example, even if the soil is more controllable, the ion density (length) after the high-temperature accelerated test is also lowered. In the attempt to solve the above problems, the industry has recently proposed a number of methods. More than one of the poly-acid compositions containing AI ^^ used to form a liquid crystal alignment film with different physical properties (for example, fish, jn: a polymer comprising polyacrylic acid and polyamine) The varnish composition of the agent (for example, refer to Patent Document 3). Acid amine, three or more polylysines having different physical properties of t3, and a poly-clear compound (for example, refer to Document 4). A varnish composition of a southern molecular material, the polyamino acid (the diamine compound synthesized by the diterpene diamine compound) is known to be used in polyimine and polyamic acid varnishes. A technique of adding a low molecular weight epoxy resin (for example, refer to Patent Document 6). Further, there have been several techniques for solving the following problems: This problem includes improving the performance of a liquid crystal display device by adding an additive to polyamic acid. As such a technique, for example, a liquid crystal alignment agent containing a polyamic acid and a hardening accelerator having an oxazine structure or an ox xazine structure (for example, see Patent Document 7) Polylysine and alkenyl A liquid crystal alignment agent (for example, refer to Patent Documents 8 and 9) and a liquid crystal alignment agent containing a polyphthalic acid and an epoxy group-containing compound (for example, refer to Patent Documents 1 and η). In addition, the company has also proposed a number of techniques for improving the performance of liquid crystal display elements by adding an additive to a compound for photo-alignment. As such a technique, for example, it is possible to include dichroism. A composition for photo-alignment of a molecule and a compound having a bis-imino group as a radical polymerizable group (for example, see Patent Document 12).
然而,利用這些先前技術,無法充分解決離 ,,可靠性的問題。例如,專利文獻7中,對於g、; :曰時的酸亞胺化中進行蒸發、昇華、分解,:使 軋知!·生所k成之影響,卻未進行研However, with these prior art techniques, the problem of separation and reliability cannot be fully solved. For example, in Patent Document 7, evaporation, sublimation, and decomposition are carried out in the acid imidization at the time of g: :, and the effect of the rolling is not affected.
的吸:專利文獻11中’問題亦包含對離子性雜質 貫施例中記載有所製作液晶顯示元件的電S 期的電厂蝴轉與歷時性的離子密度卻無關:!:般;: 9 200813158 24843pif 其原因在於:離子性雜質, 含於元件之中,而且例如亦由==作液晶顯示元件時包 液晶分解喊生離子性„由^=晶齡元件運行的 般認為,吸附離子性雜質之專,歷日守性變化。因此’— 低製作液晶顯示元件時元件^^獻:1的技術,可有效降 抑制離子性雜f的歷時 3的=性雜質,然而於 究。 X生方面仍需進行進一步的研In the case of Patent Document 11, the problem also includes that the power plant in which the liquid crystal display element is produced in the ionic impurity is not related to the diachronic ion density in the case of the ionic impurity: 200813158 24843pif The reason is that ionic impurities are contained in the components, and, for example, when the liquid crystal display element is used as the liquid crystal display element, the liquid crystal is decomposed and shattered, and the ionic property is considered to be caused by the operation of the element. The specialization, the sacred change of the calendar. So - low production of liquid crystal display components when the components ^ ^: 1 technology, can effectively reduce the ionic impurity f of the duration of the 3 = impurities, however, X. Further research is still needed
=文乂】曰本專利特開平u,345號公報 ί直日本專利特開平n — 193347號公報 【專利文獻3】國際公開〇〇/61684號手冊 【專利文獻4】國際公開〇1/〇〇〇733號手冊 5專利文獻5】日本專利特開雇-16263〇號公報 【專利文獻6】日本專利特開細_189謂號公報 【專利文獻7】曰本專利特開平9_3〇2225號公報 【專利文獻8】日本專利特開2〇〇4一341〇3〇號公報 【專利文獻9】日本專利特開平9_269491號公報 【專利文獻ίο】日本專利特開平7一23441〇號公報 【專利文獻11】日本專利特開2〇〇2一3237〇1號公報 【專利文獻12】日本專利特開2〇〇3 —27〇638號公報 考慮到上述狀況,業者期望開發出對伴隨離子密度及 離子密度歷時性變化的電氣特性之長期可#性問題加ς改 善之液晶顯示元件用液晶配向劑、使用該液晶配向劑而形 成之液晶配向膜、以及具備該液晶配向膜之液晶顯示元件。 【發明内容】 10 200813158 24843pif ㈣本發明者們為解決前述課題而進行了努力研究。結果 於具備如下的液晶配向膜之液晶顯示元件中,可賦 人、==子密歧錢可靠性:該液晶配㈣是使用包 3、 |酏胺酸及該聚醯胺酸的衍生物中的至少1個聚合 物進而包含將烯基取代納迪克酸醯亞胺化合物盥 ㈣氧乙燒,xirane)、氧環丁qoxetan/)、1喃 =irane)、氮丙.定(aziridine)、σ惡唾琳、及嚼嗪結構的乂 乂 乂 专利 专利 , , , , , , , 日本 日本 日本 193 193 193 193 193 193 193 193 193 193 193 193 193 193 193 193 193 193 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 〇 733 manual 5 patent document 5] Japanese Patent Laid-Open No. Hei-16263 No. [Patent Document 6] Japanese Patent Laid-Open Publication No. _189-No. [Patent Document 7] Japanese Patent Laid-Open No. Hei 9_3〇2225 Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei 9-269491. Japanese Patent Laid-Open Publication No. Hei. No. Hei. No. Hei. No. Hei. No. 2, No. 2-27-638. A liquid crystal alignment agent for a liquid crystal display element, a liquid crystal alignment film formed using the liquid crystal alignment agent, and a liquid crystal display element including the liquid crystal alignment film, which have been improved over a long period of time. . [Description of the Invention] 10 200813158 24843pif (4) The present inventors have made an effort to solve the above problems. As a result, in the liquid crystal display element having the liquid crystal alignment film as follows, it is possible to give a person, == sub-compliance reliability: the liquid crystal distribution (4) is in the use of the package 3, |proline and the derivative of the poly-proline At least one polymer further comprises an alkenyl-substituted nadic acid ylide imine compound 盥 (tetra) oxythiazepine, xirane), oxocyclobutanol (qoxetan), 1 arane = irane), aziridine, σ Aphrodite, and chewable structure
=口物中的至少1種加以組合而成的改良劑之液晶配向 衣作而成,而完成本發明。 、進而發現,可將藉由適當選擇前述聚醯胺酸且使用前 述液阳配向劑而製作之液晶配向膜,適當地應用於各種顯 示驅動方式之液晶顯示元件中。 、 本發明包含以下構成。 [1]一種液晶配向劑,液晶配向劑是包含聚醯胺酸或其 衍生物、烯基取代納迪克酸醯亞胺化合物、及雜環化合物 之液晶配向劑, 其特徵在於:雜環化合物具有選自以環氧乙统 (oxirane)、氧環丁烷(oxetane)、噻喃(thiirane)、氮丙 咬(aziridine)、噁唑啉、及噁嗪所組成之族群的一個或二 個以上的雜環結構。 [2]如第[1]項所述之液晶配向劑,其特徵在於··稀基取 代納迪克酸醯亞胺化合物是以下述通式(Ina)所表示之 化合物。 [化1] 200813158 24843pifThe liquid crystal alignment of at least one of the modifiers in which a combination of the modifiers is combined to complete the present invention. Further, it has been found that a liquid crystal alignment film produced by appropriately selecting the polyamic acid and using the above liquid cation-aligning agent can be suitably applied to liquid crystal display elements of various display driving methods. The present invention includes the following constitution. [1] A liquid crystal alignment agent which is a liquid crystal alignment agent comprising polylysine or a derivative thereof, an alkenyl-substituted nadic acid ruthenium imine compound, and a heterocyclic compound, characterized in that the heterocyclic compound has One or more selected from the group consisting of oxirane, oxetane, thiirane, aziridine, oxazoline, and oxazine Heterocyclic structure. [2] The liquid crystal alignment agent according to [1], wherein the dilute group-substituted nadic acid ylide compound is a compound represented by the following formula (Ina). [Chemical 1] 200813158 24843pif
,式(Ina)巾,RlR2分別表示氯、碳數卜12 =其碳數3〜6的烯基、碳數5〜8的環烷基、芳基、 或者卞基,η表示丨〜2的整數;並且於n==1時,r3表示 碳數1〜12的烧基、碳數5〜δ的環、碳數“Η的芳 基、节基、以-(CqH2q>〇r(QH2rG)u_CsH2s+] (q、^、s 分別 表示2〜6的整數,t表示〇或i,u表示卜孙的整數) 所表示之聚氧伸烷基烷基、以_(R)v_C6H4_R4(v表示〇或卜 R表示碳數1〜4的伸烷基、R4表示氫或碳數}〜4的烷基) 所表示之基、以_C6H4-T-C6H5 (T 表示_ch2…-c(CH3)2、 -CO-、-S-或者-SCV)所表示之基、或者這些基的與芳香 環直接健結的1〜3個氫被羥基取代之基;於n = 2時,R3 表示碳數2〜20的伸烷基、碳數5〜8的伸環烷基 (cycloalkylene)、a_(CqH2qO)t_(CrH2r〇VCsH2s_ (q、r、s 分別表示2〜6的整數,t表示0或1,u表示1〜3〇的整 數)所表示之聚氧伸烷基、碳數6〜12的伸芳基(arylene)、 以-⑻V-C6H4-R5- (V表示0或1,R及R5分別表示碳數1 〜4的伸烷基或者碳數5〜8的環伸烷基)所表示之基、以 -C6H4-T-C6H4· ( T 表示-CH2-、-C(CH3)2-、-CO-、-〇-、 -OC6H4_C(CH3)2_C6H4〇_、_S-、或者-S〇2_)所表示之基、 12 200813158 24843pif 或者這些基的與芳香環直接鍵結的1〜3個氫被經基取代 之基。 [3]如第[2]項所述之液晶配向劑,其特徵在於:烯基取 代納迪克酸醯亞胺化合物包含以下述結構式(工na— 1 )〜 (I na—3)所表示化合物中的一個或二個以上。 [化2], (Ina) towel, RlR2 respectively represents chlorine, carbon number 12 = alkenyl group having 3 to 6 carbon atoms, cycloalkyl group having 5 to 8 carbon atoms, aryl group or fluorenyl group, and η represents 丨~2 An integer; and when n==1, r3 represents a carbon number of 1 to 12, a carbon number of 5 to δ, a carbon number of "an aryl group, a benzyl group, and a -(CqH2q> 〇r(QH2rG)" u_CsH2s+] (q, ^, s represent an integer of 2 to 6, respectively, t represents 〇 or i, u represents an integer of Busun). The polyoxyalkylene alkyl group represented by _(R)v_C6H4_R4 (v represents 〇 Or R represents a group of a C 1 to 4 alkyl group, R 4 represents a hydrogen or a C 1 to 4 alkyl group, and _C6H4-T-C6H5 (T represents _ch2...-c(CH3) 2. A group represented by -CO-, -S- or -SCV), or a group in which 1 to 3 hydrogens directly bonded to an aromatic ring are substituted with a hydroxyl group; when n = 2, R3 represents a carbon number 2 to 20 alkylene, cycloalkylene having 5 to 8 carbon atoms, a_(CqH2qO)t_(CrH2r〇VCsH2s_ (q, r, s represent an integer of 2 to 6, respectively, and t represents 0 or 1) , u represents a polyoxyalkylene group represented by an integer of 1 to 3 Å, an arylene having a carbon number of 6 to 12, and -(8)V-C6H4-R5- (V represents 0 or 1, and R and R5 respectively represent an alkyl group having 1 to 4 carbon atoms or a cycloalkyl group having 5 to 8 carbon atoms), and -C6H4-T-C6H4· (T represents - The base represented by CH2-, -C(CH3)2-, -CO-, -〇-, -OC6H4_C(CH3)2_C6H4〇_, _S-, or -S〇2_), 12 200813158 24843pif or the The liquid crystal alignment agent according to the item [2], wherein the alkenyl-substituted nadic acid ruthenium imide compound comprises the following: One or more of the compounds represented by the structural formula (Working Na-1)~(Ina-3).
[4] 如第[1]至[3]項所述之液晶配向劑,其特徵在於: 包含相對於聚醯胺酸或其衍生物100重量份為1〜1〇〇重量 份(以總量計)之烯基取代納迪克酸醯亞胺化合物。 [5] 如第[1]至[4]項所述之液晶配向劑,其特徵在於: 雜環化合物包含具有二個以上4彡衣結構的化合物’液晶配 向劑包含相對於聚醯胺酸或其衍生物1⑻重量份為1〜1〇〇 重量份(以總量計)之化合物。 13 200813158 24843pif [6] 如第[1]至[5]項所述之液晶配向劑, 聚醯胺酸或其衍生物,錢作滅成分的四融=在於: 為胺成分的二胺反應而獲得之聚醯胺酸。 欠〜酐與作 [7] 如第[6]項所述之液晶配向劑,其特徵在 包含A成分及B成分,酸的a成分包含芳香族§欠成分 酐,芳香族四賴二酐為選自以下述結構式(ι )'、=酸二 〜(7)及(14)所組成之族群中的一個或二個以、(5) 物。 上之化合 「化31[4] The liquid crystal alignment agent according to [1] to [3], which is characterized in that it contains 1 to 1 part by weight based on 100 parts by weight of the polyaminic acid or its derivative (in total amount) Alkenyl substituted nadic acid ylide imine compound. [5] The liquid crystal alignment agent according to [1] to [4], wherein the heterocyclic compound comprises a compound having two or more four coat structures, and the liquid crystal alignment agent comprises or is relative to polyamic acid or 1 (8) parts by weight of the derivative thereof is a compound of 1 to 1 part by weight (based on the total amount). 13 200813158 24843pif [6] The liquid crystal alignment agent according to [1] to [5], poly-amic acid or a derivative thereof, and the tetra-red melting of the money as a component is: a diamine reaction for the amine component The polylysine obtained. [7] The liquid crystal alignment agent according to [6], which is characterized in that it contains an A component and a B component, and the acid component a contains an aromatic § under-reagent, and the aromatic tetra- lysine is It is selected from one or two of the groups consisting of the following structural formula (ι)', = acid two (7) and (14), and (5). The combination of the above
[8] 如第[7]項所述之液晶配向劑,其特徵在於:芳香族 四叛酸二酐為結構式(1)之化合物。 [9] 如第[7]或[8]項所述之液晶配向劑,其特徵在於: 酸的B成分包含脂肪族四羧酸二酐及脂環式四羧酸二酐中 的任一個或二個。 [10] 如第[9]項所述之液晶配向劑,其特徵在於··脂肪 族四羧酸二酐及脂環式四羧酸二酐,為選自以下述結構式 14 200813158 24843pif[8] The liquid crystal alignment agent according to [7], wherein the aromatic tetra-retensive dianhydride is a compound of the structural formula (1). [9] The liquid crystal alignment agent according to [7] or [8], wherein the acid B component comprises any one of an aliphatic tetracarboxylic dianhydride and an alicyclic tetracarboxylic dianhydride or Two. [10] The liquid crystal alignment agent according to [9], characterized in that the aliphatic tetracarboxylic dianhydride and the alicyclic tetracarboxylic dianhydride are selected from the following structural formula: 14 200813158 24843pif
(19)、(23)、(25)、(35)〜(37)、(39)、(44)、及(49) 所組成之族群中的一個或二個以上之化合物。 [化4]One or two or more compounds of the group consisting of (19), (23), (25), (35) to (37), (39), (44), and (49). [Chemical 4]
mm
[π]如第[ίο]項所述之液晶配向劑,其特徵在於:脂環 式四叛酸二酐為結構式(19)之化合物。 [12]如第[6]至[11]項所述之液晶配向劑,其特徵在 於:胺成分單獨包含A成分或者包含A成分及B成分的 兩成分,胺的A成分是以選自以下述通式(I )〜(ΥΠ) 所組成之族群中的一個或二個以上通式所表示之化合物。 [化5] 15 200813158 24843pif 關-A1〜NH2[π] The liquid crystal alignment agent according to the item [10], wherein the alicyclic tetra-retensive dianhydride is a compound of the formula (19). [12] The liquid crystal alignment agent according to [6] to [11], wherein the amine component contains the component A alone or two components of the component A and the component B, and the component A of the amine is selected from the group consisting of One or two or more compounds represented by the formulae of the group consisting of the general formulae (I) to (ΥΠ). [化5] 15 200813158 24843pif Off - A1 ~ NH2
通式(I )中,A1表示-(CH2)m。此處m表示1〜12 的整數。另外,通式(m)、( V)、(W)中,A〗獨立地表 卞早鍵、-S02-、-CO-、-CONH-、-NHCO-、 C(CH3)2-、_c(CF3)2、_(CH2)m、-〇-(CH2)nr〇-、或者 。此處m獨立地表示i〜12的整數。另外, 通式(VI )中,A2獨立地表示單鍵、s_、_c〇_、 _C(CH3)2_、-C(CF3)r或者碳數1〜ό的伸烷基。進而,與通 式(Π)〜(w)中的環己烷環或苯環鍵結之氫,亦可獨 立地被取代成_F、-CH3、-OH、-COOH、_S03H、-Ρ03Η2、 苄基或者‘羥基苄基。 [13]如第[12]項所述之液晶配向劑,其特徵在於:胺的 16 200813158 24843pif A成分是選自以下述結構式(IV — 1 )、( IV — 2)、(IV — 15)、 (IV —16)、(V — 1)〜(V —12)、(V — 33)及(VI[ —2) 所組成之族群的一個或二個以上化合物。 [化6]In the formula (I), A1 represents -(CH2)m. Here, m represents an integer of 1 to 12. Further, in the general formulae (m), (V), and (W), A is independently expressed as an early bond, -S02-, -CO-, -CONH-, -NHCO-, C(CH3)2-, _c(CF3). 2. _(CH2)m, -〇-(CH2)nr〇-, or. Here, m independently represents an integer of i to 12. Further, in the formula (VI), A2 independently represents a single bond, s_, _c〇_, _C(CH3)2_, -C(CF3)r or an alkylene group having a carbon number of 1 to fluorene. Further, the hydrogen bonded to the cyclohexane ring or the benzene ring in the formula (Π) to (w) may be independently substituted into _F, -CH3, -OH, -COOH, _S03H, -Ρ03Η2. Benzyl or 'hydroxybenzyl. [13] The liquid crystal alignment agent according to [12], characterized in that the amine 16 200813158 24843pif A component is selected from the following structural formulae (IV-1), (IV-2), (IV-15) One or two or more compounds of the group consisting of (IV-16), (V-1)~(V-12), (V-33), and (VI[-2). [Chemical 6]
17 200813158 24843pif17 200813158 24843pif
(VII-2) [14]如第[12]或[13]項所述之液晶配向劑,其特徵在 於:胺的B成分是以選自以下述通式(M)〜(M)所組 成之族群的一個或二個以上通式所表示之化合物。 [化7] 18 200813158 24843pif[14] The liquid crystal alignment agent according to [12] or [13] wherein the component B of the amine is selected from the group consisting of the following general formulae (M) to (M); One or more compounds represented by the general formula of the group. [化7] 18 200813158 24843pif
通式(Μ )中,R1 表示單鍵、-0_、-CO-、-COO_、-OCO-、 _CONH-、-CH20…CF20-或者-(CH2)e-,e 表示 1〜6 的整 數;r2表示具有類固醇骨架之基、以下述通式(xm)所 表示之基、碳數1〜30的烷基、或者苯基;於伸烷基及烷 基的碳數為2以上時,其任意的-CH2-亦可獨立地被-0-、 19 200813158 24843pif -(JH: 猫0、念^ 取代(其中氧不連續),苯基的氫亦可 獨=;、甲基、甲氧基、-氟甲氧基、二氟甲氧基或 二氟甲乳基取代,但排除·RLR2表巧基之情形。 # - ί t通式(K)巾,R獨立地表示氫或者甲基;r4 ^不虱或者碳數1〜3G雜基;R5獨立地U單鍵、_co_ 或者。 =卜通式(X)巾,Rj獨立地表示氫或者甲基;r4 ^不虱或者碳數1〜的烷基;R5獨立地表示單鍵、-co_ i者33及R7分別獨立地表示氣、彻〜30的焼In the formula (Μ), R1 represents a single bond, -0_, -CO-, -COO_, -OCO-, _CONH-, -CH20...CF20- or -(CH2)e-, and e represents an integer of 1 to 6; R2 represents a group having a steroid skeleton, a group represented by the following formula (xm), an alkyl group having 1 to 30 carbon atoms, or a phenyl group; and when the carbon number of the alkylene group and the alkyl group is 2 or more, any -CH2- can also be independently -0-, 19 200813158 24843pif - (JH: cat 0, read ^ replaced (where oxygen is discontinuous), phenyl hydrogen can also be alone;, methyl, methoxy, - Fluoromethoxy, difluoromethoxy or difluoromethyl lactyl substitution, but excluding the case of RLR2. # - ί t General (K) towel, R independently represents hydrogen or methyl; r4 ^ 不虱 or carbon number 1~3G hetero base; R5 independently U single bond, _co_ or . = general formula (X) towel, Rj independently represents hydrogen or methyl; r4 ^ not 虱 or carbon number 1~ Alkyl; R5 independently represents a single bond, -co_ i, 33 and R7 independently represent gas, and 〜30
其?:卜’通式(Χί)巾,R8表示氫或者碳數1〜3〇的烧 =,蛱數2以上的烷基的任意-CHr亦可獨立地被_〇_、_CH 或HI者^<-取代(其中氧不連續);R9獨立地表示-0· m 的伸絲;環A表示认伸苯基或者1,4-〇或Γ 表示0或1 ; b表示〇、1或2 ;,立地表示 者碳示碳數3〜基、或 碳數μ的—氟化烧基;Rl2獨立地表示“ 厌數1〜6的伸烷基;d獨立地表示〇或}。 [化8]It is: a general formula (Χί) towel, R8 represents hydrogen or a carbon number of 1 to 3 Å, and any -CHr of an alkyl group having 2 or more turns may be independently _〇_, _CH or HI. ^<-substitution (wherein oxygen is discontinuous); R9 independently represents an extension of -0·m; ring A represents a phenyl or 1,4-quinone or Γ represents 0 or 1; b represents 〇, 1 or 2;, the standing representative carbon has a carbon number of 3 to a group, or a carbon number of - a fluorinated group; Rl2 independently represents "an alkyl group having an anisotropic number of 1 to 6; d independently represents 〇 or}. 8]
R1B (XIII)R1B (XIII)
ί \ / \ 1 (R1T)r 20 200813158 24843pif 通式(XIH)中,r】3、r14及R15分別獨立地表示單 鍵、-Ο-、-COO-、-〇c〇·、-CONH-、石炭數1〜4的伸烷基、 碳數1〜3的氧伸烷基(其中氧不速續)、或者碳數1〜3 的伸纟元基氣基(其中氧不連續);ri6及R分別地獨立地 表示氫、氟或者甲基;R18表示氫、氟、氯、氰基、碳數i 〜30的烷基、碳數1〜30的烷氧基、碳數2〜30的烷氧基 烷基、一氟甲基、二氟曱基、三氟f基、一氟甲氧基、二 氟曱氧基或者三氟甲氧基;碳數2以上的烧基、烷氧基及 烧乳基烧基中的任意<Η2-可被二氣亞甲基或者以下述通 式(XIV)所表示的基取代;,環Β及環C分別獨立地表示 1,‘伸苯基或者ι,4-環伸己基;f、g及h分別地獨立地表 示0〜4的整數;i、j及k分別獨立地表示〇〜3的整數、 並且這些值的合計為1以上;1及m分別獨立地表示1或 2 〇 [化9]ί \ / \ 1 (R1T)r 20 200813158 24843pif In the general formula (XIH), r]3, r14 and R15 each independently represent a single bond, -Ο-, -COO-, -〇c〇·, -CONH- , an alkylene group having a charcoal number of 1 to 4, an oxygen alkyl group having a carbon number of 1 to 3 (in which oxygen is not accelerated), or a carbon number of 1 to 3 (wherein oxygen is discontinuous); ri6 And R independently represent hydrogen, fluorine or methyl; R18 represents hydrogen, fluorine, chlorine, cyano, an alkyl group having a carbon number of i to 30, an alkoxy group having a carbon number of from 1 to 30, and a carbon number of from 2 to 30. Alkoxyalkyl, monofluoromethyl, difluorodecyl, trifluorof-, monofluoromethoxy, difluoromethoxy or trifluoromethoxy; alkyl or alkoxy having 2 or more carbon atoms And any of the calcined bases may be substituted by a di-halogenethylene group or a group represented by the following formula (XIV); the ring and ring C each independently represent 1, 'phenylene Or ι, 4-cyclohexyl; f, g, and h each independently represent an integer of 0 to 4; i, j, and k each independently represent an integer of 〇 〜 3, and the total of these values is 1 or more; And m respectively represent 1 or 2 〇 [Chemical 9]
通式(XIV)中,R19、R20、R21及R22分別獨立地表 示碳數1〜10的烧基、或者本基’ n表示1〜1〇〇的整數。 [15]如第[14]項所述之液晶配向劑,其特徵在於··胺的 B成分是以選自以下述通式(卿一2)、(泗〜4)、(观一5)、 (M — 6)、(XI — 2)及(沿一4)所組成之族群的一個或二 21 200813158 24843pif 個以上通式所表示之化合物。 [化 10]In the formula (XIV), R19, R20, R21 and R22 each independently represent a carbon group having 1 to 10 carbon atoms, or the group 'n' represents an integer of 1 to 1 Å. [15] The liquid crystal alignment agent according to [14], wherein the B component of the amine is selected from the group consisting of the following formula (Qingyi 2), (泗~4), (view 5) One or two of the groups consisting of (M-6), (XI-2), and (along a-4) 21 200813158 24843pif Compounds represented by the above formula. [化10]
通式中,R23獨立地表示碳數3〜30的烷基或者碳數3 〜30的烷氧基,R29表示氳或者碳數丨〜孙的烷基,R30表 示氫或者碳數1〜20的烷基。 [16] 如第[1]至[15]項所述之液晶配向劑,其特徵在 於··包含二種以上之聚醯胺酸或其衍生物。 [17] —種液晶配向劑,液晶配向劑是包含聚醯胺酸或 其衍生物、烯基取代納迪克酸醯亞胺化合物、及雜環化合 物之液晶配向劑,其中 聚醯胺酸或其衍生物,是使作為酸成分的四鲮酸二酐 與作為胺成分的二胺反應而獲得之聚蕴胺酸’ 22 200813158 酸成分包含A成分及B成分,酸的a成分是選自以 下述結構式(1)、(2)、(5)〜(7)及(14)所組成之族 群的一個或一個以上化合物,酸的B成分是選自以下述鈇 構式(19)、(23)、(25)、(35)〜(37)、(39)、(44)、及 (49)所組成之族群的一個或二以上化合物, 胺成分單獨地包含A成分或者包含A成分與B成分 的兩成分,胺的A成分是選自以下述結構式 -2)、(rV-l5)、(IV — 16)、(v — 1)〜(v_i2)、(v 33)及(VH — 2)所組構成之族群的一個或二個以上化合 物,胺的B成分是以選自以下述通式(观一2)、(舰〜4)、 (珊一5)、(观一6)、(χι_2)及(χι_4)所組成之族群 的一個或二個以上通式所表示之化合物, 沐土取代、、、内适克酸醯亞胺化合物包含一個或二個以卜In the formula, R23 independently represents an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms, R29 represents an alkyl group of hydrazine or a carbon number 丨~sun, and R30 represents hydrogen or a carbon number of 1 to 20. alkyl. [16] The liquid crystal alignment agent according to [1] to [15], which is characterized in that it contains two or more kinds of polyaminic acid or a derivative thereof. [17] a liquid crystal alignment agent, which is a liquid crystal alignment agent comprising polylysine or a derivative thereof, an alkenyl-substituted nadic acid ruthenium imine compound, and a heterocyclic compound, wherein the polyamine acid or The derivative is a polyimidonic acid obtained by reacting a tetradecanoic dianhydride as an acid component with a diamine as an amine component. 22 200813158 The acid component contains the component A and the component B, and the a component of the acid is selected from the following One or more compounds of the group consisting of structural formulae (1), (2), (5) to (7), and (14), the B component of the acid is selected from the following formulas (19), (23) One or two or more compounds of the group consisting of (25), (35) to (37), (39), (44), and (49), wherein the amine component separately contains the component A or contains the component A and B. The two components of the component, the A component of the amine, are selected from the following structural formulas -2), (rV-l5), (IV-16), (v-1)~(v_i2), (v33) and (VH- 2) One or two or more compounds of the group constituted by the group, the B component of the amine is selected from the group consisting of the following formula (view 2), (ship ~ 4), (Shan Yi 5), (view one 6), (χι_2) and (χι_4) a compound represented by one or two or more formulas, a subterranean substituted, or a benzoic acid imine compound containing one or two
—雜環化合物具有選自以環氧乙烷㈤臟)、氧環丁 $ (oxetane)、嗔喃(thUrane)、氣丙〇定(拉麻此)、喔唾 itTi所組成之族群的—個或二個以上之雜環結構。- the heterocyclic compound has a group selected from the group consisting of ethylene oxide (five), oxetane, thUrane, apocytidine, and sputum itTi Or more than two heterocyclic structures.
23 200813158 24843pif [化 12]23 200813158 24843pif [Chem. 12]
(19) (23) (25) (35)(19) (23) (25) (35)
24 200813158 24843pif [化 13]24 200813158 24843pif [Chem. 13]
fV-10)fV-10)
nh2 h2nNh2 h2n
NH (V,12)NH (V, 12)
HO OHHO OH
(V-33)(V-33)
(Vfi-2) 25 200813158 24843pif [化 14](Vfi-2) 25 200813158 24843pif [Chem. 14]
通式中,R23獨立地表示碳數3〜30的烷基或者碳數3 〜30的烷氧基,R29表示氫或者碳數1〜30的烷基,R3G表 示氫或者碳數1〜20的烷基。 [化 15]In the formula, R23 independently represents an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms, R29 represents hydrogen or an alkyl group having 1 to 30 carbon atoms, and R3G represents hydrogen or a carbon number of 1 to 20 carbon atoms. alkyl. [化15]
26 200813158 24843pif26 200813158 24843pif
[18] 如第[17]項所述之液晶配向劑,其特徵在於:酸的 A成分是以結構式(1)所表示之化合物,酸的B成分是 以結構式(19)所表示之化合物, 胺的A成分是以結構式(iv 一 16)、(V — 1)、(v — 7) 及(YU — 2)所表示的一個或二個以上化合物,胺的b成 分是以通式(Μ — 5)、(XI —2)及(X[ —4)所表示的一個 或二個以上化合物, 烯基取代納迪克酸亞胺化合物是以結構式(Ina — 1)所表示之化合物, 雜環化合物包含選自4,心亞甲基雙(N,N-二縮水甘油 基苯胺)、(3-縮水甘油氧基丙基)三甲氧基矽烧、(3-縮水甘 油氧基丙基)甲基二曱氧基矽烷、2-(3,4-環氧環己基)乙基三 甲氧基石夕院、雙[(3_乙基各環氧丙烧基曱氧基)甲基]苯、 2,4,6-三(1’-氮丙啶基)-153,5-三嗪,凡1^1^四噻喃基曱基 _4’4 -—胺基二苯基甲$元、本乙細-co-2-異丙稀基嗯σ坐 琳)、以及雙(3_苯基_3,4-二氫_211-1,3-苯幷噁嗪_6-基)甲烧所 組成之組群的一個或二個以上化合物。 [19] 一種液晶配向膜,其特徵在於:將如第[1]至[18] 27 200813158 24843pif 項所述之液晶配向_膜態進倾燒而形成。 [20]-種液晶顯示元件,其是具有對向配置的—對夷 基板各自對向面的一面或兩面上形成的電極: :::基板各自對向面上形成的液晶配向膜、於一對基板 =^=夜晶層之液晶顯示元件,其特徵在於:液晶配向 肤為如弟[19]項所述之液晶配向膜。 ^本發明,可提供—雜子蚊冑、㈣於離子密 2歷%性變動的長期可靠性為良好的各種驅動方式之液 日日頒不元件。 【實施方式】 你Λ發^之液晶配向縣—組合物,其包含:將稀基取 、’、广酸又亞胺化合物與具有選自以環氧乙烷 〜oxirane)、氧環丁燒(。猶継)、π塞喃⑽1服小氮巧 :疋(azmdme)、噁唑啉、及噁嗪所組成之族 一 自固酬化合物組合而成之改良劑,以及; 自4驗及其魅物的—個或二個以上的聚合物。 1:本兔明之烯基取代納迪克酸酿亞胺化合物〉 …見就本&明所使狀烯基取代納迪克酸醯亞胺化合物 曰口以》兄,。刖4稀基取代納迪克酸醯亞胺化合物,較好 解本發明所使用聚酸胺酸或其衍生物以及雜 二二之化合物。作為如此之絲取代納迪克酸 例如可舉出以下述通式(ina)所表示之 化合物。 28 200813158 24843pif [化 16][18] The liquid crystal alignment agent according to [17], wherein the acid component A is a compound represented by the structural formula (1), and the acid B component is represented by the structural formula (19). The compound A, the A component of the amine is one or two or more compounds represented by the structural formulas (iv-16), (V-1), (v-7) and (YU-2), and the b component of the amine is One or two or more compounds represented by the formulae (Μ-5), (XI-2) and (X[-4), the alkenyl-substituted nadic acid imide compound is represented by the structural formula (Ina-1) The compound, the heterocyclic compound comprises a compound selected from the group consisting of 4, cardinyl bis(N,N-diglycidylaniline), (3-glycidoxypropyl)trimethoxysulfonate, (3-glycidyloxy) Propyl)methyl decyloxydecane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxy sylvestre, bis[(3-ethyl epoxypropyl decyloxy)methyl Benzene, 2,4,6-tris(1'-aziridine)-153,5-triazine, where 1^1^tetrathiopyranyl _4'4--aminodiphenyl $元,本乙细-co-2-isopropyl 基 嗯 坐 sits on the Lin), and double (3_phenyl_3,4-two _211-1,3- benzene Bing oxazin _6- yl) methyl burning a group consisting of two or more of the compounds. [19] A liquid crystal alignment film which is formed by injecting a liquid crystal alignment state as described in the items [1] to [18] 27 200813158 24843pif. [20] A liquid crystal display element which is an electrode formed on one surface or both surfaces of opposite surfaces of a facing substrate: ::: a liquid crystal alignment film formed on each of opposite surfaces of the substrate, The liquid crystal display element of the substrate=^=the night crystal layer is characterized in that the liquid crystal alignment film is a liquid crystal alignment film as described in [19]. According to the present invention, it is possible to provide a liquid of various driving modes in which the long-term reliability of the ionic density change is excellent in the ion density, and the components are not provided. [Embodiment] The liquid crystal alignment county-composition composition of the present invention comprises: a dilute base, a ', a wide-acid and an imine compound having a selected from the group consisting of ethylene oxide to oxirane, and an oxygen sulfonate (継 継 、 、 、 、 、 、 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 az az az az az az az az az az az az az az az az az az az az az One or more polymers of the substance. 1: The alkenyl group of the rabbit is substituted with the Nadick acid-based imine compound. ... See the "Alkenyl" substituted nadic acid ylide compound. The 刖4 dilute group replaces the nadic acid ylide imide compound, and the polyamic acid or derivative thereof and the compound of the heterobibic acid used in the present invention are preferably used. As such a silk-substituted nadic acid, for example, a compound represented by the following formula (ina) can be given. 28 200813158 24843pif [Chem. 16]
通式(I na)中,R]及R2分別表示氫、碳數1〜12 的烷基、碳數3〜6的烯基、碳數5〜8的環烷基、芳基、 或者苄基,η表示1〜2的整數。 另外,通式(I na)中,於η=1時,R3表示碳數1 〜12的烷基、碳數5〜8的環烷基、碳數6〜12的芳基、 卞基以( q、r、s分別表示 2〜6的整數,t表示0或1,u表示1〜30的整數)所表示 ^聚氧伸烷基烷基、-(RVQEU-R4 (v表示〇或i,r表示 反數1〜4的伸烧基,R4表示氫或者;5炭數1〜4的烧基)所 表不之基、以_〇6Η4·Τ_(:6Η5( T 表示_ch2-、_c(ch3)2_、_CO-、 或者-S〇2_)所表示之基、或者將這些基的與芳香環直 接鍵結的1〜3個氫以羥基取代之基。 另外,通式(Ina)中,於n = 2時,R3表示碳數2 〜20的伸烷基、碳數5〜8的環伸烷基、 -(CqH2q〇)r(CrH2r0)u-CsH2s-(q、r、s 分別表示 2〜6 的整數, t山表示0或1,u表示的整數)所表示之聚氧伸二美、’ 石反數6〜12的伸芳基(ary〗ene)、u_(R\_C6H4_R5 29 200813158 24843pif 〇或1,R及R5分別表示碳數1〜4的伸烧基或者碳數5〜 8的環伸烷基)所表示之基、以表示 _CH2_、_C(CH3)2·、_co_、·〇_、_〇c6h4_c(ch3)2_C6h4〇、 -S-、或者-S〇2_)所表示之基、或者將這些基的與芳香環 直接鍵結的1〜3個氫以羥基取代之基。 ’ 前述烯基取代納迪克酸亞胺化合物,例如,如曰本 專利第2729565號公報所記載,可使用藉由將稀基取代納 迪克酸酐(nadic acid anhydride)衍生物與二胺於80〜 220 C温度下保持〇·5〜20小,時而合成獲得之化合物、及市 售之化合物。作為稀基取代納迪克酸醢亞胺化合物之具體 例,例如可舉出以下所示之化合物。 N-曱基烯丙基雙環[2.2.1]庚-5-烯二曱醯亞胺、 N-甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞 胺、 N-曱基曱基烯丙基雙環[2·2·1]庚-5-烯-2,3-二曱醯亞 胺、 N-曱基甲基烯丙基甲基雙環[2·2· 1]庚-5-烯-2,3-二甲醯 亞胺、 N-(2_乙基己基)烯丙基雙環[2·2·1]庚-5-烯-2,3-二曱醯 亞胺、 N-(2-乙基己基)烯丙基甲基雙環Ρ·2·1]庚-5-烯-2,3-二 曱醯亞胺、 N_烯丙基_烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲醯亞胺、 N-烯丙基_烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲酿 30 200813158 24843pif 亞胺、 N-晞丙基·甲基烯丙基雙環[^^庚-^烯义^二甲醯 亞胺、 队異丙烯基,丙基雙環[2.21]庚_5_烯_2,3_二曱醯亞 胺、 N-異丙烯基-烯丙基甲基雙環[2·2·1:^_54#_2,3_:ψ 醯亞胺、 Ν-異丙烯·基曱基烯丙基雙環[2·2·η庚_5_烯_2,3_二甲 醯亞胺、 Ν-環己基·烯丙基雙環[2·2·η庚冬烯_2,3_二曱醯亞胺、 Ν-環己基-烯丙基曱基雙環[m]庚_5_烯—2,3-二曱醯 亞胺、 N-環己基·甲基烯丙基雙環卩么:^庚:烯-^二甲醯 亞胺、 队苯基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺、 N-苯基-烯丙基曱基雙環ρ·2·ι]庚-5-烯-2,3-二甲醯亞 胺、 Ν_苄基_烯丙基雙環[2.2.1]庚-5-烯-2,3_二曱醯亞胺、 Ν-苄基-烯丙基曱基雙環[2·2·1]庚-5-烯-2,3-二甲醯亞 月安、 Ν-苄基-曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞 胺、 Ν-(2’-羥基乙基)烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲醯 亞胺、 31 200813158 24843pif 1^(2’-羥基乙基)烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二 甲醯亞胺、 輕基乙基)曱基細丙基雙壤[2.2.1]庚-5-細-2,3-二 甲醯亞胺、 Ν-(2’,2’-二曱基羥基丙基)烯丙基雙環[2·2·1]庚-5-烯-2,3-二曱醯亞胺、 N-(2f,2^二甲基-3’-羥基丙基)烯丙基甲基雙環[2·2·1]庚 - 5-烯-2,3-二甲醯亞胺、 N_(2f,3丨-二搜基兩基)細丙基雙壞[2·2·1]庚_5-細-2,3-二 甲醯亞胺、 N-(2’,3f-二羥基丙基)烯丙基曱基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺、 N-(3f-羥基丙烯基)烯丙基雙環[2.2.1]庚-5_烯-2,3-二甲醯亞胺、 N-(4f-羥基環己基)烯丙基曱基雙環[2·2·1]庚-5-烯-2,3-二曱醯亞胺、 N-(4f-羥基苯基)烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯 亞胺、 N-(4’-羥基苯基)烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二 曱醯亞胺、 N-(4f-羥基苯基)曱基烯丙基雙環[2·2·1]庚-5-烯-2,3-二 曱酿亞胺、 N-(4f-羥基苯基)曱基烯丙基曱基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺、 32 200813158 24843pif N_(3’-羥基苯基)烯丙基雙環[2.2.1]庚-5-烯_2,3-二曱醯 亞胺、 Ν-(3’-羥基苯基)烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二 曱醯亞胺、 Ν_(對羥基苄基)烯丙基雙環[2·2·1]庚-5-烯-2,3-二曱醯 亞胺、 n_{2H2L羥基乙氧基)乙基}烯丙基雙環[2·2·1]庚-5-烯 -2,3-二曱酸亞胺、 羥基乙氧基)乙基}烯丙基曱基雙環[2.2· 1 ]庚 -5-烯-2,3-二曱醯亞胺、 羥基乙氧基)乙基}曱基烯丙基雙環[2·2·ΐ]庚 -5-烯-2,3-二曱酿亞胺、 N_{2’-(2f-羥基乙氧基)乙基}甲基烯丙基甲基雙環 [2·2·1]庚·5·烯-2,3-二曱醯亞胺、 Ν-π{ip羥基乙氧基)乙氧基}乙基]烯丙基雙環 [2.2.1]庚_5_細·2,3-二曱酸亞胺、 Ν_[2’_(2’_(2”老基乙氧基)乙氧基}乙基]稀丙基甲基雙 環[2·2·1]庚-5-烯-2,3-二甲醯亞胺、 叫2’_{2’-(2"-經基乙氧基)乙氧基}乙基]甲基烯丙基雙 環[2·2·1]庚-5-烯-2,3-二曱醯亞胺、 Ν]4’_(4’老基苯基亞異丙基)苯基}烯丙基雙環 庚-5-烯-2,3-二曱醯亞胺、 Ν-{4’-(4’-羥基苯基亞異丙基)苯基}烯丙基曱基雙環 [2·2·1]庚-5-烯-2,3-二曱醯亞胺、 33 200813158 24843pif N-{4’-(4’-經基苯基亞異丙基)苯基}甲基烯丙基雙環 [2.2.1]庚-5-稀-2,3_二甲龜亞胺、 以及這些化合物之寡聚物; N,NM申乙基雙(烯丙基雙環[2.2.1]庚-5-烯4,3-二甲酿 亞胺)、 " N,N’-伸乙基雙(烯丙基曱基雙環[2·2·1]庚-5-烯_2,3_二 甲醯亞胺)、 N,NW申乙基雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二 甲醯亞胺)、. Ν,Ν’-三亞曱基雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱 酸亞胺)、 风^六亞曱基雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱 酸亞胺)、 Ν,Ν’-六亞曱基雙(烯丙基甲基雙環[2·2·1]-5-烯-2,3-二 甲醯亞胺)、 N,Nf-十二亞曱基雙(烯丙基雙環[2·2·1]庚-5-烯-2,3-二 曱酿亞胺)、 Ν,Ν’-十二亞甲基雙(烯丙基曱基雙環[2·2·1]庚-5-烯 _2,3_二曱醯亞胺)、 N,Nf-環伸己基雙(稀丙基雙環[2·2·1]庚-5-稀-2,3-二甲 醯亞胺)、 Ν,Ν’-環伸己基雙(烯丙基甲基雙環[2·2·1]庚烯-2,3-二甲醯亞胺;), 1,2-雙{3,-(烯丙基雙環[2·2·1]庚-5-烯-2,3·二曱醯亞胺) 34 200813158 24843pif 丙氧基}乙燒、 1,2-雙{3’-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醢 亞胺)丙氧基}乙烷、 1,2-雙{3f-(曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯 亞胺)丙氧基}乙烧、 雙[2f-{3f-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺) 丙氧基}乙基]鱗、 雙[2’-{3’_(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二甲醯 亞胺)丙氧基}乙基]鱗、 M-雙{3f-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺) 丙氧基} 丁烷、 M_雙{3’_(烯丙基甲基雙環[2.2.1]庚冬烯-2,3-二曱醯 亞胺)丙氧基}丁院, N,N’-對伸苯基雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲 醯亞胺)、 N,Nf-對伸苯基雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、 N,Nf-間伸苯基雙(烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲 醯亞胺)、 Ν,Ν’-間伸笨基雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 Ν,Ν’-{(1-甲基)-2,4-伸苯基}雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 N,Nf-對苯二甲基雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二 35 200813158 24843pif 甲醯亞胺)、 N,Nf-對苯二曱基雙(烯丙基曱基雙環[2.2.1]庚-5-烯 -2,3-二甲醯亞胺)、 Ν,Ν’-間苯二曱基雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二 曱醯亞胺)、 Ν,Ν’-間苯二甲基雙(烯丙基甲基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺), 2,2_雙[4^{4’_(烯丙基雙環[2.2.1]庚-5·烯-2,3_二曱醯亞 胺)苯氧基}苯基]兩烷、 2.2- 雙[4’_{4-(烯丙基曱基雙環[2.2.1]庚-5-烯_2,3-二甲 醯亞胺)苯氧基}苯基]丙烧、 2.2- 雙[4f-{4’·(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲 醯亞胺)苯氧基}苯基]丙烷、 雙{4-(烯丙基雙環[2·2·1]庚-5-烯-2,3-二曱醯亞胺)苯基} 甲烷、 雙{4-(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺) 苯基}曱烷, 雙{4-(曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺) 苯基}曱烷、 雙{4-(曱基烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱醯 亞胺)苯基}甲烷、 雙{4-(烯丙基雙環[2·2·1]庚-5-烯-2,3-二曱醯亞胺)苯基} 醚、 雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺) 36 200813158 24843pif 苯基}醚、 雙{4-(甲基烯丙基雙環[2·2·1]庚-5-烯-2,3-二曱醯亞胺) 笨基}醚、 雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基} 石風、 雙{4_(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺) 苯基風、 雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺) 本基}職、 1,6-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺;h3-羥基己烷、 1,12-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞 胺)-3,6-二經基十二焼、 1,3_雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-5_ 羥基環己烷、 1,5-雙{3f_(烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲醯亞胺) 丙氧基}-3-羥基戊烷、 Μ-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-2- 羥基苯、 雙(烯丙基曱基雙環[2·2·1]庚-5-烯-2,3-二曱醯亞 知)-2,5-二赵基苯、 Ν,>Γ-對(2-羥基)苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 N,Nf-對(2-羥基)苯二甲基·雙(烯丙基曱基環[2.2.1]庚 37 200813158 24843pif -5-烯-2,3-二曱醯亞胺)、 N,N’-間(2-羥基)苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 N,N’-間(2-羥基)苯二曱基-雙(曱基烯丙基雙環[2·2·1] 庚-5-烯-2,3-二曱醯亞胺)、 N,lsT-對(2,3-二羥基)苯二甲基-雙(烯丙基雙環[2.2.1]庚 -5-烯-2,3-二甲醯亞胺)、 2,2-雙[4’-{4’_(烯丙基雙環[2.2.1]庚-5_烯-2,3_二甲醯亞 胺輕基笨乳基}苯基]丙烧、 雙{4-(烯丙基甲基雙環[2.2.1]庚_5_烯-2,3-二甲醯亞 胺)-2-羥基苯基}甲烷、 雙{3-(烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲醯亞胺)-4-羥基笨基}醚、 雙{3-(曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞 胺)-5-輕基苯基}諷、 1,1,1-三K-(烯丙基曱基雙環[2.2.1]庚·5-烯-2,3_二曱 醯亞胺)}苯氧基甲基丙烷、 1^^’,1^’_三(乙烯基甲基烯丙基雙環[2.2.1]庚-5-烯-2,3_ 二曱醯亞胺)異氰尿酸酯、 以及這些化合物之寡聚物等。 進而,本發明所使用之烯基取代納迪克酸醯亞胺化合 物,亦可為以包含非對稱的伸烧基、伸苯基的下述結構式 所表示之化合物。 38 200813158 24843pif [化 17]In the formula (I na), R) and R2 each represent hydrogen, an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 3 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, an aryl group or a benzyl group. , η represents an integer of 1 to 2. Further, in the formula (I na), when η = 1, R3 represents an alkyl group having 1 to 12 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, an aryl group having 6 to 12 carbon atoms, or a fluorenyl group ( q, r, s represent an integer of 2 to 6, respectively, t represents 0 or 1, u represents an integer of 1 to 30, and represents a polyoxyalkylene alkyl group, -(RVQEU-R4 (v represents 〇 or i, r represents the alkyl group of the inverse number 1 to 4, R4 represents a hydrogen or a base of 5 carbon atoms of 1 to 4, and _〇6Η4·Τ_(:6Η5 (T represents _ch2-, _c) (ch3) a group represented by 2_, _CO-, or -S〇2_), or a group in which 1 to 3 hydrogens directly bonded to the aromatic ring of these groups are substituted with a hydroxyl group. Further, in the formula (Ina) When n = 2, R3 represents an alkylene group having a carbon number of 2 to 20, a cycloalkyl group having a carbon number of 5 to 8, and -(CqH2q〇)r(CrH2r0)u-CsH2s-(q, r, s respectively An integer representing 2 to 6, an integer represented by 0 or 1, u is an integer represented by poly), a aryl group of aryl (6), and an aryl group (ary ene), u_(R\_C6H4_R5 29 200813158 24843pif 〇 or 1, R and R5 represent a group represented by a carbon number of 1 to 4 or a ring alkyl group having a carbon number of 5 to 8, respectively, to represent a group represented by _CH2_, _C(CH3)2·, _co_, 〇_, _〇c6h4_c(ch3)2_C6h4〇, -S-, or -S〇2_), or direct bonding of these groups to the aromatic ring The above-mentioned alkenyl-substituted nadic acid imide compound, for example, as described in Japanese Patent No. 2729565, may be used by substituting a dilute group for nadic anhydride (nadic). And a compound obtained by synthesizing a derivative of the acid anhydride with a diamine at a temperature of 80 to 220 C at a temperature of from 5 to 20 ° C, and a commercially available compound, as a specific example of a rare base-substituted nadic acid ylide compound. For example, the compounds shown below are mentioned. N-Mercaptopropylbicyclo[2.2.1]hept-5-ene diimine, N-methylallylmethylbicyclo[2.2.1] Hg-5-ene-2,3-dimethylimine imine, N-mercapto-mercaptopropylbicyclo[2·2·1]hept-5-ene-2,3-diimine, N - mercaptomethylallylmethylbicyclo[2·2·1]hept-5-ene-2,3-dimethylimine, N-(2-ethylhexyl)allylbicyclo[2· 2·1]hept-5-ene-2,3-diimineimine, N-(2-ethylhexyl)allylmethylbicycloindole·2·1] -5-ene-2,3-diimineimine, N-allyl-allylbicyclo[2·2·1]hept-5-ene-2,3-dimethylimine, N- Allyl-allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethyl broth 30 200813158 24843pif imine, N-mercaptopropyl methallyl bicyclo [^^g -^ene^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ [2·2·1:^_54#_2,3_:ψ 醯 imine, Ν-isopropene·ylmercaptopropylbicyclo[2·2·ηg _5_ene_2,3_dimethyl hydrazine Imine, fluorene-cyclohexyl allyl bicyclo [2·2·η-glycolene 2,3 bis quinone imine, Ν-cyclohexyl-allyl fluorenylbicyclo[m]g _5_ Alkene-2,3-diimineimine, N-cyclohexyl·methallylbicycloindole: ^heptene: ene-^dimethylimine, phenyl-allyl bicyclo [2.2.1 Hept-5-ene-2,3-diimineimine, N-phenyl-allylhydrazylbicyclo ρ·2·ι]hept-5-ene-2,3-dimethylimine, Ν_Benzyl-allylbicyclo[2.2.1]hept-5-ene-2,3-diimine, Ν-benzyl-allylhydrylbicyclo[2·2·1]g- 5-ene-2,3-dimethyl hydrazine, hydrazine-benzyl- Allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, Ν-(2'-hydroxyethyl)allylbicyclo[2·2·1]hept-5 -ene-2,3-dimethylimine, 31 200813158 24843pif 1^(2'-hydroxyethyl)allylhydrylbicyclo[2.2.1]hept-5-ene-2,3-dimethylhydrazine Imine, light ethyl ethyl) decyl fine propyl double soil [2.2.1] hept-5- fine-2,3-dimethyl quinone imine, Ν-(2',2'-dimercapto hydroxypropyl Allylbicyclo[2·2·1]hept-5-ene-2,3-diimineimine, N-(2f,2^dimethyl-3'-hydroxypropyl)allyl Methyl bicyclo[2·2·1]hept-5-ene-2,3-dimethylimine, N_(2f,3丨-disoyl), propyl double bad [2·2·1 Geng_5-fine-2,3-dimethylimine, N-(2',3f-dihydroxypropyl)allylhydrylbicyclo[2.2.1]hept-5-ene-2,3 - Diimine, N-(3f-hydroxypropenyl)allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-(4f-hydroxycyclohexyl) Allyl indenylbicyclo[2·2·1]hept-5-ene-2,3-diindoleimine, N-(4f-hydroxyphenyl)allylbicyclo[2.2.1]hept-5 -ene-2,3-diimineimine, N-(4'-hydroxyphenyl)allylmethylbicyclo[2.2.1]hept-5-ene -2,3-diimine, N-(4f-hydroxyphenyl)nonylallylbicyclo[2·2·1]hept-5-ene-2,3-diindoleimine, N -(4f-hydroxyphenyl)nonylallylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-diimineimine, 32 200813158 24843pif N_(3'-hydroxyphenyl)ene Propylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine, Ν-(3'-hydroxyphenyl)allylhydrylbicyclo[2.2.1]hept-5-ene -2,3-diimine, Ν-(p-hydroxybenzyl)allylbicyclo[2·2·1]hept-5-ene-2,3-diindoleimine, n_{2H2L hydroxyethyl Oxy)ethyl}allylbicyclo[2·2·1]hept-5-ene-2,3-didecanoate, hydroxyethoxy)ethyl}allylhydrylbicyclo[2.2· 1]hept-5-ene-2,3-diimideimine, hydroxyethoxy)ethyl}mercaptopropylbicyclo[2·2·ΐ]hept-5-ene-2,3-di Brewing imine, N_{2'-(2f-hydroxyethoxy)ethyl}methylallylmethylbicyclo[2·2·1]hept-5-ene-2,3-dipyrene Amine, Ν-π{iphydroxyethoxy)ethoxy}ethyl]allylbicyclo[2.2.1]hept-5-fine·2,3-didecanoic acid imide, Ν_[2'_( 2'_(2" old ethoxy) ethoxy} ethyl] propylene Methylbicyclo[2·2·1]hept-5-ene-2,3-dimethylimineimine, called 2'_{2'-(2"-carbyloxy)ethoxy}B Methylallylbicyclo[2·2·1]hept-5-ene-2,3-diimineimine, Ν] 4'-(4'-old phenyl isopropylidene)phenyl }allylbicyclohept-5-ene-2,3-diimineimine, Ν-{4'-(4'-hydroxyphenyl isopropylidene)phenyl}allyl fluorenylbicyclo[2 ·2·1]hept-5-ene-2,3-diindoleimine, 33 200813158 24843pif N-{4'-(4'-p-phenylphenylidene)phenyl}methylallyl Bicyclo[2.2.1]hept-5-rare-2,3-dimethylmerimimine, and oligomers of these compounds; N,NM-ethyl bis(allylbicyclo[2.2.1]hept-5- Alkene 4,3-dimethylenimine), " N,N'-extended ethyl bis(allylhydrazinobicyclo[2·2·1]hept-5-ene_2,3_dimethylhydrazine Imine), N, NW, ethyl bis(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), Ν, Ν'-triazinyl bis(ene) Propylbicyclo[2.2.1]hept-5-ene-2,3-didecanoic acid imide), hexamethylene bis(allylbicyclo[2.2.1]hept-5-ene-2, 3-didecanoic acid imide), hydrazine, Ν'-hexa Mercapto bis(allylmethylbicyclo[2·2·1]-5-ene-2,3-dimethylimine), N,Nf-dodedecylbis(allylbicyclo[2] ·2·1]hept-5-ene-2,3-diindoleimine), hydrazine, Ν'-docamethylene bis(allylhydrazinobicyclo[2·2·1]hept-5 -ene-2,3_diimide), N,Nf-cyclohexyl bis(dipropylbicyclo[2·2·1]hept-5-lean-2,3-dimethylimine) , Ν,Ν'-cyclohexyl bis(allylmethylbicyclo[2·2·1]heptene-2,3-carboximine;), 1,2-double {3,-(ene Propylbicyclo[2·2·1]hept-5-ene-2,3·diindoleimide) 34 200813158 24843pif propoxy}Ethylene, 1,2-double {3'-(allylyl) Bicyclo[2.2.1]hept-5-ene-2,3-carboximine)propoxy}ethane, 1,2-bis{3f-(mercaptopropylbicyclo[2.2.1] Hg-5-ene-2,3-diimineimine)propoxy}ethid, bis[2f-{3f-(allylbicyclo[2.2.1]hept-5-ene-2,3- Dimethyl imidate) propoxy}ethyl] squara, bis[2'-{3'_(allyl fluorenylbicyclo[2.2.1]hept-5-ene-2,3-dimethyl sulfoxide Amine)propoxy}ethyl]scale, M-double {3f-(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine) Butane, M_double {3'_(allylmethylbicyclo[2.2.1]heptene-2,3-diimineimine)propoxy}butyl, N,N'- P-phenylene bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,Nf-p-phenylene bis(allylmethylbicyclo[2.2 .1]hept-5-ene-2,3-carboximine), N,Nf-inter)phenylbis(allylbicyclo[2·2·1]hept-5-ene-2,3 - dimethyl quinone imine), hydrazine, Ν'- 伸 基 bis (allylmethyl bicyclo [2.2.1] hept-5-ene-2,3-diimine), hydrazine, hydrazine '-{(1-methyl)-2,4-phenylene} bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), N,Nf- P-Benzyl bis(allylbicyclo[2.2.1]hept-5-ene-2,3-di 35 200813158 24843pif formamidine), N,Nf-p-phenylenediyl bis(allyl) Indenylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), hydrazine, Ν'-m-phenylenediyl bis(allylbicyclo[2.2.1]hept-5- Alkene-2,3-diimine), hydrazine, Ν'-m-xylylene bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dioxime Amine), 2,2_bis[4^{4'_(allylbicyclo[2.2.1]hept-5-ene-2,3_dioxin Phenoxy}phenyl]dioxane, 2.2-bis[4'_{4-(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-dimethylimine) benzene Oxy}phenyl]propane, 2.2-bis[4f-{4'·(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine) phenoxy }phenyl]propane, bis{4-(allylbicyclo[2·2·1]hept-5-ene-2,3-diimideimine)phenyl} methane, double {4-(allyl Base bisbicyclo[2.2.1]hept-5-ene-2,3-diimineimine) phenyl}decane, bis{4-(decylallylbicyclo[2.2.1]hept-5 -ene-2,3-dimethylimine imine) phenyl}decane, bis{4-(decylallylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-diindole Imine)phenyl}methane, bis{4-(allylbicyclo[2·2·1]hept-5-ene-2,3-diimideimine)phenyl} ether, double {4-( Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine) 36 200813158 24843pif Phenyl}ether, double {4-(methylallylbicyclo[2·2 ·1]hept-5-ene-2,3-diimineimine) phenyl)ether, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethyl醯imino)phenyl] stone, double {4_(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-diimineimine) phenyl , double {4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), benzyl, 1,6-bis(allylbicyclo[2.2 .1]hept-5-ene-2,3-diimineimine; h3-hydroxyhexane, 1,12-bis(methylallylbicyclo[2.2.1]hept-5-ene-2, 3-diimineimine)-3,6-di-transyloxime, 1,3-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine )-5_ hydroxycyclohexane, 1,5-bis{3f_(allylbicyclo[2·2·1]hept-5-ene-2,3-dimethylimine imine) propoxy}-3- Hydroxypentane, bismuth-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)-2-hydroxybenzene, bis(allylhydrazinobicyclo[2· 2·1]hept-5-ene-2,3-dioxime]-2,5-ditridecylbenzene, anthracene, >Γ-p-(2-hydroxy)benzenedimethyl-bis(ene) Propylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), N,Nf-p-(2-hydroxy)benzylidene·bis(allylhydrazino ring [2.2 .1]Geng 37 200813158 24843pif -5-ene-2,3-diimineimine), N,N'-m-(2-hydroxy)benzenedimethyl-bis(allylbicyclo[2.2.1] Hg-5-ene-2,3-diimineimine), N,N'-m-(2-hydroxy)benzodiazepine-bis(fluorenyl) Propylbicyclo[2·2·1]hept-5-ene-2,3-diimineimine), N, lsT-p-(2,3-dihydroxy)benzenedimethyl-bis(allyl) Bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), 2,2-bis[4'-{4'-(allylbicyclo[2.2.1]hept-5_ Alkene-2,3-dimethylimine, light base, phenyl]propane, double {4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-di Formamidine)-2-hydroxyphenyl}methane, bis{3-(allylbicyclo[2·2·1]hept-5-ene-2,3-dimethylimine)-4-hydroxyl Styyl ether, double {3-(mercaptopropylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine)-5-light phenyl}, 1,1 , 1-tris-K-(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-diimine]}phenoxymethylpropane, 1^^', 1^' _Tri(vinyl methallyl bicyclo [2.2.1] hept-5-ene-2,3-diimide) isocyanurate, and oligomers of these compounds and the like. Further, the alkenyl-substituted nadic acid ruthenium imide compound used in the present invention may be a compound represented by the following structural formula containing an asymmetric stretching group and a stretching phenyl group. 38 200813158 24843pif [Chem. 17]
本發明所使用之前述烯基取代納迪克酸醯亞胺化合物 中,可單獨使用如這些之烯基取代納迪克酸醯亞胺化合 物,亦可作為這些化合物中的二種以上之混合物而使用。 作為前述烯基取代納迪克酸醯亞胺化合物,較好的化 合物可舉出以下化合物。 N,NM申乙基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯 亞胺)、 N,NW申乙基-雙(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二 甲醯亞胺)、 39 200813158 24843pif N,NM申乙基-雙(甲基烯丙基雙環[2·2·1]庚-5-烯-2,3-二 曱醯亞胺)、 Ν,Ν’-三亞曱基·雙(烯丙基雙環[2.2.1]庚-5_烯-2,3-二曱 酉藍亞胺)、 N,Nf-六亞曱基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱 聽亞胺)、 Ν,Ν’-六亞曱基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 十二亞甲基-雙(烯丙基雙環[2·2·1]庾各烯-2,3-二 甲醯亞胺)、 Ν,Ν’-十二亞曱基-雙(烯丙基曱基雙環[2.2.1]庚-5-烯 二甲醯亞胺)、 Ν,Ν’-環伸己基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲 酉藍亞胺)、 N,NL環伸己基-雙(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、 Ν,Ν-對伸苯基-雙(烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲 醯亞胺:)、 N,Nf-對伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 N,Nf_間伸苯基-雙(烯丙基雙環[2·2·1]庚-5-烯_2,3_二曱 醯亞胺)、 Ν,Ν’-間伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 40 200813158 24843pif N,N,-{(1-甲基)-2,4-伸苯基卜雙(烯丙基雙環[2.2.1]庚 -5-烯-2,3-二甲醯亞胺)、 N,NL對苯二曱基-雙(烯丙基雙環[2·2·1]庚-5-烯-2,3_二 曱醯亞胺)、 N,Nf-對苯二甲基-雙(烯丙基曱基雙環[2.2.1]庚冬烯 -2,3-二曱醯亞胺)、 Ν,Ν’-間苯二曱基-雙(烯丙基雙環[2·2·1]庚-5_烯-2,3-二 甲醯亞胺)、 Ν,Ν’-間苯二甲基-雙(烯丙基曱基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺)、 2,2·雙[4’-{4’_(烯丙基雙環[2·2·1]庚-5-烯_2,3_二曱醯亞 胺)苯氧基}苯基]丙烷、 2,2_雙[4’-{4’-(烯丙基曱基雙環[2.2.1]庚_5_烯-2,3-二曱 醯亞胺)苯氧基}苯基]丙烧、 2,2-雙[4f-{4’_(曱基烯丙基雙環[2·2·1]庚-5-烯二甲 醯亞胺)苯氧基}苯基]丙烷、 雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)苯基} 甲烷、 雙{4-(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺) 苯基}曱烷、 雙{4-(曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺) 苯基}曱烷、 雙{4-(甲基烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱醯 亞胺)苯基}甲烷、 41 200813158 24843pif 雙{4-(烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲醯亞胺)苯 基}驗、 雙{4-(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺) 苯基}醚、 雙{4-(曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺) 苯基}醚、 雙{4-(烯丙基雙環[2·2·1]庚-5-烯-2,3-二曱醯亞胺)苯基} 石風、 雙{4-(烯丙基曱基雙環[2-2-1]庚-5-烯-2,3-二曱醯亞胺) 苯基}•砜、 雙{4-(曱基烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲醯亞胺) 苯基}職。 作為前述烯基取代納迪克酸醯亞胺化合物,更好的化 合物可舉出以下化合物。 Ν,Ν’-伸乙基-雙(烯丙基雙環[2·2·1]庚-5-烯二甲醯 亞胺)、 N,Nf-伸乙基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二 甲醯亞胺)、 Ν,Ν’-伸乙基_雙(甲基烯丙基雙環[2·2·1]庚-5_烯-2,3-二 曱醯亞胺)、 N,Nf_三亞甲基-雙(烯丙基雙環[2.2.1]庚-5_烯-2,3-二曱 醯亞胺)、 N,N’_六亞曱基-雙(烯丙基雙環[2.2.1]庚-5_烯-2,3-二甲 醯亞胺)、 42 200813158 24843pif N,N’-六亞曱基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 N,N’-十二亞曱基-雙(烯丙基雙環[2·2·1]庚-5-烯-2,3-二 曱醯亞胺)、 Ν,ίνΓ-十二亞曱基-雙(烯丙基曱基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺)、 Ν,Ν’-環伸己基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱 醯亞胺)、 Ν,Ν’-環伸己基-雙(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、 Ν,Ν’-對伸苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱 醯亞胺)、 Ν,Ν’-對伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 Ν,Ν’-間伸苯基-雙(烯丙基雙環[2·2·1]庚-5-烯-2,3-二曱 醯亞胺)、 Ν,Ν’-間伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、 Ν,Ν4(1-曱基)-2,心伸苯基}雙(烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲醯亞胺)、 Ν,Ν’-對苯二曱基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二 曱醯亞胺)、 N,Nf-對苯二甲基-雙(烯丙基曱基雙環[2.2.1]庚-5-烯 -2,3-二甲醯亞胺)、 43 200813158 24843pif N,N’-間苯二曱基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二 曱醯亞胺)、 N,Nf-間苯二曱基-雙(烯丙基曱基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺)、 2.2- 雙[4’-{4’-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞 胺)苯氧基}苯基]丙烧、 2.2- 雙[4’-{44烯丙基曱基雙環[2.2.1]庚_5_烯_2,3_二甲 fc亞胺)苯氧基}苯基]丙烧、 2.2- 雙[4^{4,胃(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲 酉藍亞胺)苯氧基}苯基]丙烧、 雙{4-(烯丙基雙環[2.2.1]庚_5_烯-2,3_二曱醯亞胺)苯基} 甲烷、 雙{4-(烯丙基曱基雙環[2.2.1]庚-5_烯-2,3-二甲醯亞胺) 苯基}甲烷、 雙{4-(曱基烯丙基雙環[2.2.1]庚-5_烯-2,3-二甲醯亞胺) 苯基}曱烷、 雙{4-(曱基烯丙基曱基雙環[2·2·1]庚-5-烯-2,3-二甲醯 亞胺)苯基}甲烷。 較前述烯基取代納迪克酸醯亞胺化合物更好的化合 物,可舉出:以下述結構式(Ina — 1)所表示之雙{4-(烯 丙基雙環[2·2·1]庚-5-烯-2,3-二曱醯亞胺)苯基}甲烷、以下 述結構式(Ina-2)所表示之Ν,Ν’-間伸苯基_雙(缚丙基 雙環[2·2·1]庚j烯-2,3-二曱醯亞胺)、以及以下述結構式 (I — 3)所表不之N,Nf-六亞曱基-雙(歸丙基雙環[2 2 1] 44 200813158 24843pif 庚-5-烯-2,3-二甲醯亞胺)。 [化 18]In the above alkenyl-substituted nadic acid ylidene imide compound to be used in the present invention, an alkenyl-substituted nadic acid ruthenium imide compound such as these may be used singly or as a mixture of two or more of these compounds. As the above alkenyl-substituted nadic acid ylidene imide compound, preferred compounds include the following compounds. N, NM-ethyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,NW-ethyl-bis(allylhydrazinobicyclo[2.2.1 ]hept-5-ene-2,3-dimethylimineimine), 39 200813158 24843pif N, NM-ethyl-bis(methylallylbicyclo[2·2·1]hept-5-ene-2,3 - bisinimide), hydrazine, Ν'-trimethylene bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dioxanimine), N,Nf- Hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diindoleimine), anthracene, Ν'-hexamethylene-bis(allylmethyl) Bicyclo[2.2.1]hept-5-ene-2,3-diimineimine), dodecamethylene-bis(allylbicyclo[2·2·1]nonene-2,3- Dimethyl imine), hydrazine, Ν'-taudecyl-bis(allylhydrazinobicyclo[2.2.1]hept-5-enedimethylanilide), hydrazine, Ν'-ring extension Hexyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylindoleimine), N,NL cyclohexyl-bis(allylhydrazinobicyclo[2.2.1 ]hept-5-ene-2,3-dimethylimine), fluorene, fluorene-p-phenyl-bis(allylbicyclo[2·2·1]hept-5-ene-2,3- Dimethyl imine:), N, Nf-p-phenylene-double ( Propylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), N,Nf_inter)phenyl-bis(allylbicyclo[2·2·1]g -5-ene-2,3-diimine), hydrazine, Ν'-inter)phenyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-di曱醯imine), 40 200813158 24843pif N,N,-{(1-methyl)-2,4-phenylphenyl bis(allylbicyclo[2.2.1]hept-5-ene-2,3 -dimethylimine), N,NL-p-phenylenediyl-bis(allylbicyclo[2·2·1]hept-5-ene-2,3-diimide), N, Nf - p-Benzyl-bis(allyl-decylbicyclo[2.2.1]heptene-2,3-diimineimine), hydrazine, Ν'-m-phenylenedi-yl-bis(allyl Bicyclo[2·2·1]hept-5-ene-2,3-carboximine), hydrazine, Ν'-m-xylylene-bis(allylhydrazinobicyclo[2.2.1] Hg-5-ene-2,3-diimineimine), 2,2·bis[4'-{4'-(allylbicyclo[2·2·1]hept-5-ene_2, 3_diimine imine)phenoxy}phenyl]propane, 2,2_bis[4'-{4'-(allylhydrazinobicyclo[2.2.1]hept-5-ene-2, 3-diimineimine)phenoxy}phenyl]propane, 2,2-bis[4f-{4'-(mercaptopropylbicyclo[2·2·1]hept-5-ene Mercaptoimine)phenoxy}phenyl]propane, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-diimideimine)phenyl} methane, double {4-(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-diimineimine) phenyl}decane, bis{4-(decylallylbicyclo[2.2 .1]hept-5-ene-2,3-carboximine) phenyl}decane, bis{4-(methallylhydrazinobicyclo[2.2.1]hept-5-ene-2 ,3-diindoleimine)phenyl}methane, 41 200813158 24843pif bis{4-(allylbicyclo[2·2·1]hept-5-ene-2,3-dimethylimine) benzene }, double {4-(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-diimideimine) phenyl}ether, double {4-(decyl allyl Bicyclo[2.2.1]hept-5-ene-2,3-diimineimine) phenyl}ether, bis{4-(allylbicyclo[2·2·1]hept-5-ene- 2,3-diindoleimine)phenyl} stone wind, double {4-(allylhydrazinobicyclo[2-2-1]hept-5-ene-2,3-diimineimine) Phenyl}•sulfone, double {4-(mercaptopropylbicyclo[2·2·1]hept-5-ene-2,3-dimethylimine) phenyl}. As the above alkenyl-substituted nadic acid ylidene imide compound, preferred compounds include the following compounds. Ν,Ν'-extended ethyl-bis(allylbicyclo[2·2·1]hept-5-enedimethylanilide), N,Nf-extended ethyl-bis(allylmethylbicyclo) [2.2.1]hept-5-ene-2,3-dimethylimine), hydrazine, Ν'-extended ethyl-bis(methylallylbicyclo[2·2·1]hept-5_ Alkene-2,3-diimineimine), N,Nf_trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), N , N'_hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), 42 200813158 24843pif N,N'-hexamethylene-based Bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), N,N'-dodedecyl-bis(allylbicyclo[2· 2·1]hept-5-ene-2,3-diimineimine), hydrazine, ίνΓ-taudecyl-bis(allylhydrylbicyclo[2.2.1]hept-5-ene- 2,3-diimine), hydrazine, Ν'-cyclohexyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), hydrazine, Ν'-cyclohexyl-bis(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-carboximine), hydrazine, Ν'-p-phenylene-bis(ene) Propylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), hydrazine, hydrazine - p-phenyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), fluorene, Ν'-interphenylene-bis(allyl Bicyclo[2·2·1]hept-5-ene-2,3-diimineimine), fluorene, Ν'-inter)phenyl-bis(allylmethylbicyclo[2.2.1]g -5-ene-2,3-dimethylimine), hydrazine, Ν4(1-indenyl)-2, phenylphenyl}bis(allylbicyclo[2·2·1]hept-5- Alkene-2,3-dimethylimine), hydrazine, Ν'-p-phenylenediyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimine ), N,Nf-p-xylylene-bis(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), 43 200813158 24843pif N,N'- m-Benzadienyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), N,Nf-m-benzodiazepine-bis(allylhydrazine) Bicyclo[2.2.1]hept-5-ene-2,3-diimineimine), 2.2-bis[4'-{4'-(allylbicyclo[2.2.1]hept-5-ene -2,3-dimethylimine imine)phenoxy}phenyl]propane, 2.2-bis[4'-{44allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3 _ dimethyl fc imine) phenoxy} phenyl] propyl, 2.2- bis [4 ^ {4, stomach (methylallyl bicyclo [ 2.2.1]hept-5-ene-2,3-dimethyl phthalimide)phenoxy}phenyl]propane, double {4-(allylbicyclo[2.2.1]hept-5-ene -2,3_diimine)phenyl}methane, bis{4-(allylhydrylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine) phenyl }methane, bis{4-(decylallylbiscyclo[2.2.1]hept-5-ene-2,3-dimethylimine) phenyl}decane, double {4-(decyl allylic Base bisbicyclo[2·2·1]hept-5-ene-2,3-dimethylimine)phenyl}methane. The compound which is more preferable than the above-mentioned alkenyl-substituted nadic acid ylidene imide compound is exemplified by a double {4-(allylbicyclo[2·2·1]g which is represented by the following structural formula (Ina-1). -5-ene-2,3-diimineimine)phenyl}methane, anthracene represented by the following structural formula (Ina-2), Ν'-meta-phenylene-bis(co-propylbicyclo[2] ·2·1]heptene-2-eneimine), and N,Nf-hexaindolyl-bis(propylidenebicyclo) represented by the following structural formula (I-3) 2 2 1] 44 200813158 24843pif G-5-ene-2,3-dimethylimine). [Chem. 18]
<2.本發明所使用之雜環化合物> 本發明所使用之雜環化合物,具有選自以環氧乙烷 (oxirane)、氧環丁烧(oxetane)、嗟喃(thiirane)、氮丙 唆(aziridine)、以及喔嗤琳所組成之族群的一個或二個以 上之雜環結構。前述雜環化合物,可為具有前述雜環結構 的一種化合物,亦可為二種以上的化合物。一個前述雜環 化合物中,可僅具有一種雜環結構,亦可具有二種以上雜 環結構。另外,一個前述雜環化合物中,可具有一個前述 雜環結構,但較好的是具有二個以上前述雜環結構。 另外,雜環化合物,可為在侧鏈上具有雜環結構之聚 合物,亦可為共聚物。在側鏈長具有雜環結構之聚合物, 45 200813158 24843pif J為在側鏈上具有料結構的單 鍵上具有雜環結構的單體鱼不 ^物,亦可為在側 物:在側鏈上具有雜環結構之共=環結構的單體之共聚 雜環結構的二種以上單 取:’可為在側鏈上具有 物。 種以上早體與具有雜環結構的單體之4<2. Heterocyclic compound used in the present invention> The heterocyclic compound used in the present invention has a selected from the group consisting of oxirane, oxetane, thiirane, and nitrogen. Aziridine, and one or more heterocyclic structures of the group consisting of 喔嗤 。. The above heterocyclic compound may be one compound having the above heterocyclic structure, or may be two or more kinds of compounds. One of the aforementioned heterocyclic compounds may have only one heterocyclic structure, and may have two or more heterocyclic structures. Further, one of the aforementioned heterocyclic compounds may have one of the above heterocyclic structures, but preferably has two or more of the above heterocyclic structures. Further, the heterocyclic compound may be a polymer having a heterocyclic structure in a side chain or a copolymer. A polymer having a heterocyclic structure in a side chain length, 45 200813158 24843pif J is a monomeric fish having a heterocyclic structure on a single bond having a material structure in a side chain, and may also be in a side material: in a side chain Two or more kinds of copolymerized heterocyclic structures of a monomer having a heterocyclic ring structure having a heterocyclic structure: ' may have a substance in a side chain. 4 kinds of precursors and monomers having a heterocyclic structure
‘述雜铺射具有㈣子 A I 液晶配向劑抑制離子密产以 3别处雜被化合物之 不明確,但一沪埤炎^二、、^長^穩定性優異之理由尚 雜原子與聚醯胺酸;的】合物中的雜環結構中的 的膜中的雜環化合物的二;(偏:膜$成液晶配向膜時 關。因此,前述雜環化合物,例較^及有 作用之^原子可與聚酿胺酸的反應之、可引起這些 環結二要具有環氧乙燒(°xirane)作為雜 化合物)、下;;細為「環氧w ㈣ 雜環化有棘了垸(Gxetane)作為雜環結構之 亦稱為「氧環丁烧^ 下,亦稱=_)作為雜環結構之雜環化合物(以 r . :、噻喃(thllrane)化合物」)、主要具有氮丙啶 ==作為雜環結構之雜環化合物(以下有^ 為料yazmdme)化合物」)、以及主要具有射琳作 ί )車rf之雜環化合物(以下,亦稱為「。惡㈣化合 」乂子的是,對溶解本發明所使用之聚醯胺酸或其衍 46 200813158 24843pif 生物的溶劑為可溶。 作為氧環丁烧(oxetane)化合物,可舉出··雙[(3-乙 基-3-環氧丙烷基甲氧基)甲基]苯、雙[(3_乙基_3_環氧丙烷 基甲氧基)曱基苯基]甲烷、雙[(3_乙基_3_環氧丙烷基曱氧基) 甲基苯基]_、雙[(3-乙基-3-環氧丙烷基甲氧基)甲基苯基] 丙烷、雙[(3-乙基-3-環氧丙烷基曱氧基)甲基苯基]颯、雙[(3_ 乙基環氧丙烷基甲氧基)甲基苯基]_、雙[(3•乙基_3_環 氧丙烷基曱氧基)甲基苯基;]六氟丙烷、三乙基_3_環氧丙 烧基甲氧基)甲基]笨、,及四[(3_乙基1環氧丙淀基甲氧基) 曱基]苯等。其他亦可舉出:具有環氧丙烷基之寡聚物及聚 合物。 作為噻喃(thiirane )化合物,可舉出:例如依照 JOrg.Chem.,28,229(1963)中記載的方法,將苯基縮水甘油 基醚、丁基縮水甘油基_、3,3,3_三氟甲基氧化_、氧化 苯乙烯、六氟氧化丙烯、氧化環己烯、汴縮水甘油基酞醯 亞胺、(九氟-N-丁基環氧化物、全氟乙基縮水甘油基鍵、 環氧氯丙烧、環氧溴丙院、N,N-二縮水甘油基苯胺、以及 3·[2_(王氟己基)乙氧基]_ι,2_環氧丙燒、乙二醇二 油 細、聚乙二醇二縮水甘油基醚、丙二醇二縮水油細、 二丙二醇二縮水甘油基醚、聚丙二醇二縮水甘油基醚、新 戊二醇二縮水甘油基轉、〗,6_&二醇二縮水甘油基醚、甘 油二縮水甘油基醚、2,2-二溴新戊二醇二縮水甘油基醚、 以及3-(Ν,Ν-二縮水甘油基)胺基丙基三甲氧基矽烷、 1,3,5,6_四縮水甘油基_2,4-己二醇、N,RN,,Nl四縮水甘油基 47 200813158 24843pif =二曱苯二胺、U·雙(N,N_二縮水甘油驗基甲基)環己 烷、n,w,n’,縮水甘油基妙二胺基二苯基甲烧、以 及HN-稀丙基-ν'縮水甘油基)胺基丙基三 炫中 =水甘油基的氧取代成硫,且將前述縮水甘油^取代成 %石瓜乙烷(ethylene sulfide)基之化合物等。 作為氮丙啶基化合物,可舉出:2 其 卜 z,4,6義二(1麵虱丙口疋 基)-ι,3,5-二。秦、ω_氮丙咬基丙酸办二經基曱基庚醇三 醋:2,4,6·三(2-曱基_1_氮丙咬基)·^·三嗪、2,4,6-三(2· ^基-=丙絲)_],3,5_三嗪、4,4ι_雙(乙烯基亞絲缓基胺 =)一本基曱烷、雙(2_乙基_丨_氮丙啶基)笨-^·二甲醯胺、 三(2-乙基-1-氮丙啶基)苯_U,5-三曱醯胺、雙(2_乙基二丨-氮 丙啶基)癸二酸醯胺、1,6-雙(乙烯基亞胺基羰基胺基 烷、2,4-二伸乙基醯脲曱苯、Ul羰基-雙伸乙基亞胺"、聚 亞曱基_雙乙基脲(C2〜C4)、以及Ν,Ν,-雙(4,6-二伸乙^ 亞月女基-1,3,5-二嘻-2-基)六亞甲基一胺等。其他亦可舉出· 具有氮丙啶基之寡聚物及聚合物。 作為噁唑啉化合物,可舉出:2,2’_雙(2-噁唑琳)、丨2 4_ 二(2_噁唑啉基_2)苯、4-呋喃-2-基亞甲基苯基_4;^惡哇 酮、1,4_雙(4,5_二氫-2_噁唑基)苯、1,3_雙(4,5_二氫_^噁 哇基)苯、2,3_雙⑷異丙烯基_2_噁唑啉1基)丁烷、2,2,_雙_4_ 卞基-2-σ惡唾琳、2,6-雙(異丙基坐琳-2-基)吼。定、22, 亞異丙基雙(4-第三丁基-2-噁唑啉)、2,2’-亞異丙基雙(4_苯 基琳)、2,2l亞甲基雙(4-第三丁基-2-喔哇琳)、及2 2,_ 亞甲基雙(4-苯基-2-噁唑啉)等。其他,亦可舉出如 48 200813158 24843pif (商品名:日本觸媒股份有限公司製)之具有°惡 上基之XK合物及寡聚物。 减乙⑥化合物,例何舉t縮水甘油基峻型 =匕匕合物、师1狀族環氧乙烷化合物、縮水甘油 ^曰11%氧乙烧化合物、縮水甘油基胺型環氧乙燒化合 物、雜環式環氧乙咖合物、包含環氧乙絲之丙烯酸系 化合物、矽烷型環氧乙烷化合物等。'The description of the miscellaneous paving has (4) sub-AI liquid crystal alignment agent to inhibit the ion density production of the compound at 3 other places is not clear, but the reason for the excellent stability of a 埤 埤 ^ ^, ^ ^ ^ ^ is still a hetero atom and polyamine a compound of the heterocyclic ring in the heterocyclic structure of the compound; (part: when the film is a liquid crystal alignment film). Therefore, the above heterocyclic compound, for example, has an effect ^ The reaction of the atom with poly-aracine can cause the ring to have ethylene bromide (βxirane as a hetero compound), and the lower; the epoxy (w) heterocyclic ring has a spine ( Gxetane) as a heterocyclic structure, also known as "oxycyclobutane, also known as =_" as a heterocyclic compound heterocyclic compound (r. :, thioran (thllrane) compound), mainly having nitrogen and hydrogen A pyridine == a heterocyclic compound (hereinafter referred to as a yazmdme compound) as a heterocyclic structure, and a heterocyclic compound mainly having a ruthenium (hereinafter, also referred to as ". evil (four) compound" 乂The solvent for dissolving the polylysine used in the present invention or its derivative 46 200813158 24843pif organism is soluble. Examples of the oxetane compound include bis[(3-ethyl-3-epoxypropenylmethoxy)methyl]benzene and bis[(3_ethyl_3_epoxy). Propane methoxy)nonylphenyl]methane, bis[(3_ethyl_3_epoxypropenyl methoxy)methylphenyl]-, bis[(3-ethyl-3-epoxy) Propane methoxy)methylphenyl]propane, bis[(3-ethyl-3-epoxypropenyl methoxy)methylphenyl]anthracene, bis[(3_ethyl propylene oxide methoxy) Methylphenyl]-, bis[(3•ethyl_3_epoxypropenyloxy)methylphenyl;]hexafluoropropane, triethyl_3_epoxypropyl methoxy Methyl) is stupid, and tetra[(3-ethyl 1 epoxidized methoxy) decyl] benzene and the like. Other examples include oligomers and polymers having an oxypropylene group. Examples of the thiirane compound include phenyl glycidyl ether, butyl glycidyl group, and 3, 3, 3 - 3 according to the method described in JOrg. Chem., 28, 229 (1963). Fluoromethyl oxidation _, styrene oxide, hexafluoropropylene oxide, cyclohexene oxide, guanidinium hydrazide, (nonafluoro-N-butyl epoxide, perfluoroethyl glycidyl bond, Epoxy chloropropene, epoxy bromide, N,N-diglycidyl aniline, and 3·[2_(Wangfluorohexyl)ethoxy]_ι, 2_epoxypropene, ethylene glycol Fine, polyethylene glycol diglycidyl ether, propylene glycol dicondensate oil, dipropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl, -6, diol Diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, and 3-(anthracene, Ν-diglycidyl)aminopropyltrimethoxydecane 1,3,5,6_tetraglycidyl 2,4-hexanediol, N,RN,,Nl tetraglycidyl 47 200813158 24843pif = Diphenylene diamine, U·double (N N-diglycidylmethyl)cyclohexane, n,w,n', glycidyl diaminodiphenylcarbamate, and HN-dil-v'glycidyl)aminopropyl In the case of the base, the water glyceryl group is substituted with sulfur, and the glycidol is substituted with a compound of the ethylene sulfide group. The aziridine compound may, for example, be 2, 4, 6 or 2 (1 虱 虱 疋 ))-ι, 3, 5 - 2 . Qin, ω_Aziridine-based propionic acid, bis-hydrazinyl heptanol, vinegar: 2,4,6·tris(2-indolyl-1_azepine), ^·triazine, 2,4 ,6-tris(2·^-based-=propane)_], 3,5-triazine, 4,4ι_bis (vinyl sulfite-based amine)-based decane, double (2_B丨_丨_aziridine group) stupid-^·dimethylamine, tris(2-ethyl-1-aziridine)benzene_U,5-tridecylamine, bis(2-ethyl)丨-aziridine) decanoic acid decylamine, 1,6-bis(vinyliminocarbonylaminoalkane, 2,4-diethylidene hydrazine, Ulcarbonyl-double-stranded ethyl Amines ", polyarylene-diethylurea (C2~C4), and Ν,Ν,-bis (4,6-di-extension-ethyl]--------- -yl) hexamethylene monoamine, etc. Other examples include oligomers and polymers having an aziridine group. As the oxazoline compound, 2,2'-double (2-oxo) Zolinium), 丨2 4_bis(2-oxazolinyl-2-)benzene, 4-furan-2-ylmethylenephenyl_4;^vowacean, 1,4_bis (4,5_ Dihydro-2-oxazolyl)benzene, 1,3_bis(4,5-dihydro-^-wodoyl)benzene, 2,3-bis(4)isopropenyl-2-oxazoline-1-yl) Alkane, 2, 2, _ double _4_ fluorenyl-2- sigma, 2,6 - Bis(isopropyl sitin-2-yl) oxime. Ding, 22, isopropylidene bis(4-tert-butyl-2-oxazoline), 2,2'-isopropylidene bis(4-phenylene), 2,2l methylene bis ( 4-tert-butyl-2-indolyl), and 2 2,_methylenebis(4-phenyl-2-oxazoline) and the like. Other examples include XK compounds and oligomers having a ketone base such as 48 200813158 24843pif (trade name: manufactured by Nippon Shokubai Co., Ltd.). Decrease the compound of 6-6, for example, what is the glycidyl group of the glycidyl group = the compound of the formula, the oxirane compound of the group 1 , the glycidyl compound, the 11% oxyethylene compound, the glycidylamine type A compound, a heterocyclic epoxy-acetate compound, an acrylic compound containing an ethylene oxide, a decane-type oxirane compound, or the like.
,作為縮水甘油基醚型環氧乙烷化合物市售品,例如可 舉出· Epikote 100卜 Ep彳kote 10〇2、Epikote 1003、Epikote 1004、Epikote l〇〇7、Epikote 1009、Epikote 1010( Yuka ShellAs a commercially available product of a glycidyl ether type oxirane compound, for example, Epikote 100, Ep彳kote 10〇2, Epikote 1003, Epikote 1004, Epikote l〇〇7, Epikote 1009, Epikote 1010 (Yuka) Shell
Epoxy (股)製)、Epikote 8〇7 ( Yuka Shell Ep〇Xy (股) 製)’作為脂肪環狀族環氧乙烧化合物市售品,例如CY一Epoxy (manufactured by Epoxy Co., Ltd.) and Epikote 8〇7 (manufactured by Yuka Shell Ep〇Xy Co., Ltd.) as a commercial product of a fatty ring-shaped epoxy epethane compound, such as CY
175、CY- 177、CY- 179 (CIBA-GEIGY 公司製)、ERL 一4234、ERL-4299、ERL-4221、同 4206 ( U.C.C·公司 製);作為縮水甘油基酯型環氧乙烷化合物市售品,例如: シa —夕、、彳> 508 (昭和電工(股)製)、AralditCY—182、175, CY-177, CY-179 (manufactured by CIBA-GEIGY Co., Ltd.), ERL-4234, ERL-4299, ERL-4221, and 4206 (manufactured by UCC·Company); as a glycidyl ester type oxirane compound For sale, for example: シa — 夕, 彳 508 (Showa Denko (share) system), AralditCY 182,
Araldit CY — 192、Araldit CY — 184 ( CIBA— GEIGY 公司 衣)、EPICL0N 200、EPICL0N 400 ( Dainippon Ink (股) 製)、Epikote 871、Epikote 872 (Yuka Shell Epoxy (股) 製)、ED — 5661、ED — 5662 ( Celanese Coating (股)製),· 作為縮水甘油基胺型環氧乙烷化合物,例如:四縮水甘油 基二胺基二苯基甲烷、三縮水甘油基對胺基酚、三縮水甘 油基間胺基酚、二縮水甘油基苯胺、二縮水甘油基曱苯胺、 四縮水甘油基間苯二曱基二胺、二縮水甘油基三溴苯胺、 49 200813158 24843pif 四縮水甘油基雙胺基甲基環己烷;作為雜環式環氧乙烷化 合物市售品’例如Araldit PT81 〇( CIBA — GEIGY公司製)、Araldit CY — 192, Araldit CY — 184 (CIBA – GEIGY), EPICL0N 200, EPICL0N 400 (Dainippon Ink), Epikote 871, Epikote 872 (Yuka Shell Epoxy), ED — 5661, ED — 5662 (made by Celanese Coating), as a glycidylamine-type oxirane compound, for example, tetraglycidyldiaminediphenylmethane, triglycidyl-p-aminophenol, triple-shrinkage Glyceryl m-amino phenol, diglycidyl aniline, diglycidyl aniline, diglycidyl isophthalonitrile diamine, diglycidyl tribromoaniline, 49 200813158 24843pif diglycidyl bisamine Methylcyclohexane; commercially available as a heterocyclic oxirane compound, such as Araldit PT81® (CIBA – manufactured by GEIGY),
Epikote RXE — 15 ( Yuka Shell Epoxy (股份)製)、epiteC (曰產化學(股份)製);作為包含環氧乙烷基之丙烯酸系 化合物,可將具有環氧乙烷基的自由基聚合性化合物單獨 地及/或與其他自由基聚合性化合物一同於溶劑中進行自 由基聚合轉得。作為具有環氧6絲的自由絲合化合 物、,例如可舉出··__水甘油基酯、f基丙烯酸縮水 二油基、α-乙基丙烯酸縮水甘沽基酯、α_正丙基丙烯酸 甘油基知、α_正丁基丙烯酸縮水甘油基酯、丙烯酸_3,斗_ ^氧丁基酯、曱基丙烯酸_3,4_環氧丁基酯、丙烯酸_6,'環 ,,基酉日、甲基丙稀酸_6,7_環氧己基酯、心乙基丙烯酸_6,7_ =己基酯、Ν-[4_(2,3_環氧丙氧基)_3,5_二甲基节基]丙烯 ΐ^#Ν_[4·(2,3_環氧喊基>3>二甲基苯基丙基]丙烯 旦轉另外’此處所舉出之環氧乙烧化合物之多數為高分子 但作為本發明所使用之環氧乙烧化合物 ,並非被分 甘2制’例如亦可使用如雙紛Α或者雙紛F的二縮水 、、夜曰j樣之低分子量體。其中,若為低分子量體則有向 液曰曰^之可能性,故而較好的是高分子量體。 油$其!^^型%氧乙燒化合物,例如可舉出:(3、缩水甘 甲^土)二甲氧基石夕力完、(3'縮水甘油氧基丙基)曱基二 、2-(3,4鐵環己基)乙基三甲氧基魏、5,6_ 乳己基三乙氧基魏,縮水甘油氧基丙基)二甲基乙 50 200813158 氧基矽烷、(3-縮水甘油氧基丙基)曱基二乙氧基矽烷等。 為了使環氧乙烷基的效果顯著化,亦可於本發明所使 用之環氧乙烧化合物中添加助觸媒。 作為助觸媒,例如可舉出·· σ比17各、味唾、啦嗤、啦12定、 吼嗪、嘴σ定、叫丨σ朵、,嗤、苯幷味17坐、異三聚氰酸等。這 些之中,以2-曱基口米嗤、2-乙基-4-曱基1:7米嗤、2-十七基口米 唑、4-甲基-2-苯基咪唑、1-苄基-2-曱基咪唑、2_乙基-4-曱 基_1,(2’_氮基乙基)口米σ坐、2-乙基-4_曱基-1-[2’-(3’’,5?’-二月安基 三嗦基)乙基]σ米吐、笨幷畔/坐等17米嗤彳厅生物為宜。這些助 觸媒,可單獨使用或者將2種以上組合使用,一般而言, 較好的是,以相對於環氧乙烷化合物(以總量計)為0.01 〜10重量份的比例使用。 作為本發明所使用之噁嗪化合物,例如可舉出:下述 通式(a)〜(f)所表示之化合物,但並不特別限定於這 些〇 [化 19]Epikote RXE — 15 (manufactured by Yuka Shell Epoxy Co., Ltd.) and epiteC (manufactured by Seiko Chemical Co., Ltd.); as an acrylic compound containing an oxirane group, radical polymerizable having an oxirane group The compound is obtained by radical polymerization of the compound alone and/or together with other radically polymerizable compounds in a solvent. Examples of the free silk compound having an epoxy 6 filament include, for example, water glycidyl ester, f-based acrylic acid-deficient dioleyl group, α-ethyl acrylate glycidyl ester, and α-n-propyl group. Acrylic glyceryl, α-n-butyl acrylate glycidyl ester, acrylic acid _3, oxo oxy butyl ester, methacrylic acid _3, 4 epoxide butyl ester, acrylic acid -6, 'ring, Base Day, methacrylic acid _6,7_epoxyhexyl ester, heart ethene _6,7_ = hexyl ester, Ν-[4_(2,3_epoxypropoxy)_3,5_ Dimethyl] propylene ΐ Ν [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ Most of them are polymers, but the epoxy ethene compound used in the present invention is not classified into two types. For example, it is also possible to use a divergent water such as a double or a double F, and a low molecular weight body such as a nightingale. Among them, in the case of a low molecular weight body, there is a possibility of enthalpy, and therefore a high molecular weight body is preferred. The oil is a ^^ type % oxyethylene compound, for example, (3, shrinkage) Glycyrrhizin , (3' glycidoxypropyl) decyl di, 2-(3,4 iron cyclohexyl) ethyl trimethoxy Wei, 5,6- hexylhexyl triethoxy Wei, glycidoxypropyl) Dimethylethylene 50 200813158 Oxydecane, (3-glycidoxypropyl)decyldiethoxydecane, and the like. In order to make the effect of the oxirane group remarkable, a catalyst can also be added to the epoxy ethene compound used in the present invention. Examples of the co-catalyst include, for example, σ ratio 17 each, taste saliva, 嗤 嗤, 啦 12 定, 吼 azine, mouth σ 、, 丨 朵 朵, 嗤, benzoquinone taste 17 sitting, heterotrimerization Cyanate and the like. Among these, 2-indole base rice, 2-ethyl-4-mercapto 1:7 m hydrazine, 2-17-base azole, 4-methyl-2-phenylimidazole, 1- Benzyl-2-mercaptoimidazole, 2-ethyl-4-indenyl-1, (2'-nitroethyl) hydroxy sylylene, 2-ethyl-4- fluorenyl-1-[2' -(3'',5?'-February Anji Sansyl) Ethyl] sigma sputum, awkward side / sitting and waiting 17 meters 嗤彳 hall creatures is appropriate. These catalysts may be used singly or in combination of two or more kinds. In general, it is preferably used in a proportion of 0.01 to 10 parts by weight based on the total amount of the oxirane compound (in terms of the total amount). The oxazine compound to be used in the present invention may, for example, be a compound represented by the following formulas (a) to (f), but is not particularly limited to these compounds.
51 200813158 24843pif 通式(a)、(b)、(c)、(d)、(e)、(f)中,r]&r2/分 別表示碳數1〜10的有機基,R3至R6分別本—&二、+ = 〜衣不氣或者石反 數1〜6的烴基,X表示單鍵、-0-、各、s!、w Λ -CO- Λ -CONH-、-NHCO-、-C(CH3)2-、-C(CF3)2…(CH )、 -S-、-CO-、-C(CH3)2-、-C(CF3)2_4者碳數丨〜3 的伸烷基。 通式(a)、(b)、(c)、(d)、(e)、(f)中,與苯環、^環 鍵結的氫亦可獨立地被取代成_F、_CH 〇Η、、 -S〇3H、或者-ί>〇3Η2。 -0-(CH2)m-0·、或者-S-(CH2)m-S-,m 表示 n _數m。' 另外’通式(〇、(f)中,Y獨立地表示單鍵二_〇_、51 200813158 24843pif In the general formulae (a), (b), (c), (d), (e), (f), r]&r2/ respectively represent an organic group having a carbon number of 1 to 10, and R3 to R6; Separately -&2, + = ~ a gas-free or stone-reverse number 1 to 6 hydrocarbon group, X represents a single bond, -0-, each, s!, w Λ -CO- Λ -CONH-, -NHCO- , -C(CH3)2-, -C(CF3)2...(CH), -S-, -CO-, -C(CH3)2-, -C(CF3)2_4, carbon number 丨~3 alkyl. In the general formulae (a), (b), (c), (d), (e), (f), the hydrogen bonded to the benzene ring or the ring may be independently substituted into _F, _CH 〇Η , -S〇3H, or -ί>〇3Η2. -0-(CH2)m-0·, or -S-(CH2)m-S-, m represents n _ number m. In the 'other' formula (〇, (f), Y independently represents a single bond _〇_,
另外,本發明所使用之噁嗪化合物,包含在側鏈上具 有喔唤結構之絲物及聚合物、在域上具有喔嗪 寡聚物及聚合物。 作為以通式(a)所表示之。惡嗪化合物,例如可 以下列結構式及通細表示之㈣化合物。 [化 20]Further, the oxazine compound to be used in the present invention comprises a filament having a stimulating structure in a side chain and a polymer, and a azine pyrimide and a polymer in the domain. It is represented by the general formula (a). The oxazine compound can be, for example, a compound of the following formula (4). [Chem. 20]
㈣) (a,2) 通式(a~2)中,只1 好的是碳數1〜20的垸基睛的是碳數1〜3G的院基,更 52 200813158 24843pif 作為以通式(b)表示之噁嗪化合物,例如可舉出:以 下列結構式及通式所表示之噪嗪化合物。 [化 21](4)) (a, 2) In the general formula (a~2), only 1 is a carbon number of 1 to 20, and the base of the carbon is 1 to 3G, and 52 is the base of the 200813158 24843pif. b) The oxazine compound to be represented, for example, is a oxazine compound represented by the following structural formula and formula. [Chem. 21]
㈣) {5-2}(iv)) {5-2}
53 200813158 24843pif 通式(b —2)、(b—8)、(b—10)中,R1 較好的是, 分別獨立為碳數1〜30的烷基,更好的是碳數1〜20的烷 基。 作為以通式(c)所表示之噁嗪化合物,例如可舉出以 下列結構式及通式所表示之噁嗪化合物。 [化 22]53 200813158 24843pif In the general formulae (b-2), (b-8), (b-10), R1 is preferably an alkyl group independently having a carbon number of 1 to 30, more preferably a carbon number of 1~ 20 alkyl groups. The oxazine compound represented by the formula (c) includes, for example, an oxazine compound represented by the following structural formula and formula. [化22]
54 200813158 24843pif54 200813158 24843pif
(c-10)(c-10)
{0-14) 通式(c — 2)、(c — 4)、(c一6)、(c一8)、(c一 10)、(c 一 12)中,R1較好的是碳數1〜30的烧基,更好的是碳數 1〜20的烧基。 作為以通式(d)所表示之噁嗪化合物,例如可舉出: 以下列結構式所表示之噁嗪化合物。 [化 23] 55 200813158 24843pif{0-14) In the general formulae (c-2), (c-4), (c-6), (c-8), (c-10), (c-12), R1 is preferably carbon. The number of the alkyl groups of 1 to 30 is more preferably a carbon number of 1 to 20. The oxazine compound represented by the formula (d) is, for example, an oxazine compound represented by the following structural formula. [Chem. 23] 55 200813158 24843pif
(d-7)(d-7)
(d_8)(d_8)
作為以通式(e)表示之噁嗪,例如可舉出以下列結構 式表示之σ惡嗪化合物。 56 200813158 24843pif [化 24]The oxazine represented by the formula (e) is, for example, a sigrozine compound represented by the following formula. 56 200813158 24843pif [Chem. 24]
構式所表示之σ惡嗓化合物。 [化 25]The σ oxime compound represented by the configuration. [Chem. 25]
57 200813158 24843pif57 200813158 24843pif
這些之中,更好地舉出:以結構式(b—l)、(c—1)、 (c一3)、(c一5)、(c一7)、(c一9)、(d— 1)〜(d — 6)、 (e — 3)、(e — 4)、(f—2)〜(f—4)所表示之秦化合 58 200813158 24843pif 物0 W述噁嗪化合物,例如可藉由與w〇2〇〇4/〇〇97〇8、日 本專利特開平11 — 12258號公報、日本專利特開2〇〇4 — 352670號公報中所記載方法同樣的方法來製造。 <3.本發明所使用之聚醯胺酸或者其衍生物> 本發明所使用之聚醯胺酸或其衍生物,於製成後述液 晶配向劑岐溶解於溶劑之形態,於將其液晶配向劑製成 後述液晶配向膜時’是可形成以聚酿亞胺為域分的液晶 配向胲之成分。作為如此之聚醯胺酸或其衍生铷,也丨‘可 舉出L酸、可溶性聚輕胺、聚gi胺酸g旨、^及聚 酿胺酸義等。更具體而言,可舉出:⑴聚醯胺酸的全 部胺基與祕進行脫水_反應㈣叙㈣亞胺、⑵ 進行部分性脫水閉環反應而形成之部分聚醯空胺、⑶聚 醯胺酸的誠被變換細旨之聚_酸§旨、⑷ 酸二 物中所含的酸二酐的一部分取代成有機二誠而反 跡㈣料㈣、糾(5)使該聚雜 ir之勿的一部分或者全部進行脫水閉環反應而 物’:為,成分中的—個成分,亦可為二個以:成二 鈿述?胺酸或其衍生物,較# ~ B 的四賴二《料胺成’㈣為酸成分 ^ i ± 刀的—^反應而獲得之聚醯胺 酉义。J發明中,可使用如此之聚醯胺酸。 珂述聚醯胺酸或其衍生物,可藉由 的反應而獲得。本發明之四_二軒,可;用 59 200813158 24843pif 以上之四賴讀,但四驗二酐的—部分亦可被取代成 二賊。此處,二細Μ目對於四紐二技比率,較好 是10 mol%以下。 本發明之二胺,可使用—種或二種以上之二胺,但二 胺的-部分亦可被取代成單胺。此處,較好的是,將單胺 相對於二胺之比率設為1〇 mol%以下。Among these, it is better to mention: structural formula (b-1), (c-1), (c-3), (c-5), (c-7), (c-9), D-1)~(d-6), (e-3), (e-4), (f-2)~(f-4) Qin Qinhe 58 200813158 24843pif 0W oxazine compound, For example, it can be produced by the same method as the method described in Japanese Patent Laid-Open No. Hei 11-12258, Japanese Patent Application Laid-Open No. Hei No. Hei No. Hei. <3. Polylysine or derivative thereof used in the present invention> Polylysine or a derivative thereof used in the present invention is prepared by dissolving a liquid crystal alignment agent described later in a solvent. When the liquid crystal alignment agent is formed into a liquid crystal alignment film to be described later, it is a component which can form a liquid crystal alignment enthalpy in the form of a polyimide. Examples of such a polyamic acid or a derivative thereof include L acid, soluble polyamine, polygilic acid, and polyamic acid. More specifically, (1) all of the amine groups of poly-proline are dehydrated and reacted (four) (iv) imine, (2) part of the polyether amine formed by partial dehydration ring closure reaction, (3) polydecylamine The acidity is changed by the specific purpose of the poly-acid §, (4) part of the acid dianhydride contained in the acid two is replaced by organic two sincere and reversal (four) material (four), correct (5) to make the poly ir Part or all of the dehydration ring-closing reaction, the product ': is, the component of the component, or two of them: two to describe the amino acid or its derivative, compared to #~B The amine is '(4) is the polyamine derivative obtained by the acid component ^ i ± knife-^ reaction. In the J invention, such a polyamine can be used. The poly-proline or a derivative thereof can be obtained by a reaction. The fourth invention of the present invention can be used; the use of 59 200813158 24843pif for the above four readings, but the portion of the four dianhydrides can also be replaced by the second thief. Here, the ratio of the two fine items to the four-two-two technique is preferably 10 mol% or less. As the diamine of the present invention, one type or two or more kinds of diamines may be used, but the - part of the diamine may be substituted with a monoamine. Here, it is preferred that the ratio of the monoamine to the diamine is 1 〇 mol% or less.
前述四叛酸二酐,可任意地選擇-個或二以上的化合 物使用。當使用二個以上的四鏡二酐時,較好的是,使 周芳香族岭酸二作為酸的Λ成分m防族四叛酸 二酐及脂環式_酸二_—個或兩個作為酸的B成分。 這些四魏二I可分別使用—個或二個以上的化合物。 另外,為=用本發明之聚_酸作為液晶配向劑的 成分,較好的疋4可溶解於溶劑之形g。為了 之聚醯胺酸製成該可溶之職,較好的是適當選擇用作酸 成分之四羧酸二酐。 此處,=用作酸的A成分之前述芳香族 酐’例如可舉HX下缝構式⑴〜(18)所表示之酸 二酐作為具體例。下述芳香族四魏二 以結構式(1)、⑺、(5)、⑷、⑺ 更好地舉出 二酐,最好地舉出:以結構式)所表不之酸 稱式所表不之均苯四甲酸二 酐0 [化 26]The above four ortho-acid dianhydrides can be used arbitrarily for one or two or more compounds. When two or more tetrahedral dianhydrides are used, it is preferred that the aromatic succinic acid is used as the bismuth component of the acid, the anti-family tetrahydrous dianhydride, and the alicyclic _acid two or two. As the B component of the acid. These tetra-di-I can use one or two or more compounds, respectively. Further, in the case where the poly-acid of the present invention is used as a component of the liquid crystal alignment agent, it is preferred that the ruthenium 4 is soluble in the form of the solvent g. In order to prepare the soluble substance for the polyamic acid, it is preferred to appropriately select the tetracarboxylic dianhydride used as the acid component. Here, the aromatic anhydride which is used as the component A of the acid, for example, may be exemplified by the acid dianhydride represented by the HX undercut structures (1) to (18). The following aromatic tetrazins are more preferably represented by the structural formulae (1), (7), (5), (4), (7), and preferably by the acid formula represented by the structural formula. No pyromellitic dianhydride 0 [Chem. 26]
(3) 60 200813158 24843pif(3) 60 200813158 24843pif
另外,作為用作酸的B成分之前述脂肪族四羧酸二酐 及脂環式四羧酸二酐,例如具體可例示以下述結構式(19) 61 200813158 24843pif (67,)所表示之酸二酐。 [化 27]In addition, as the aliphatic tetracarboxylic dianhydride and the alicyclic tetracarboxylic dianhydride which are used as the component B of the acid, for example, an acid represented by the following structural formula (19) 61 200813158 24843pif (67,) can be specifically exemplified. Diacid anhydride. [化27]
Q Ο Ο CH30Q Ο Ο CH30
(20) CH3 CH; tri 〇 m CH3 CH {22}(20) CH3 CH; tri 〇 m CH3 CH {22}
β b (23)β b (23)
ch3 b (21)Ch3 b (21)
GG
OO
0 k, 「 1 rr<〇 厂 0 0 0 y (32) (33) (34) 62 200813158 24843pif0 k, ” 1 rr<〇厂 0 0 0 y (32) (33) (34) 62 200813158 24843pif
(3S) (39) (40) (41)(3S) (39) (40) (41)
(42)(42)
(46) (45)(46) (45)
63 200813158 24843pif63 200813158 24843pif
上述四羧酸二酐之中,較好地舉出:以結構式(19) 〜(39)及(49)所表示之酸二酐,更好地舉出以結構式 64 200813158 24843pif (19)、(23)、(25)、(35)〜(37)、(39)、(44)及(49) 所表示之酸二酐’尤其好地舉出以結構式(19)所表示之 1,2,3,4-環丁烷四甲酸二酐。 另外,為了將本發明之聚醯胺酸或其衍生物製成可溶 於溶劑的聚醯亞胺’較好的是使用以結構式(24)、(35) 〜(44)、(49)、(50)、(53)及(6〇)所表示之酸二酐。 本發明之四羧酸一酐,亦可單獨使用以結構式(丨)〜 (67)所表示之四羧酸二酐,亦可將二種以上組合使用。 ( 使用芳香族四羧酸二酐、脂妨族四羧酸二酐及脂環式四羧 酸二酐(尤其好的是均笨四甲酸二酐、1,2,3,4-環丁烧四曱 酸二酐)之下述液晶配向膜(該液晶配向膜是包含由本發 明之四緩酸二酐合成的聚醢胺酸之液晶配向劑而形成),可 賦予包含該液晶配向膜的液晶顯示元件以特別好的離子密 度。 進而,本發明之四羧酸二酐,亦可使用除以結構式(1) 〜(67)所表示之四羧酸二酐以外的其他四敌酸二昕。其 I 他四羧酸二酐為任意,但例如亦可舉出··具有側鏈結構之 四缓酸二酐。使用具有侧鏈結構的四叛酸二酐之下述液晶 配向膜,可增加包含該液晶配向膜之液晶顯示元件中的預 傾角(pretilt angle ),該液晶配向膜是使用包含由本發明之 四叛酸一酐合成的聚醯胺酸之液晶配向劑而形成。 對於具有侧鏈結構之四羧酸二酐並無特別限定,但於 本發明中,可較好地使用具有以下述結構式(68)及(69) 所表示的類固醇骨架的化合物。 65 200813158 24843pif [化 28]Among the above tetracarboxylic dianhydrides, acid dianhydrides represented by structural formulas (19) to (39) and (49) are preferably mentioned, and structural formula 64 200813158 24843pif (19) is more preferable. The acid dianhydride represented by (23), (25), (35) to (37), (39), (44), and (49) is particularly preferably represented by the structural formula (19). , 2,3,4-cyclobutane tetracarboxylic dianhydride. Further, in order to form the polylysine of the present invention or a derivative thereof into a solvent-soluble polyimine, it is preferred to use structural formulas (24), (35) to (44), (49). Acid dianhydride represented by (50), (53) and (6). In the tetracarboxylic acid monoanhydride of the present invention, the tetracarboxylic dianhydride represented by the structural formula (丨) to (67) may be used alone, or two or more of them may be used in combination. (Using aromatic tetracarboxylic dianhydride, alicyclic tetracarboxylic dianhydride, and alicyclic tetracarboxylic dianhydride (especially good is tetraphenyl dianhydride, 1,2,3,4-cyclobutane) a liquid crystal alignment film which is formed by a liquid crystal alignment agent comprising polyamic acid synthesized by the tetrazoic acid dianhydride of the present invention, which is capable of imparting a liquid crystal containing the liquid crystal alignment film. The display element has a particularly good ion density. Further, the tetracarboxylic dianhydride of the present invention may be used in addition to the tetracarboxylic acid diterpene other than the tetracarboxylic dianhydride represented by the structural formulas (1) to (67). The I-tetracarboxylic dianhydride is arbitrary, and, for example, a tetrabasic acid dianhydride having a side chain structure, and the following liquid crystal alignment film having a side chain structure of four resorcinic dianhydrides may be used. A pretilt angle in a liquid crystal display element comprising the liquid crystal alignment film which is formed using a liquid crystal alignment agent comprising polylysine synthesized by the four resorcinic acid anhydrides of the present invention. The tetracarboxylic dianhydride of the chain structure is not particularly limited, but in the present invention, A compound having a steroid skeleton represented by the following structural formulas (68) and (69) is preferably used. 65 200813158 24843pif [Chem. 28]
酸之四羧酸二酐中可使用之前述其他四羧The aforementioned other tetracarboxylic acid which can be used in the acid tetracarboxylic dianhydride
前ΐ具有側鏈結構的四舰二酐,當 酸二时/明目的之粑圍内亦可有其他各種形態的四羧 如此之進而其他的四㈣二軒,可單獨使用 種,或者將二種以上組合使用。 上反應的進行,因此可容易地控制所得聚合物(聚酿胺酸) 的分子量。羧酸酐相對於四羧酸酐之比率,若不損害本發 另外,本發明之四羧酸二酐中所使用之四羧酸二酐的 —部分,亦可被取代成羧酸無水物。藉由將四羧酸二酐的 —部分取代成羧酸酐,可引起聚合反應的終止,可抑制以 66 200813158 24843pif 明之效果即可,但作為標準,較好的是將其設為總四羧酸 二野量的ΙΟιπο〗%以下。 如前所述,本發明之液晶配向劑中所含聚醯胺酸,為 四羧酸二酐與二胺反應獲得之聚合物。 本發明所使用之二胺,可任意選擇一個或二個以上化 合物。二胺,例如可單獨使用直鏈狀的二胺作為Α成分, =可將該A成分的二胺與作為b成分之具有侧鏈結構的二 月。於使用二個以上二胺之情形時,例如較好的是, 且叙狀一胺作為胺的A成分,使用具有倒鏈結構的二 月^作為胺的B成分。這些二胺,可分別使用一個或 上的化合物。 Μ Λ 構之 (να) 一作為則述胺的Α成分之二胺,若為不具有側鏈結 一月女,貝丨j可杜土、把 敗主- 1忍咚擇,但較好地舉出以通式(I )〜 所表示之二胺。 67 200813158 24843pif H^N 一The four-ship dianhydride with a side chain structure in the front , can also have other various forms of tetracarboxylic acid and other four (four) two pores in the square of the acid/bright purpose. It can be used alone or two. The above combination is used. The progress of the above reaction proceeds, so that the molecular weight of the obtained polymer (polylactoic acid) can be easily controlled. The ratio of the carboxylic anhydride to the tetracarboxylic anhydride may not be impaired, and the portion of the tetracarboxylic dianhydride used in the tetracarboxylic dianhydride of the present invention may be substituted with the carboxylic acid anhydride. By substituting a portion of the tetracarboxylic dianhydride to a carboxylic acid anhydride, the termination of the polymerization reaction can be caused, and the effect of 66 200813158 24843 pif can be suppressed, but as a standard, it is preferably set as the total tetracarboxylic acid. The amount of the second wild is ΙΟιπο〗% below. As described above, the polyphthalic acid contained in the liquid crystal alignment agent of the present invention is a polymer obtained by reacting a tetracarboxylic dianhydride with a diamine. The diamine used in the present invention may be arbitrarily selected from one or two or more compounds. As the diamine, for example, a linear diamine can be used alone as a quinone component, and = a diamine of the component A and a bivalent having a side chain structure as a component b can be used. In the case where two or more diamines are used, for example, it is preferred that the amine is used as the component A of the amine, and the component B having the reversed structure as the amine is used. For these diamines, one or more compounds may be used separately. Μ 构 之 ( ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν ν The diamine represented by the formula (I)~ is exemplified. 67 200813158 24843pif H^N one
{〇 (It) ⑽ 〇V) (V) (Vf) (VI!) nh2 通式(I )中,A1表示_(CH2)m-。此處m表示1〜12 的整數。另外,通式(IH)、(V)、(YU)中,A1分別獨立 地表示單鍵、-0-、-S-、_S_S---S02-、-CO·、-CONH-、 _NHCO-、-C(CH3)2_、-C(CF3)2_、_(CH2)m-、-0-(CH2)m_0-、 或者-S-(CH2)m_S-。此處ni獨立地表不1〜12的整數。另 外,通式(VI)中,A2獨立地表示單鍵、-0-、-S-、_CO-、 -C(CH3)2-、-C(CF3)2-或者碳數1〜6的伸烷基。進而,通式 (Π)〜(W)中的與環己烷環或者苯環鍵結之氫,亦以 可獨立地被取代成-F、_CH3' -OH、-CO〇H、-S03H、-Ρ03Η2、 苄基或者4-羥基节基。 作為以通式(I )所表示之二胺,例如可舉出··以結 68 200813158 24843pif 構式(I 一 1)〜(I —4)所表示之二胺。 [化 30] H2M(CH2)2MH2 H2M(CH2}4NH2 H2N(CH2)6NH2 h2m(ch2)12nh2 (Μ) _ (I-3) {M} 作為以通式(Π)所表示之二胺,例如可舉出:以結 構式(π — 1)、( π —2)所表示之二胺。 [化 31]{〇 (It) (10) 〇V) (V) (Vf) (VI!) nh2 In the general formula (I), A1 represents _(CH2)m-. Here, m represents an integer of 1 to 12. Further, in the general formulae (IH), (V), and (YU), A1 independently represents a single bond, -0-, -S-, _S_S---S02-, -CO·, -CONH-, _NHCO-, respectively. , -C(CH3)2_, -C(CF3)2_, _(CH2)m-, -0-(CH2)m_0-, or -S-(CH2)m_S-. Here ni independently represents an integer from 1 to 12. Further, in the formula (VI), A2 independently represents a single bond, -0-, -S-, _CO-, -C(CH3)2-, -C(CF3)2- or a carbon number of 1 to 6 alkyl. Further, the hydrogen bonded to the cyclohexane ring or the benzene ring in the formula (Π) to (W) may be independently substituted with -F, _CH3'-OH, -CO〇H, -S03H, - Ρ03Η2, benzyl or 4-hydroxyl group. The diamine represented by the formula (I) is, for example, a diamine represented by the structure (I-1) to (I-4) of the group 68 200813158 24843pif. H2M(CH2)2MH2 H2M(CH2}4NH2H2N(CH2)6NH2 h2m(ch2)12nh2 (Μ) _ (I-3) {M} As a diamine represented by the formula (Π), for example The diamine represented by the structural formula (π - 1) and (π - 2) can be mentioned.
Η2Ν-<^)-ΝΗ2 Η2Ν 闕 闕 作為以通式(m)所表示之二胺,例如可舉出:以結 構式(m — 1)〜(m—3)所表示之二胺。 [化 32]Η2Ν-<^)-ΝΗ2 Η2Ν 阙 阙 The diamine represented by the formula (m) is, for example, a diamine represented by the structural formula (m-1) to (m-3). [化32]
作為以通式(IV)所表示之二胺,例如可舉出··以結 構式(IV — 1)〜(IV — 16)所表示之二胺。 69 200813158 24843pif [化 33] ^~~NH2 (IV-1) H2N—*NH2 (lV-2)The diamine represented by the formula (IV) is, for example, a diamine represented by the structural formulae (IV-1) to (IV-16). 69 200813158 24843pif [Chem. 33] ^~~NH2 (IV-1) H2N—*NH2 (lV-2)
H2NH2N
(IV-3)(IV-3)
HOOCHOOC
OHOH
H2r 、_ (胸)H2r, _ (chest)
HO h2n— »—nh2 (JV-7)HO h2n— »—nh2 (JV-7)
COOHCOOH
n2rr、叫 (fV_8) / H2M1 —nh2N2rr, called (fV_8) / H2M1 —nh2
〒03H2 ho3s h2nx ^ 'NH2 (IV-12) (JV-9) (IV-1t)〒03H2 ho3s h2nx ^ 'NH2 (IV-12) (JV-9) (IV-1t)
作為以通式(V)所表示之二胺,例如可舉出:以結 構式(V — 1)〜(V — 34)所表示之二胺。 70 200813158 24843pif [化 34] Η#—NH2 H2N (V-1)The diamine represented by the formula (V) is, for example, a diamine represented by the structural formula (V-1) to (V-34). 70 200813158 24843pif [化 34] Η#—NH2 H2N (V-1)
-NH2 (V-2) (V»3)-NH2 (V-2) (V»3)
(V-7) (V-6) /GH3 —/^X 邮\ NH2 Η2ΝΛ_^ν^ΝΗ2 QH3 - (V«9)(V-7) (V-6) /GH3 —/^X 邮\ NH2 Η2ΝΛ_^ν^ΝΗ2 QH3 - (V«9)
(ν·12) ,〇、 h2nh;v /r h^/-nh2 h2n^ /r^v^v-N^ η2ι^γ^τ_υ ynh2 (V-13) (V-14) {V-15) _·~〇"〇ν〇χ〇^_ (V^16) (V-17) 71 200813158 24843pif Η2Ν· (V-18)(ν·12) , 〇, h2nh; v /rh^/-nh2 h2n^ /r^v^vN^ η2ι^γ^τ_υ ynh2 (V-13) (V-14) {V-15) _·~ 〇"〇ν〇χ〇^_ (V^16) (V-17) 71 200813158 24843pif Η2Ν· (V-18)
IsIH2 h2n-IsIH2 h2n-
(XA19)(XA19)
H2N (V-20) (V,21)H2N (V-20) (V, 21)
HaN NH2 叫 (\A23) (V^22) h2n-HaN NH2 is called (\A23) (V^22) h2n-
(V*24) 删2 “ '\^ΙΙ 、\ // (V-25)(V*24) Delete 2 " '\^ΙΙ , \ // (V-25)
(V-26)(V-26)
H2N (V-27)H2N (V-27)
(V-31) (ν·32)(V-31) (ν·32)
作為以通式(VI)所表示之二胺,例如可舉出··以結 72 200813158 24843pif 構式(vi-l)〜(VI — 6)所表示之二胺。 [化 35]The diamine represented by the formula (VI) is, for example, a diamine represented by the formula (vi-1) to (VI-6) of the formula 72 200813158 24843pif. [化35]
(Vi-2) (VM)(Vi-2) (VM)
(νμδ) {Vl-δ) 作為以通式(VH)表示之二胺,例如可舉出··以結構 式(W — 1)〜(YU — 16)所表示之二胺。 [化 36](νμδ) {Vl-δ) The diamine represented by the formula (VH) is, for example, a diamine represented by the structural formula (W-1) to (YU-16). [化36]
(Vikl) (VH-2) (Vi 1-3} h3c ch3 Η2Ν vy" (Vil-5)(Vikl) (VH-2) (Vi 1-3} h3c ch3 Η2Ν vy" (Vil-5)
〇AU6) 73 200813158 24843pif〇AU6) 73 200813158 24843pif
H2HH2H
NH2 (VII-7)NH2 (VII-7)
NH2 %N (V|j«9)NH2 %N (V|j«9)
nh2 (Vli-8)Nh2 (Vli-8)
(ViP10) _*41) (VH-12)(ViP10) _*41) (VH-12)
(VU-IS) (VIM 6} 這些之中,較好地舉出以結構式(IV —1)〜(IV — 5)、 (IV-15)、(IV—16)、(V-l)〜(V-12)、(V—26)、 (V—27)、(V—31)、(V—33)、(VI — 1)、(VI — 2)、(VI v 一6)、(YU — 1)〜(W —5)所表示之二胺,最好地舉出以 結構式(IV— 1)、(IV —2)、(rv — 15)、(IV — 16)、(v — 1) 〜(V — 12)、(V— 33)、(W — 2)所表示之二胺。 本發明之二胺,可單獨使用以前述通式(I )〜(W) 所表示之二胺,亦可使用二種以上。本發明之二胺中的以 前述通式(I )〜(W)所表示之二胺的莫耳比,可根據 經選擇的以前述通式(I )〜(W)所表示之二胺的結構、 及所期望的離子密度進行調整,以二胺的總量計,較好的 74 200813158 24843pif 疋1〜100%,更好的是5〜80〇/〇。 如前所^ ’本發明之二胺,可㈣— 二胺’但尤其於如VA型液晶顯示元件、之 元^s™贿㈣以件料求«大翻/ΓρΪ afe)之用途中,較好的是,使用具有侧鏈結構的2 為胺的β成分。 傅扪一胺作 Γ(VU-IS) (VIM 6) Among these, the structural formulae (IV-1) to (IV-5), (IV-15), (IV-16), (Vl)~(( V-12), (V-26), (V-27), (V-31), (V-33), (VI-1), (VI-2), (VI v-6), (YU — 1) The diamine represented by (W-5) is preferably exemplified by structural formulae (IV-1), (IV-2), (rv-15), (IV-16), (v). 1) a diamine represented by (V-12), (V-33), (W-2). The diamine of the present invention may be used singly as shown in the above formula (I) to (W). The amine may be used in combination of two or more kinds. The molar ratio of the diamine represented by the above formulas (I) to (W) in the diamine of the present invention may be selected according to the above formula (I)~ The structure of the diamine represented by (W) and the desired ion density are adjusted, preferably 74 200813158 24843 pif 疋 1 to 100%, more preferably 5 to 80 〇 / 以 based on the total amount of the diamine. As before, the diamine of the present invention may be (tetra)-diamine', but especially in the case of a VA type liquid crystal display element, the element ^sTM bribe (four) in order to obtain a large turn / ρΪ afe) of applications, it is preferable that a side chain having a structure of β 2 to the amine component.扪 扪 胺 胺 作
於本說明書中,所謂具有側鍵結構之二胺,意 連接二個胺基的取代基作為主鏈時,自 ^鍵 可表™!角(—_之具有“ 之一。#,猎由使用具有側鏈結構的二贿四魏 ^應:、可提供-種具有相對於高分子主鏈為側鏈基之聚酿 胺酸或者聚醯亞胺(支鏈聚軸或者支鏈㈣亞胺: 此的由包含具有相對於高分子主鏈為侧鏈基之聚酿胺酸^ 者聚醯亞胺的液晶配向劑所形成之液晶配向膜,可加大液 晶顯示元件中的預傾角(pretilt angle)。此情形例如記^= 前述專利文獻1(曰本專利特開平n_ 193345號公報)中。 因此,具有侧鏈結構的二胺中之侧鏈,可根據所要求 的預傾角(pretilt angle)適當選擇。例如較好地舉出:該 側鏈的碳數為3以上之基。具體而言,可舉出·· (1) 可具有取代基之苯基、可具有取代基之環己基伸 苯基、可具有取代基之雙(環己基)伸苯基、或者碳數3以 上之烧基、稀基或者块基、 (2) 可具有取代基之苯氧基、可具有取代之環己氧 基、可具有取代基之雙(環己基)氧基、可具有取代基之笨 75 200813158 24843pif 基環己氧基、可具有取代基之環己基苯氧基、或者碳數3 以上之烷氧基、烯基氧基或者炔基氧基、 (3) 苯基羰基、或者碳數3以上之烷基羰基、烯基羰 基或者炔基幾基、 (4) 苯基獄基氧基、或者碳數3以上之烧基獄基氧 基、細基幾基氧基或者快基獄基氧基、 (5) 可具有取代基之本基氧基幾基、可具有取代基之 環己基氧基羰基、可具有取代基之雙(環己基)氧基羰基、 可具有取代基之雙(環己基)苯基氧基裁基、可具有取代基 之環己基雙(苯基)氧基羰基、或者碳數3以上之烷基氧基 羰基、烯基氧基幾基或者快基氧基幾基、 (6) 苯基胺基羰基、或者碳數3以上之烷基胺基幾 基、烯基胺基羰基或者炔基胺基羰基、 (7) 碳數3以上之環狀伸烷基、 (8) 可具有取代基之環己基伸烷基、可具有取代基之 苯基伸烷基、可具有取代基之雙(環己基)伸烷基、可具有 取代基之環己基苯基伸烷基、可具有取代基之雙(環己基) 苯基伸燒基、可具有取代基之苯基烷基氧基、烷基苯基氧 基羰基、或者烧基聯苯基氧基幾基、 (9) 被:!:元基、氟取代烧基、或者烧氧基取代之苯基、 或者環己基、以及 (10) 二個以上的苯環或者環己烷環以單鍵鍵結、或 者經由-0-、-COO-、-OCO-、_C0NH_或者碳數1〜3的伸 烷基鍵結之烷基、一氟取代烷基、或者被烷氧基取代之環 76 200813158 24843pif 集合基、或者具有類固醇骨架的基等,但並不限定於這些 此處,作為「取代基」,可舉出:烷基、烷氧基、或烷 氧基烷基等。 另外,雙(環己基)或者雙(笨基)亦可被伸烷基所間隔。 另外,於本說明書中,於所謂「烷基」、「烯基」、「炔 基」時,可為線狀,亦可為分支狀。 本每明所使用之具有侧鏈結構之二胺,具體而言,可 舉出以下述通式(Μ)〜(Xu)所表示之二胺。 [化 37]In the present specification, a diamine having a side bond structure, a substituent which is intended to link two amine groups, is used as a main chain, and the self-bonding can be expressed as a TM angle (-_ has one of "#. A bribe with a side chain structure should provide: a poly-chitoic acid or a polyimine (a branched poly- or a branched (tetra) imine) having a side chain group relative to the polymer backbone: The liquid crystal alignment film comprising a liquid crystal alignment agent comprising a polyacrylamide having a side chain group with respect to a polymer main chain, which can increase a pretilt angle in the liquid crystal display element. In this case, for example, the above-mentioned Patent Document 1 (Japanese Patent Laid-Open Publication No. No. 193345). Therefore, the side chain of the diamine having a side chain structure can be adjusted according to the required pretilt angle. For example, the number of carbon atoms in the side chain is preferably 3 or more. Specific examples thereof include (1) a phenyl group which may have a substituent, and a cyclohexyl group which may have a substituent. a phenyl group, a bis(cyclohexyl)phenyl group which may have a substituent, or a carbonyl group or a dilute group having a carbon number of 3 or more Or a block group, (2) a phenoxy group which may have a substituent, a cyclohexyloxy group which may have a substituent, a bis(cyclohexyl)oxy group which may have a substituent, and a stupid group which may have a substituent 75 200813158 24843pif base ring An oxy group, a cyclohexylphenoxy group which may have a substituent, an alkoxy group having 3 or more carbon atoms, an alkenyloxy group or an alkynyloxy group, (3) a phenylcarbonyl group, or an alkylcarbonyl group having a carbon number of 3 or more , alkenylcarbonyl or alkynyl, (4) phenyl phenyloxy, or a carbyloxy group having a carbon number of 3 or more, a thioloxy group or a fast phenyloxy group, (5) a benzyloxy group which may have a substituent, a cyclohexyloxycarbonyl group which may have a substituent, a bis(cyclohexyl)oxycarbonyl group which may have a substituent, a bis(cyclohexyl)phenyloxy group which may have a substituent A cyclyl group, a cyclohexyl bis(phenyl)oxycarbonyl group which may have a substituent, an alkyloxycarbonyl group having a carbon number of 3 or more, an alkenyloxy group or a fast oxy group, (6) benzene a arylaminocarbonyl group, or an alkylamino group having a carbon number of 3 or more, an alkenylaminocarbonyl group or an alkynylaminocarbonyl group, (7) a ring having 3 or more carbon atoms An alkyl group, (8) a cyclohexylalkyl group which may have a substituent, a phenylalkyl group which may have a substituent, a bis(cyclohexyl)alkyl group which may have a substituent, a cyclohexylbenzene which may have a substituent An alkylene group, a bis(cyclohexyl)phenyl extended group which may have a substituent, a phenylalkyloxy group which may have a substituent, an alkylphenyloxycarbonyl group, or an alkylbiphenyloxy group, (9) by: :: a carboxyl group, a fluorine-substituted alkyl group, or an alkyl group substituted with an alkoxy group, or a cyclohexyl group, and (10) two or more benzene rings or a cyclohexane ring bonded by a single bond, or Alkyl group bonded via -0-, -COO-, -OCO-, _C0NH_ or a C 1 to 3 alkyl group, a monofluoro substituted alkyl group, or a ring substituted by an alkoxy group. 200813158 24843pif Collective group Further, the base having a steroid skeleton or the like is not limited thereto. Examples of the "substituent" include an alkyl group, an alkoxy group, or an alkoxyalkyl group. Alternatively, bis(cyclohexyl) or bis(stupyl) may be interrupted by an alkyl group. Further, in the present specification, in the case of "alkyl group", "alkenyl group" or "alkynyl group", it may be in the form of a line or a branch. Specific examples of the diamine having a side chain structure used in the present invention include diamines represented by the following formulas (Μ) to (Xu). [化37]
通式(VI)中,Ri表示單鍵、κ〇…c〇〇_、_〇c〇_、 _CON=-、:CH2〇…CF2a或者<CH2)e、e 表示卜6 的整 數:R表示,有類固醇骨架的基、以下述通式(χ旧所 表示的基炭數1〜3〇的烧基、或者苯基;於前述伸烧 及前述絲的碳數為2以上時,其任意的_CH2_亦可獨立地 被Ο 01-〇1-或者_(^_取代(其中氧不連續),繼 該絲賴亦可獨立地贼、甲基、甲氧基一氟甲氧基、 -氣曱乳基或者三氟甲氧基取代,但雛_r1_r2表示节基 ^ Ί η ΎτΛ 0 77 200813158 24843pif [化 38]In the general formula (VI), Ri represents a single bond, κ〇...c〇〇_, _〇c〇_, _CON=-, :CH2〇...CF2a or <CH2)e, and e represents an integer of Bu6: R It is a group having a steroid skeleton, or a phenyl group having a base carbon number of 1 to 3 Å represented by the following formula: or a phenyl group; and when the carbon content of the above-mentioned stretched yarn and the yarn is 2 or more _CH2_ can also be independently Ο 01-〇1- or _(^_substitution (where oxygen is discontinuous), followed by the thief, methyl, methoxy-fluoromethoxy, - gas-milk-based or trifluoromethoxy substituted, but chick _r1_r2 represents the nodal group ^ Ί η Ύ Λ Λ 0 77 200813158 24843pif [化38]
〇c) 碳數1〜30的烷基;R5獨立地表示單鍵、一 通式⑻中,R3獨立地表示氫或者甲基;r4表示氣 CO-或者 通,(X)巾,R3獨立地表錢或切基;以表 =石歧W30㈣基;R5獨立地表示單鍵、_c〇 或Ϊ笨^。及R?分別獨立地表示氫、碳數1〜㈣絲、 [化 39]〇c) an alkyl group having 1 to 30 carbon atoms; R5 independently represents a single bond; in the general formula (8), R3 independently represents hydrogen or a methyl group; r4 represents a gas CO- or a pass, (X) a towel, and R3 independently represents money. Or a base; to the table = stone difference W30 (four) base; R5 independently represents a single bond, _c〇 or Ϊ ^ ^. And R? independently represent hydrogen, carbon number 1 to (four) filament, [Chem. 39]
R 10 d R11 H2N〇i-R 10 d R11 H2N〇i-
\ h12\ h12
(ΧΙΪ) 78 200813158 24843pif 通式(XI)中’ R8表示氫或者碳數1〜3〇的烧基,碳 數2以上之前述烷基的任意的七玛·,亦可獨立地被_〇_、 -CH=CH诚者-CEC-取代(其中氧不連續);R9獨立地表 示-0-或者碳數i〜6的伸烷基;環A表示1,4-伸苯基或者 M-環伸己基;a表示〇或1 ; b表示〇、1或2 ; c獨立地 表示0或1。 通式(XH)中’ R1G表示碳數3〜30的烷基、或者碳數 〕〜%的一氟化烧基;Rn表示氫、碳數1〜30的烧基、或 者碳數1〜30的一氟化烷基;R12獨立地表示_〇_或碳數1 〜6的伸院基;d獨立地表示〇或1。 [化 40](ΧΙΪ) 78 200813158 24843pif In the general formula (XI), 'R8' represents hydrogen or a calcined group having 1 to 3 carbon atoms, and any of the above-mentioned alkyl groups having 2 or more carbon atoms may be independently _〇_ , -CH=CH Cheng-CEC-substitution (wherein oxygen is discontinuous); R9 independently represents -0- or alkylene with a carbon number i~6; ring A represents 1,4-phenylene or M-ring Extending the base; a means 〇 or 1; b means 〇, 1 or 2; c independently represents 0 or 1. In the general formula (XH), 'R1G represents an alkyl group having 3 to 30 carbon atoms or a fluorinated alkyl group having a carbon number of 3% to 5%; Rn represents hydrogen, a alkyl group having 1 to 30 carbon atoms, or a carbon number of 1 to 30. The monofluorinated alkyl group; R12 independently represents _〇_ or a carbon number of 1 to 6; and d independently represents 〇 or 1. [40]
通式(ΧΠ)中,Ri3、RM&R]5分別獨立地表示單鍵、 …COO…OCO…c〇NH_、碳數卜4的伸烷基、碳 數1〜3的氧基伸烷基(其中氧不連續)、或者碳數1〜3 的伸院基氧基(其巾氧*連續);Rn分別獨立地表 不氫、氟或者曱基;R18表示氫、氟、氯、說基、碳數卜 3〇的、杈數1〜3〇的烷氧基、碳數2〜3〇的烷氧基烷 基三一氟曱基、二氟甲基、三氟甲基、一氟甲氧基、二氟 甲氧基或者三氟曱氧基;碳數2以上之前述燒美、院負昊 以及烧氧舰基中的任意的偶_,亦可被二 79 200813158 以下述通式(XIV)所表示之基取代;環B及環C分別獨 立地表示1,4-伸苯基或者1,4-環伸己基;f、g及h分別獨 立地表示0〜4的整數;i、j及k分別獨立地表示0〜3的 整數、且這些值的合計為1以上;1及m分別獨立地表示 1或2。 [化 41]In the formula (ΧΠ), Ri3, RM&R]5 each independently represent a single bond, ...COO...OCO...c〇NH_, an alkylene group of carbon number 4, an alkyloxy group having a carbon number of 1 to 3 ( Wherein the oxygen is discontinuous, or the carbon number is 1 to 3 (the towel oxygen* is continuous); Rn independently represents hydrogen, fluorine or sulfhydryl; R18 represents hydrogen, fluorine, chlorine, sulfhydryl, carbon Alkoxy group having a number of 1 to 3 fluorene, alkoxyalkyltrifluoroindolyl having 2 to 3 fluorene, difluoromethyl, trifluoromethyl, monofluoromethoxy , difluoromethoxy or trifluorodecyloxy; any of the above-mentioned burnt beauty, hospital negative enthalpy, and any of the oxygen-burning ship bases having a carbon number of 2 or more may also be exemplified by the following formula (XIV) The substituents are represented; ring B and ring C each independently represent a 1,4-phenylene group or a 1,4-cyclohexyl group; f, g and h each independently represent an integer of 0 to 4; i, j and k each independently represents an integer of 0 to 3, and the total of these values is 1 or more; 1 and m each independently represent 1 or 2. [化41]
通式(XIV)中,R19、R2G、R21及R22分別獨立地表 示碳數1〜10的燒基、或者苯基,η表示1〜100的整數。 另外,通式(Κ)中,與形成類固醇骨架的碳鍵結之 氫,亦可獨立地被取代成-CH3。 以通式(M)所表示之二胺,例如可舉出:以下述通 式或者結構式(W — 1)〜(M — 43)所表示之二胺。 [化 42] 80 200813158 24843pifIn the formula (XIV), R19, R2G, R21 and R22 each independently represent a carbon group having 1 to 10 carbon atoms or a phenyl group, and η represents an integer of 1 to 100. Further, in the formula (Κ), hydrogen bonded to the carbon forming the steroid skeleton may be independently substituted with -CH3. The diamine represented by the formula (M) may, for example, be a diamine represented by the following general formula or structural formula (W-1) to (M-43). [化42] 80 200813158 24843pif
(V1IM) {Vlll-2) (Viii-3)(V1IM) {Vlll-2) (Viii-3)
(vm-6)(vm-6)
通式(M — 1)〜(M — 11)中,R23較好地表示碳數 3〜30的烷基或者碳數3〜30的烷氧基,更好地表示碳數5 〜2 5的烧基或者碳數5〜2 5的烧氧基。另外,R24較好地 表示碳數1〜30的烧基或者碳數1〜30的烧氧基,更好地 表示碳數3〜25的烷基或者碳數3〜25的烷氧基。 81 200813158 24843pif [化 43]In the general formulae (M-1) to (M-11), R23 preferably represents an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms, more preferably a carbon number of 5 to 2 5 An alkyl group having a burning group or a carbon number of 5 to 2 5 . Further, R24 preferably represents a burnt group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms, more preferably an alkyl group having 3 to 25 carbon atoms or an alkoxy group having 3 to 25 carbon atoms. 81 200813158 24843pif [化 43]
(V\\\A2) (VHM3) R25 / 0=0(V\\\A2) (VHM3) R25 / 0=0
(_-14) ,R26 ? (VfiMS) (VIIM7)(_-14) , R26 ? (VfiMS) (VIIM7)
通式( —12)〜(M — 15)中,R25較好地表示碳數 4〜30的烷基,更好地表示碳數6〜25的烷基。通式(Μ — 16)及(Μ—17)中,R26較好地表示碳數6〜30的烷基, 更好地表示碳數8〜25的烷基。 [化 44] 82 200813158 24843pifIn the formula (12) to (M-15), R25 preferably represents an alkyl group having 4 to 30 carbon atoms, more preferably an alkyl group having 6 to 25 carbon atoms. In the formula (Μ-16) and (Μ-17), R26 preferably represents an alkyl group having 6 to 30 carbon atoms, more preferably an alkyl group having 8 to 25 carbon atoms. [化44] 82 200813158 24843pif
°Or27 H2N°Or27 H2N
.{VIIi-19) {Vlll-tS}.{VIIi-19) {Vlll-tS}
(Vlll-20)(Vlll-20)
h2nH2n
(Vim22)(Vim22)
_ 卜23)_ 卜 23)
H2HH2H
、〇〇
>27 h2n (V!lh24)>27 h2n (V!lh24)
(Vili-25)(Vili-25)
h2n H2M oH2n H2M o
►28 (VI1I-27)►28 (VI1I-27)
(Vll^28) 83 200813158 24843pif f.(Vll^28) 83 200813158 24843pif f.
(VIII-29) ⑽卜30)(VIII-29) (10) Bu 30)
O.O.
?28 (VHi~32)?28 (VHi~32)
H2NH2N
R27R27
H2N (VHI-3S)H2N (VHI-3S)
NN
‘R28‘R28
H2NH2N
ch3 ch3 Si-O-Si-R27 CH3 ch3 於通式(M — 18)〜(M — 37)中,R27較好地表示碳 數1〜30的烷基、或者碳數1〜30的烷氧基,更好地表示 碳數3〜25的烷基或者碳數3〜25的烷氧基。另外,, 較好地表示-Η、-F、碳數1〜30的烷基、碳數1〜30的烷 84 200813158 24843pif 氧基、-CN、-OCH2F、-OCHF2或者-OCF3,更好地表示碳 數3〜25的烷基或者碳數3〜25的烷氧基。 [化 45]Ch3 ch3 Si-O-Si-R27 CH3 ch3 In the formula (M-18)~(M-37), R27 preferably represents an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms. The group preferably represents an alkyl group having 3 to 25 carbon atoms or an alkoxy group having 3 to 25 carbon atoms. Further, -Η, -F, an alkyl group having 1 to 30 carbon atoms, and an alkane 84 having a carbon number of 1 to 30 are preferably represented. 200813158 24843pif oxy group, -CN, -OCH2F, -OCHF2 or -OCF3, more preferably It represents an alkyl group having 3 to 25 carbon atoms or an alkoxy group having 3 to 25 carbon atoms. [化45]
\\
這些之中,較好地舉出以通式(M—1)〜(M — 11) 所表示之二胺。更好地舉出以通式(M —2)、(M —4)、( Μ 85 200813158 24843pif 一 5)及(M — 6)所表不之二胺。 於前述通式(IX)中,較好的是,二個「NH2-Ph-R5-〇-」 中的一個鍵結於類固醇骨架的3位,另一個鍵結於6位。 另外,較好的是,二個胺基分別與苯基環碳鍵結,且相對 於R5的鍵結位置於間位或對位鍵結。 作為以通式(IX)所表示之二胺,例如可挙出:以結 構式(K 一 1)〜(IX —4)所表示之二胺。 [化 46]Among these, a diamine represented by the formula (M-1) to (M-11) is preferably mentioned. More preferably, the diamines represented by the formulae (M-2), (M-4), (Μ 85 200813158 24843pif-5) and (M-6) are mentioned. In the above formula (IX), it is preferred that one of the two "NH2-Ph-R5-〇-" is bonded to the 3-position of the steroid skeleton, and the other is bonded to the 6-position. Further, it is preferred that the two amine groups are bonded to the phenyl ring carbon, respectively, and the bonding position with respect to R5 is bonded to the meta or para position. As the diamine represented by the formula (IX), for example, a diamine represented by the structural formula (K-1) to (IX-4) can be obtained. [Chem. 46]
於前述通式(X)中,二個「NH2_(R7-)Ph-R5-0-」分 別與苯基環的碳鍵結,但較好的是,與相對於類固醇骨架 所鍵結的碳為間位或對位的礙鍵結。另外^二個胺基分別 86 200813158 24843pif 與苯基環碳鍵結,但較好的是,相對於R5於間位或對位鍵 結。 以通式(X)所表示之二胺,例如可舉出:以結構式 (X—1)〜(X — 8)所表示之二胺。 [化 47] 87 200813158 24843pifIn the above formula (X), two "NH2_(R7-)Ph-R5-0-" are bonded to the carbon of the phenyl ring, respectively, but preferably, the carbon bonded to the steroid skeleton For the meta or alignment barrier. Further, two amine groups are respectively 86 200813158 24843pif bonded to a phenyl ring carbon, but preferably, it is bonded to the meta or para position relative to R5. The diamine represented by the formula (X) may, for example, be a diamine represented by the structural formula (X-1) to (X-8). [化47] 87 200813158 24843pif
88 200813158 24843pif88 200813158 24843pif
侧2 89 200813158 24843pifSide 2 89 200813158 24843pif
於前述通式(XI)中,二個胺基分別與苯基環的碳鍵 結,較好的是,相對於R9於間位或對位鍵結。 作為以通式(XI)所表示之二胺,例如可列舉:以通 式(XI — 1)〜(XI — 8)所表不之二胺。 [化 48] R29 R29In the above formula (XI), the two amine groups are bonded to the carbon of the phenyl ring, respectively, and it is preferred to bond to the meta or para position with respect to R9. The diamine represented by the formula (XI) may, for example, be a diamine represented by the general formula (XI-1) to (XI-8). [化48] R29 R29
90 200813158 24843pif90 200813158 24843pif
R29R29
nh2 R30 h2mNh2 R30 h2m
r3Gr3G
NH2 91 200813158 24843pifNH2 91 200813158 24843pif
通式(X[—1)〜(XI — 3)中,R29較好地表示_H、 碳數1〜30的烷基;通式(X!一4)〜(XI —8)中,r30 更好地表示-Η、壤數1〜20的烧基。In the general formula (X[-1] to (XI-3), R29 preferably represents _H, an alkyl group having 1 to 30 carbon atoms; and in the formula (X!-4) to (XI-8), r30 It is better to represent the base of Η and soil with a number of 1 to 20.
於刖迷通式 , · J齊本巷‘ 結,較好的是相對於RU於間位或對位鍵妗。 以通式(Μ)所表示之二胺,例^ -1)〜(Μ-3)所表示之二胺。了舉出.以通式(观 [化 49]In the 刖 刖 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , The diamine represented by the formula (Μ), the diamine represented by the formula (-1) to (Μ-3). Give a general formula (view 49)
(ΧΙΜ)(ΧΙΜ)
(ΧΙΙ-2) 92 200813158 24843pif r32(ΧΙΙ-2) 92 200813158 24843pif r32
(X^3) 於通式(迎叫) 6〜2〇的燒基,只32志、 力中,RJ]較好地表示碳數 本發明之二胺=表示_H或者碳數1〜㈣烧基。 所表示之H種,簡述通式()〜(邪) Γ 巾之具有側鏈結構之二胺°=二種以上。本發明之二胺 侧鏈結構之二—的旲斗比,可根據具有經選擇的 進行調整,較好的f 、及所期望的預傾角(pretilt angle ) 進而,疋1〜1〇〇% ’更好的是10〜100%。 所表示之二胺ί =二胺,可使用除以通式⑴〜㈤ 側鏈結構之二卜以通式()〜(观)所表示之具有 意,例如可兴々以外的其他二胺。如此的其他二胺為任 芴系二胺、^目具有秦結構之萘系二胺、具有苟結構之 r通式(Μ);:有石夕氧烧鍵之石夕氧垸系二胺、或者具有 對c以外的侧鏈結構之二胺。 下述通式〔υΓ糸—胺亚無特別限定’但可較好地使用以 [化50])所表示之化合物作為本發明之二胺。(X^3) in the general formula (welcome) 6~2〇 of the burning group, only 32 志, force, RJ] better represents the carbon number of the present invention diamine = _H or carbon number 1 ~ (four) Burning base. The H species shown are a brief description of the diamines having a side chain structure of the general formula () to (evil), and two or more kinds. The ratio of the dip of the diamine side chain structure of the present invention may be adjusted according to the selected one, preferably f, and a desired pretilt angle, and further, 疋1 to 1%%. Better is 10 to 100%. The diamine ί = diamine represented by the formula (1) to (f) side chain structure may be represented by the formula () to (view), for example, other diamines other than the oxime. Such other diamines are any of the fluorene-based diamines, the naphthalene-based diamines having a Qin structure, the rhythm (Μ) having a fluorene structure, and the diarrhea-based diamines having a sulphur-oxygen bond. Or a diamine having a side chain structure other than c. The following formula [υΓ糸-amine is not particularly limited], but a compound represented by [Chem. 50]) can be preferably used as the diamine of the present invention.
(XV) 通式(XV)中 R及R」4分別獨立地表示碳數丨〜3 93 200813158 24843pif 的烷基或者苯基、A3獨立地表示亞甲基、伸苯基或者被烷 基取代的伸苯基。1表示1〜6的整數,m表示1〜1〇的整 數。 進而,其他二胺,並不限定於前述矽氧烷系二胺,例 如可較好地使用以下述通式(Γ)〜(8,)所表示之化合物 作為本發明之二胺。 [化 51](XV) In the formula (XV), R and R"4 each independently represent a carbon number of 3~3 93 200813158 24843pif of an alkyl group or a phenyl group, and A3 independently represents a methylene group, a phenyl group or an alkyl group. Stretch phenyl. 1 represents an integer of 1 to 6, and m represents an integer of 1 to 1 。. Further, the other diamine is not limited to the above-mentioned alkoxy-based diamine. For example, a compound represented by the following formula (Γ) to (8,) can be preferably used as the diamine of the present invention. [化 51]
(8?)中 分別獨立地表示碟 通式(Γ)〜 數3〜30的烷基。 另外,本發明 R35及心 之二胺中所使用之除通 、1)〜Οαι) 94 200813158 24843pif 以外的前述其他二胺,並不限定於前述矽氧烷系二胺等, 當然在達成本發明目的之範圍内亦存在其他各種形態的二 胺。另外,前述其他二胺,可單獨使用一種,或者^二種 以上組合使用。 ’ 本發明之二胺,可藉由適當選擇二胺的種類及其組 合,而賦予使用本發明之液晶配向劑所形成之液晶配向膜 以合適的預傾角(pretiit angle )。 f(8?) independently represent the alkyl group of the formula (Γ) to the number of 3 to 30. Further, the other diamines other than the ones used in the R35 and the diamine of the present invention, and the above-mentioned diamines are not limited to the above-mentioned alkoxynane-based diamines, and of course, the present invention has been achieved. Various other forms of diamines are also present within the scope of the purpose. Further, the other diamines may be used singly or in combination of two or more kinds. The diamine of the present invention can be imparted with a suitable pretiit angle by using a liquid crystal alignment film formed using the liquid crystal alignment agent of the present invention by appropriately selecting the kind of the diamine and the combination thereof. f
於VA型液晶顯示元件之情形時,常要求有肋〜卯。 左右的大預傾角;於OCB型液晶顯示元件之愔卑當 要求™右的預你於™型液晶件: STN型液晶顯示元件之情形時,常要求有3〜1〇◦左右的預 傾角,以及於IPS型液晶顯示元件之情形時,常要求有〇 〜y左右的預傾角。因此,可使用具有侧鏈結構的二胺來 適當调整預則之本發明之液晶配向劑,可應用於任音 類的液晶顯示元件中。 ' α 如前所述,本發明之二胺所使用之二胺的一部分, 可被取代成單胺。藉由將二胺的—部分取代成單胺:、 起聚合反應的終止,可抑趣以前的反應的進行,因此 容易地抑制所得聚合物(聚_酸)的分子量。單_ 於二胺之比率,在不損害本發明效果的朗内可有變化: 作為標準,較好的是設為總胺量的10mol%以下。 本發明之^酿胺酸或其衍生物可具有任意的重量平 分子量。對於前述聚醯胺酸或其衍生物的重量平均分子旦 亚!特別限定,但於用作液晶配向劑的成分之情形時,^ 95 200813158 24843pif 好的是5xl03以上,更好的是ixi〇4以上。具有5xl〇3以上 的重量平均分子量之聚龜胺酸或其衍生物,於j:段境〉夜曰配 向膜之步驟中並不蒸發,因而作為液晶配向劑的成分具有 較佳的物性。 此處,利用凝膠滲透層析法(GPC)法來測定聚酿胺 酸或其衍生物的重量平均分子量。例如,將所得聚醉胺酉处 或其衍生物以二甲基曱醯胺(DMF)稀釋成聚醯胺酸戈^In the case of a VA type liquid crystal display element, ribs to 卯 are often required. The large pre-tilt angle of the left and right; the ambiguity of the OCB type liquid crystal display element requires that the TM right pre-existing in the TM type liquid crystal device: in the case of the STN type liquid crystal display element, a pretilt angle of about 3 to 1 常 is often required. In the case of an IPS type liquid crystal display element, a pretilt angle of about 〇~y is often required. Therefore, the liquid crystal alignment agent of the present invention can be suitably adjusted by using a diamine having a side chain structure, and can be applied to a liquid crystal display element of any sound type. 'α As described above, a part of the diamine used in the diamine of the present invention may be substituted with a monoamine. By substituting a portion of the diamine to a monoamine: the termination of the polymerization reaction proceeds, the progress of the previous reaction can be suppressed, so that the molecular weight of the obtained polymer (poly-acid) can be easily suppressed. The ratio of the mono-diamine to the diamine may be changed without impairing the effects of the present invention. As a standard, it is preferred to set the amount of the total amine to 10 mol% or less. The amine acid or derivative thereof of the present invention may have any weight average molecular weight. For the weight average molecular weight of the aforementioned polyaminic acid or its derivative! It is particularly limited, but in the case of being used as a component of a liquid crystal alignment agent, it is preferably 5x10 or more, more preferably ixi〇4 or more. The polyglycolic acid or a derivative thereof having a weight average molecular weight of 5 x 1 〇 3 or more does not evaporate in the step of the section: the night 曰 alignment film, and thus has a preferable physical property as a component of the liquid crystal alignment agent. Here, the weight average molecular weight of polyacrylic acid or a derivative thereof is determined by a gel permeation chromatography (GPC) method. For example, the obtained polydamine or its derivative is diluted with dimethyl decylamine (DMF) to form polyglycolic acid.
衍生物的濃度約為1重量。/❶,使用Chromatopac C〜^ 孝製作所製)、將DMF作為展開溶劑且利用凝膠渗;秀爲二 分析(GPC)法進行測定,進行聚苯乙烯換算,藉此 聚醒胺酸或其衍生物的重量平均分子量。進而,為了,乂 好的精度進行聚醯胺酸及聚丙烯酸等之Gpc測定5而萝^ 將磷酸、鹽酸、硝酸、硫酸等無機酸及溴化鋰、氯化二= 無機鹽溶解於DMF溶劑而形成之展開溶劑。” 告本發明之聚醯胺酸或其衍生物,可採用公知的方法 製造。例如,於具備原料投入口、氮氣導入口、溫度計、 授拌機及冷凝n的反應m,添加以通式(〗)二( ::示之二胺中的一種或者二種以上,根據情況加入選自 望量::種或二種以上二胺,進而根據需要加入所期 或二種以上,、隹I、:: 4)以及四鲮酸二酐中的-種 總 投入量,較好的是設為與 進而視需要投入羧酸酐。此時四羧酸二酐的 ‘月女的總矣耳數大致為等莫耳 96 200813158 24843pif (莫耳比為〇·9〜1·1左右)。 藉由於攪拌下、於溫度〇〜70°c下反應1〜48小時, 可獲得聚醢胺酸的溶液。另外,藉由加熱以提高反應溫度 (例如,50〜80°C ),亦可獲得分子量小之聚醯胺酸。 本發明之聚醯胺酸,以大量的不良溶劑使其沈澱,再 藉由過濾等將固形分與溶劑完全分離,以IR、NMR進行 分析,藉此可對其進行鑑定。進而,以KOH及NaOH等 強鹼水溶液將固形的聚醯胺酸分解後,以有機溶劑進行萃 取,以GC ' HPLC或者GC —MS進行分析,藉此可對所 使用的單體進行鑑定。 對於所獲得之聚醯胺酸的溶液,為了將其調整為所期 望的黏度,可用溶劑將其稀釋後使用。 另外,於將本發明之聚醯胺酸製成作為聚醯胺酸衍生 物之可溶性聚醯亞胺之情形時,可將聚醯胺酸溶液與作為 脫水劑之醋酸酐、丙酸酐、三氟醋酸酐等酸酐、以及作為 脫水閉環觸媒之三乙胺、吡啶、三曱吡啶等三級胺,於溫 度20〜150°C下進行醯亞胺化反應而獲得。 或者,亦可使用大量的不良溶劑(曱醇、乙醇、異丙 醇等醇系溶劑及二醇系溶劑)使聚醯胺酸自聚醯胺酸溶液 中析出,再將析出的聚醢胺酸於曱苯、二甲苯等溶劑中, 與和前述同樣的脫水劑及脫水閉環觸媒一同,於溫度20〜 150°C下進行醯亞胺化反應而獲得。 於前述醯亞胺化反應中,脫水劑與脫水閉環觸媒之比 例,較好的是0.1〜10 (莫耳比)。二個的合計使用量,較 97 200813158 24843pif 好的是,相對於所使用的四羧酸二酐中所含酸二酐的總莫 耳里為1·5〜10倍莫耳。可藉由調整該化學性醯亞脸化的 脫水劑、觸媒量、反應溫度以及反應時間,而控制醯亞胺 化的程度,且獲得部分聚醯亞胺。 所得聚醯亞胺,將其與溶劑分離,於後述的溶劑中, 亦可使將前述烯基取代納迪克酸醯亞胺化合物與選自前述 雜環化合物中的至少1種加以組合而形成之改良劑共同再 浴解,而作為液晶配向背]使用,或者亦可在不與溶劑分離 下添加該改良劑而作為液晶配向劑使芾。 另外,如前所述,本發明之四羧酸二酐所使用的酸二 酐的一部分亦可被取代成有機二羧酸。若使用有機二觀酸 及四羧酸二酐來製造本發明之聚醯胺酸,則可獲得聚醯胺 酉欠-1 胺共聚物。此處,有機二缓酸相對於四叛酸二肝之 比率’若在不損害本發明效果的範圍内即可,作為標準, 較好的是設為10 mol%以下。 進而,藉由將該聚醯胺酸-聚醯胺共聚物進行化學性醯 亞胺化,可製造聚醯胺醯亞胺。 <4·本發明之液晶配向劑> 本發明之液晶配向劑包含:前述烯基取代納迪克酸酸 亞胺化合物、前述雜環化合物、及前述本發明之聚醯胺酸 或其衍生物。本發明之液晶配向劑,就黏度等物性的調整、 獲得的容易性、步驟的簡單化等觀點而言,可進而包含溶 劑’亦可進而包含通常的液晶配向劑中所包含的各種添加 劑。 98 200813158 24843pifThe concentration of the derivative is about 1 weight. /❶, using Chromatopac C~^ 孝制制制制), using DMF as a developing solvent and using gel permeation; the show is measured by the second analysis (GPC) method, and polystyrene conversion is performed to obtain a polyamine acid or a derivative thereof. The weight average molecular weight of the material. Further, in order to accurately measure the Gpc of polyacrylic acid and polyacrylic acid, 5, and the inorganic acid such as phosphoric acid, hydrochloric acid, nitric acid or sulfuric acid, and lithium bromide or chlorinated di-inorganic salt are dissolved in the DMF solvent. The solvent is developed. The poly-proline or the derivative thereof of the present invention can be produced by a known method. For example, the reaction m having a raw material inlet, a nitrogen gas inlet, a thermometer, a mixer, and a condensation n is added to the formula ( 〗 〖) Two: or two or more of the diamines, depending on the situation, are selected from the group of: one or two or more kinds of diamines, and then added as needed or two or more, 隹I, :: 4) and the total amount of the total amount of tetradecanoic acid dianhydride, it is preferable to set the carboxylic anhydride to be added as needed. At this time, the total number of ears of the 'four month's tetracarboxylic dianhydride is approximately Etc 96 96 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 By heating to increase the reaction temperature (for example, 50 to 80 ° C), a polyglycine having a small molecular weight can also be obtained. The polyproline of the present invention is precipitated with a large amount of poor solvent, and then filtered. The solid fraction is completely separated from the solvent and analyzed by IR and NMR, thereby allowing it to be carried out. Further, the solid polylysine is decomposed by a strong alkali aqueous solution such as KOH or NaOH, and then extracted with an organic solvent, and analyzed by GC 'HPLC or GC-MS, whereby the monomers used can be identified. For the solution of the obtained polyamic acid, in order to adjust it to a desired viscosity, it may be diluted with a solvent and used. Further, the polylysine of the present invention is made into a poly-proline derivative. In the case of soluble polyimine, the polyproline solution can be used as an anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride as a dehydrating agent, and triethylamine, pyridine or triterpenoid as a dehydration ring-closing catalyst. A tertiary amine such as pyridine is obtained by carrying out a hydrazine imidization reaction at a temperature of 20 to 150° C. Alternatively, a large amount of a poor solvent (an alcohol solvent such as methanol, ethanol or isopropanol and a glycol solvent) may be used. The polyamic acid is precipitated from the polyaminic acid solution, and the precipitated polylysine is dissolved in a solvent such as toluene or xylene, together with the same dehydrating agent and dehydration ring-closing catalyst as described above, at a temperature of 20醯iamine at ~150 °C In the above hydrazine imidization reaction, the ratio of the dehydrating agent to the dehydration ring-closing catalyst is preferably 0.1 to 10 (mole ratio). The total amount of the two is better than that of 97 200813158 24843pif. The total molar amount of the acid dianhydride contained in the tetracarboxylic dianhydride used is from 1. 5 to 10 times the molar amount. The amount of the dehydrating agent and the amount of the catalyst can be adjusted by adjusting the chemical 醯 sub-face. And the reaction temperature and the reaction time, and the degree of imidization is controlled, and a part of the polyimine is obtained. The obtained polyimine is separated from the solvent, and the alkenyl group may be substituted in the solvent described later. The modifier of the Nadick acid ylide imine compound and at least one selected from the group consisting of the above heterocyclic compounds is used together as a liquid crystal alignment back, or may be added without being separated from the solvent. The modifier is used as a liquid crystal alignment agent to cause enthalpy. Further, as described above, a part of the acid dianhydride used in the tetracarboxylic dianhydride of the present invention may be substituted with an organic dicarboxylic acid. When the polydiamide of the present invention is produced using an organic dicarboxylic acid and a tetracarboxylic dianhydride, a polyamine amine oxime-1 amine copolymer can be obtained. Here, the ratio of the organic di-hypo-acid to the four-repulsive di-hepatic liver' may be within a range that does not impair the effects of the present invention, and is preferably 10 mol% or less as a standard. Further, the polyamidoquinone imine can be produced by chemically imidating the polyamine-polyamine copolymer. <4. Liquid crystal alignment agent of the present invention> The liquid crystal alignment agent of the present invention comprises the above alkenyl-substituted nadic acid acid imine compound, the above heterocyclic compound, and the aforementioned polyglycine or derivative thereof . The liquid crystal alignment agent of the present invention may further contain various additives contained in a usual liquid crystal alignment agent from the viewpoints of adjustment of physical properties such as viscosity, ease of availability, simplification of steps, and the like. 98 200813158 24843pif
前述液晶配向劑中的改良劑的烯基取代納迪克酸酿亞 =合物之包含率,較好的是,每1〇〇重量份之液晶配 劑中的聚_酸或其财物,簡量計,A卜_重量 份、更好的是1〜7〇重量份、更每的是卜50重量份,I ,用作液晶齡元件輕電氣触長期默之誠而言為 更好。 本發明之前述液晶配向劑中的改 期穩定之 物,以總量計,為卜刚崎:,聚_或其街生 更好的是卜㈣量份。更好岐1〜7Q重量份、 前述雜環化合物中前述雜产 量,取決於雜環結構的^ 液晶配向劑中的含 密度的降低以及其歷時性增力 之關係,如前所述並料定,祕祕合物間 上述效果的表現有_。 心忍為,雜環結構的量與 液晶配向劑中環氧乙烷化人 化合物中的環氧乙烷έ士 二〇 3罝,於將環氧乙烷 相對於聚ϋ胺酸或其财物^環氧乙烧時,較好的是, 劑中氧環丁烧化合物的含旦':、.1:80重量%。液晶配向 環丁垸結構換算錢環了= ’㈣Τ魏合物中的氧 酸或其街生物為CU〜8G =。,較好的是’相對於聚酿胺 嗝(thiirane)化合物的八旦里/〇另外,液晶配向劑中噻 構換算成嗟喘時,較好二Γ 塞^匕合物中的嗟喃結 目對於聚酿胺酸或其衍生物 99 200813158 24843pif 為0.1〜80重量%。另外,液 於編心 〜80重:心:入1目對於聚醯胺酸或其衍生物為〇.〗 於以卜液日日配向劑中噁唑啉化合物的含量, 的:化合物中的德唾琳結構換 疋^目對於聚醯胺酸或其衍生物為Qi〜8妙^子 f 其街生物輕Γ〜δ(^=㈣岐,相對於㈣胺酸或 另外,於雜環化合物包含二種 時,液晶配向劑中雜環結形 的各個雜環結構的比例而求出。 *辰化5物中 迪克代, =r?=:r歷時性二件 里比# ’祕的是αΐ〜’更好的是〇 5〜5 本發明之聚醯胺酸或其衍生物, 或其衍生物。例如,若為聚醮胺酸,則=述:;胺酸 的Α成分或者Β成分與前述胺的Α成分^ ^處酸 而獲得之聚醯胺酸、使前述酸的Α成分成刀反應 =八成分或者B成分反應而獲得之酸胺 j刀或B絲與喊胺的4絲及^分反的 來酿胺酸、以及使前述酸的A成分及 二又传之The inclusion ratio of the alkenyl-substituted nadic acid-based compound of the modifier in the liquid crystal alignment agent is preferably a poly-acid or a property thereof per 1 part by weight of the liquid crystal formulation. In terms of A, _ parts by weight, more preferably 1 to 7 parts by weight, and even more than 50 parts by weight of I, I, as a liquid crystal age component light electrical touch long-term silent is better. The above-mentioned liquid crystal alignment agent of the present invention is stable in terms of the total amount, and it is Bugangqi: in terms of the total amount, it is better that the poly_ or its street is a (four) amount. More preferably, from 1 to 7 parts by weight, the aforementioned heterogeneous amount in the above heterocyclic compound depends on the decrease in the density of the liquid crystal alignment agent of the heterocyclic structure and the relationship of its diachronic increase, as described above. The performance of the above effects between the secret secrets is _. For the heart, the amount of the heterocyclic structure and the ethylene oxide oxime in the oxiranidated human compound in the liquid crystal alignment agent, in the case of ethylene oxide relative to poly-amic acid or its property ^ In the case of epoxy bake, it is preferred that the oxygen ring-containing compound in the agent contains denier::, 1:80% by weight. Liquid crystal alignment Cyclopentadiene structure conversion money ring = ‘(4) Τ Τ 中 Τ Τ 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其 或其Preferably, it is 'in comparison with the thiirane compound of the octagonal 〇 / 〇. In the liquid crystal alignment agent, the thioform is converted into the sputum, and the bismuth sulphate in the bismuth The target is 0.1 to 80% by weight for poly-aracine or its derivative 99 200813158 24843pif. In addition, the liquid is woven in the heart of ~80 weight: heart: into the 1 mesh for poly-proline or its derivative is 〇. 〗 〖 In the liquid in the daily aligning agent oxazoline compound content, of: in the compound The salivary structure is changed for the poly-proline or its derivative is Qi~8 Miao^f f, its street bio-small Γ~δ(^=(四)岐, relative to the (tetra)amine or otherwise, contained in the heterocyclic compound In the case of two kinds, the ratio of each heterocyclic ring structure in the heterocyclic ring shape of the liquid crystal alignment agent is determined. *Dick generation in the Chening 5, =r?=:r diachronic two pieces of the ratio ##'s secret is αΐ ~' More preferably 〇5~5 The polyaminic acid of the present invention or a derivative thereof, or a derivative thereof. For example, if it is a poly-proline, the oxime component or the quinone component of the amine acid is The polyamine acid obtained by the acid component of the above-mentioned amine, the hydrazine component of the acid, the sulfonium component of the acid, the acid component of the eight-component or the component B, and the filament of the B-line and the sulfonamide. ^There is the opposite of the tyrosine acid, and the A component of the aforementioned acid and the second pass
成分及B成分反應喊得之聚醯魏㈣胺的A 100 200813158 24843pifComposition and component B reacted to the agglomeration of Wei (tetra)amine A 100 200813158 24843pif
c 本發明之液晶配向劑中聚醯胺酸或其衍生物的包含 率,可根據將液晶配向劑塗佈於基板上的塗佈方法作適當 選擇。例如,通常的液晶顯示元件的製造步驟中所使用之 印刷機(包含平板印刷機(offset priter )及喷墨印刷機; 以下,簡稱為「印刷機」)中所使用液晶配向劑中聚醯胺酸 或其衍生物的包含率,以總量計,較好的是0.5〜30重量 %,更好的是1〜15重量%,可根據與液晶配向劑的黏度 的關係作適當調整。 本發明所使用之溶劑,廣泛地包含聚醯胺酸、可溶性 χκ酉&亞胺、以及xjx &&胺life亞胺等南分子成分的製造步驟及 用途中所通常使用的溶劑,可根據使用目作適當選擇。該 溶劑,較好的是,(1)對聚醯胺酸及可溶性聚醯亞胺為易 溶性之非質子性極性有機溶劑、(2)包含以改變表面張力 而改善塗佈性等為目的之溶劑的混合溶劑。 若將這些溶劑加以例示,則如下所述。 ο)對聚醯胺酸及可溶性聚醯亞胺為良溶劑之非質子 性極性有機溶劑(以下,非質子性極性有機溶劑),例二可 例示:队甲基_2_吡咯啶酮、二甲基咪唑啉§同、甲基己 酿胺、队甲基丙醯胺、Ν,Ν-二曱基乙醯胺、二 = 二曱基曱賴、跟二乙基甲_、: ㈣、 I 丁内_、γ•戊_。這些之中,更好地例示:Ν_^ 吡咯啶酮、二甲基咪唑啉酮、γ_丁内酯、丫_戊内酯等。土 (2)以改變表面張力錢#塗佈性等為目^之 I以下,其他溶劑),例如為:乳酸烷基酯、曱美3 ^ 101 200813158 24843pif 氧基庚醇、四氫萘、異佛爾酮、乙二醇單丁基醚等乙二醇 單烷基醚,二乙二醇單乙基醚等二乙二醇單烷基醚,乙二 醇單烷基醚或者醋酸苯酯、三乙二醇單烷基醚、丙二醇單 丁基醚等丙二醇單烷基醚,丙二酸二乙酯等丙二酸二烷基 酯、二丙二醇單曱基醚等二丙二醇單烷基醚,這些醋酸酯 類等酯化合物。這些之中,更好地例示:乙二醇單丁基醚、 二乙二醇單乙基醚、丙二醇單丁基醚、二丙二醇單曱基醚 等。 ^ 丄*τ ΙΛ 七,▼ r? -Η- /,L· 、七七,τ r? > \ -rn r^> 刁P '貝丁Ί生征Ί王汾肖y汉六浴/角里矢貝汉,WJ气y思 液晶配向劑的印刷性、塗佈性、溶解性以及保存穩定性等 作適當設定。相對而言,非質子性極性溶劑的溶解性及保 存穩定性較其他溶劑優異,而其他溶劑存在印刷性及塗佈 性優異的傾向。 如前所述,本發明之液晶配向劑亦可包含各種添加 劑。作為各種添加劑,可分別根據目的將除聚醯胺酸或其 衍生物以外的高分子化合物、或者低分子化合物選擇使用。 例如,將對有機溶劑為可溶性的高分子化合物作為添 加劑,且添加這些添加劑,藉此可控制所形成之液晶配向 膜的電氣特性及配向性。作為該高分子化合物之例子,可 舉出:聚醯胺、聚胺基曱酸酯、聚脲(polyurea)、聚酯、 聚環氧化物、聚酯多元醇、聚矽氧改質聚胺基甲酸酯、聚 矽氧改質聚酯等。 另外,作為低分子化合物之添加劑,例如:(1)於期 望增加塗佈性時為了相關目的可使用界面活性劑,(2)於 102 200813158 24843pifc The content of polyphthalic acid or a derivative thereof in the liquid crystal alignment agent of the present invention can be appropriately selected depending on the coating method in which the liquid crystal alignment agent is applied onto the substrate. For example, a printing machine used in a manufacturing process of a general liquid crystal display element (including an offset priter and an ink jet printer; hereinafter, simply referred to as "printer") is used in a liquid crystal alignment agent. The content of the acid or its derivative is preferably from 0.5 to 30% by weight, more preferably from 1 to 15% by weight based on the total amount, and can be appropriately adjusted depending on the relationship with the viscosity of the liquid crystal alignment agent. The solvent used in the present invention broadly comprises a solvent commonly used in the production steps and uses of polymolecular acid, soluble χκ酉&imine, and xjx &&amine amine imine; Make appropriate choices according to the purpose of use. The solvent is preferably (1) an aprotic polar organic solvent which is soluble in polylysine and a soluble polyimine, and (2) which is intended to improve coating properties by changing surface tension. A solvent mixture of solvents. When these solvents are exemplified, they are as follows. ο) An aprotic polar organic solvent (hereinafter, an aprotic polar organic solvent) which is a good solvent for poly-proline and soluble polyimine, and the second example can be exemplified by a group of methyl-2_pyrrolidone and two. Methyl imidazoline § the same, methyl hexylamine, methacrylamide, hydrazine, hydrazine-dimercaptoacetamide, bis-dimercaptopurine, bis-diethylcarbazone, and (tetra), I Ding _, γ • _. Among these, 例_^ pyrrolidone, dimethylimidazolidinone, γ-butyrolactone, 丫-valerolactone, and the like are more preferably exemplified. The soil (2) is changed to the surface tension, the coating property, etc., and other solvents, for example, alkyl lactate, yam 3 ^ 101 200813158 24843 pif oxyheptanol, tetrahydronaphthalene, iso Ethylene glycol monoalkyl ether such as phorone or ethylene glycol monobutyl ether; diethylene glycol monoalkyl ether such as diethylene glycol monoethyl ether; ethylene glycol monoalkyl ether or phenyl acetate; a propylene glycol monoalkyl ether such as triethylene glycol monoalkyl ether or propylene glycol monobutyl ether; dipropylene glycol monoalkyl ether such as dialkyl malonate or dipropylene glycol monodecyl ether; These ester compounds such as acetates. Among these, ethylene glycol monobutyl ether, diethylene glycol monoethyl ether, propylene glycol monobutyl ether, dipropylene glycol monodecyl ether, and the like are more preferably exemplified. ^ 丄*τ ΙΛ 七,▼ r? -Η- /,L·,七七,τ r? > \ -rn r^> 刁P 'Beeting Ί生Ί王汾肖y Han Liu Bath/角里矢Behan, WJ gas y liquid crystal alignment agent printability, coating properties, solubility and storage stability, etc. are appropriately set. On the other hand, the solubility and storage stability of the aprotic polar solvent are superior to those of other solvents, and other solvents tend to be excellent in printability and coating properties. As described above, the liquid crystal alignment agent of the present invention may also contain various additives. As the various additives, a polymer compound other than polyamic acid or a derivative thereof or a low molecular compound can be selected and used depending on the purpose. For example, a polymer compound which is soluble in an organic solvent is used as an additive, and by adding these additives, electrical characteristics and alignment properties of the formed liquid crystal alignment film can be controlled. Examples of the polymer compound include polyamine, polyamino phthalate, polyurea, polyester, polyepoxide, polyester polyol, and polyoxygen modified polyamine. Formate, polyoxymethylene modified polyester, and the like. Further, as an additive of a low molecular compound, for example, (1) a surfactant may be used for a related purpose when it is desired to increase the coatability, (2) at 102 200813158 24843pif
必須增加抗靜電性時,可使用 A 與基板的密著性及耐研磨性_ ’ 3)於期望增加 偶合劑,另外⑷於低;wTi^可使时垸偶合劑及鈦系 用醯亞胺化_ 4細醯亞舰之情形時,可使 ^為前述魏偶合歉例子,可舉出:乙烯基三甲氧 二石乙稀基二乙氧基石夕垸、N必胺基乙基)各胺基丙 基:基一甲减魏、叫胺基乙基)各胺基丙基甲基三 :乳基魏、對胺基苯基三甲氧基魏、_基苯基三乙 乳基㈣、軸絲基三^氧基魏、間胺|苯基二乙氧 基=烷、3-胺基丙基三曱氧基矽烷、3_胺基丙基三乙氧基 矽=、3_縮水甘油氧基丙基三曱氧基矽烷、3_縮水甘油氧 基丙基曱基二曱氧基矽烷、2_(3,4_環氧基環己基)乙基三曱 虱基矽虼、3-氯丙基曱基二甲氧基矽烷、3_氯丙基三曱氧 基矽烷、3_曱基丙烯醯氧基丙基三甲氧基矽烷、3_巯基丙 ^二甲氧基矽烷、N_(l,3-二甲基亞丁基)-3-(三乙氧基曱矽When it is necessary to increase the antistatic property, the adhesion between A and the substrate and the abrasion resistance _ '3) can be used to increase the coupling agent, and (4) is low; wTi^ can be used as a ruthenium coupling agent and titanium ruthenium amide. In the case of the _ 4 醯 醯 舰 舰 舰 , , , , , 醯 醯 醯 醯 醯 醯 为 为 为 为 为 为 为 为 为 为 为 为 为 合 合 合 合 合 合 合 合 合 合 合 合 合 合 合 合Alkyl group: a group of a minus wei, called an aminoethyl group) each aminopropyl methyl three: lactyl-wei, p-aminophenyl trimethoxy- Wei, _ phenyl phenyl triethyl lactyl (four), axis Silk-based methoxy-, meta-amine|phenyldiethoxy=alkane, 3-aminopropyltrimethoxy decane, 3-aminopropyltriethoxy hydrazine=, 3_glycidyloxy Propyltrimethoxy decane, 3-glycidoxypropyl decyl decyloxydecane, 2-(3,4-epoxycyclohexyl)ethyltrimethylsulfonium, 3-chloropropane曱 methoxy dimethoxy decane, 3- chloropropyl tridecyloxy decane, 3-mercapto propylene methoxy propyl trimethoxy decane, 3 fluorenyl propyl dimethoxy decane, N _ (l, 3-dimethylbutylene)-3-(triethoxyhydrazine
烧基)-1-丙基胺、风忡_雙[3_(三甲氧基曱矽烷基)丙基]乙二 胺等。 作為前述醯亞胺化觸媒之例子,較好的是添加:三甲 胺、二乙胺、三丙胺、三丁胺等脂肪族胺類;N,n_二曱基 苯胺、N,N-二乙基苯胺、曱基取代苯胺、羥基取代苯胺等 芳香族胺類;吡啶、甲基取代吡啶、羥基取代吡啶、喹啉、 甲基取代啥啉、羥基取代喹啉、異喹啉、甲基取代異喹啉、 經基取代異喹啉、咪唑、曱基取代咪唑、羥基取代咪唑等 %式胺類等之觸媒。尤其可舉出:N,N-二曱基苯胺,鄰一 103 200813158 24843pif 間…對-羥基苯胺,鄰_、間_、對羥基吡啶,異喹啉等。 石夕文兀偶合劑之添加量,通常為聚酸胺酸或其衍生物總 重量的0〜10重量%,較好的是〇1〜3重量%。 ife亞胺化觸媒之添加量,通常相對於聚醯胺酸或其衍 生物的‘基’為0 0^5等量(equip〇nderance),較好的是 0·05〜3等量。 其他添加劑之添加量,根據其用途而不同,通常為聚The alkyl group is 1-propylamine, the air enthalpy_bis[3_(trimethoxydecyl)propyl]ethylenediamine, and the like. As an example of the ruthenium amide catalyst, it is preferred to add an aliphatic amine such as trimethylamine, diethylamine, tripropylamine or tributylamine; N,n-didecylaniline, N,N-di Aromatic amines such as ethyl aniline, mercapto substituted aniline, hydroxy substituted aniline; pyridine, methyl substituted pyridine, hydroxy substituted pyridine, quinoline, methyl substituted porphyrin, hydroxy substituted quinoline, isoquinoline, methyl substitution A catalyst such as an isoquinoline, a trans-substituted isoquinoline, an imidazole, a mercapto-substituted imidazole, a hydroxy-substituted imidazole, or the like. In particular, N,N-dimercaptoaniline, o-103 200813158 24843pif, p-hydroxyaniline, o-, m-, p-hydroxypyridine, isoquinoline and the like. The addition amount of the Shi Xiwen coupling agent is usually 0 to 10% by weight, preferably 1 to 3 % by weight based on the total weight of the polyamic acid or the derivative thereof. The addition amount of the ife imidization catalyst is usually equal to 0 ^ 5 equal amount with respect to the 'base' of the poly-proline or its derivative, and is preferably 0. 05 to 3 equivalent. The amount of other additives added varies depending on the application, usually poly
酿胺酸或其衍生物總重量的0〜30重量%,較好的是0.1 〜10重量%。 本电明所使用之液晶配向劑之其他較佳形態 一種以上聚醯胺酸之組合物。 例如若為包含二種聚醯胺酸之液晶配向劑,則可舉 出·包含第一聚醯胺及第二聚醯胺酸之液晶配向劑;該第 胺t使用四羧酸二酐及二胺的一個或二個中具有侧 鍵結構的化合物,該第二聚醯胺酸中不使用四羧酸二酐及 ,胺中的任一個中具有侧鏈結構的化合物。更具體而言, ,聚___種’酸的A成分及β成分的—個或兩個與 胺的A成分反應轉得之㈣胺酸或其衍生物工 (以下, 稱為㈣胺酸工」),另—種為酸的A成分及B成分的 二個或兩個與胺的B成分反應而獲得之聚_酸或其衍生 物立(以下,亦稱為「聚醯胺酸Π」)。 一本發明之聚_酸!與聚醯胺酸Κ組合物,是藉由 將前述聚酿贿1與聚__混合而製備。經混合的聚 ^胺酸1與聚酿胺酸Π之重量比,較好的是I /Π =99/1〜 104 200813158 24843pif 50/50 ’更好的是I / Π = 95/5〜80/20。該重量比,可根據 所求出的預傾角(pretilt angle)作適當調整,若提高聚酿 胺酸Π的比率,則可加大預傾角。 另外,本發明之液晶配向劑,可僅包含聚醯胺酸工及 Π ’亦可進-步包含除聚雜酸;^^以外的聚賴 其衍生物。 丽述二胺I ,使用一種或二種以上之二胺,至少使The total weight of the tyrosine acid or its derivative is from 0 to 30% by weight, preferably from 0.1 to 10% by weight. Other preferred embodiments of the liquid crystal alignment agent used in the present invention are a combination of one or more polylysines. For example, in the case of a liquid crystal alignment agent containing two kinds of polyamic acid, a liquid crystal alignment agent containing a first polyamine and a second polyamic acid; and the tetraamine dianhydride and the second amine are used. A compound having a side bond structure in one or two of the amines, and a tetracarboxylic dianhydride and a compound having a side chain structure in any of the amines are not used in the second polyamic acid. More specifically, one or two of the A component and the β component of the poly-_' acid' are reacted with the A component of the amine to convert it to (iv) an amine acid or a derivative thereof (hereinafter, referred to as (tetra) aminic acid) The other is a poly-acid or a derivative thereof obtained by reacting two or two components of the acid component A and the component B with the amine component B (hereinafter, also referred to as "polyammonium citrate" "). A poly-acid of the invention! The composition with polyphosphonium amide is prepared by mixing the above-mentioned poly brittle 1 with poly-_. The weight ratio of the mixed polyamic acid 1 to the polystyrene citrate is preferably I / Π = 99 / 1 ~ 104 200813158 24843pif 50 / 50 'better is I / Π = 95/5~80 /20. The weight ratio can be appropriately adjusted according to the obtained pretilt angle, and if the ratio of the polystyrene is increased, the pretilt angle can be increased. Further, the liquid crystal alignment agent of the present invention may contain only a polyglycolic acid and a ruthenium, and may further comprise a polylactic acid derivative other than a polyacid. Lithium diamine I, using one or more diamines, at least
用以前述通式(Π)〜(Μ)所表示之二胺。由前述胺的 Α成分與S羧酸二酐合成之前述聚醯胺酸〗,可有效地賦 予包含使用包含前述聚醯胺酸工的液晶配向劑所形成的液 晶配向膜之液晶顯示元件,以良好的離子密度。 另外一fe I,根據需要亦可併用任意的直他二 胺。此處,作為其他二胺,可舉出以前述通式(哑)二(涎) ,(ΧΛΟ所表示之二胺、或者料二胺、残烧系二胺 前述聚酿胺酸I中的二胺中的前述胺的 比,可根據經選擇的以前述通式(〗)〜(狐)所表示 二胺的結構、及所期望的離子密度及長期可靠性進= 整,以總量計,^好的是卜⑽%,更好的是5〜戰。 另-方面,前述聚醯胺酸Π,可有致地賦予包含ς 已含該聚醯胺酸n的液晶配向劑而形成的液晶配向 晶顯示元件,以合適的預傾角。 、/ 前述聚醯胺酸D中的二胺中之前述胺的B , 性地使用以通式(Μ)〜(M)所丧干& 刀,代表 )所录不的一種或二種以上 105 200813158 24843pif 二胺,但作為可併用之二胺,可舉出以前述通式式(I ) 〜(W)所表示之二胺、魏垸系二胺等。 人藉由將前述聚醯胺酸I與聚醯胺酸2加以組合(混 δ ) 了賦予作為本發明之液晶配向劑之較佳特性。 〆印具體而言,對於作為聚醯胺酸的原料之二胺,藉由適 當,擇所使用二胺的種類及其組合,可賦予使用本^明之 、、、曰物而元成之液晶配向膜以更良好的離子密度及合適的 預傾角。It is used for the diamine represented by the above formula (Π)~(Μ). The polyamic acid synthesized from the sulfonium component of the amine and the S carboxylic acid dianhydride can effectively impart a liquid crystal display element comprising a liquid crystal alignment film formed using the liquid crystal alignment agent containing the polyglycolic acid. Good ion density. Alternatively, any of the direct diamines may be used in combination as needed. Here, examples of the other diamine include the above-mentioned general formula (dummy) bis(涎), (diamine represented by hydrazine, or diamine of the residue, and diamine of the residual calcined diamine). The ratio of the aforementioned amine in the amine can be determined based on the selected structure of the diamine represented by the above formula (?) to (fox), and the desired ion density and long-term reliability. ^好是卜(10)%, more preferably 5~战. In another aspect, the above polyphosphonium phthalate can preferentially impart a liquid crystal alignment formed by a liquid crystal alignment agent containing cerium containing the polyaminic acid n. The crystal display element is at a suitable pretilt angle. / / The above-mentioned amine B in the diamine of the poly-proline D is used as a dry & knife represented by the formula (Μ)~(M) (1) one or more of the above-mentioned 105 200813158 24843pif diamines, but as the diamine which can be used in combination, a diamine or a fluorinated diamine represented by the above formula (I) to (W) may be mentioned. Wait. The combination of the polyamic acid I and the polyamic acid 2 (mixed δ) imparts a preferred property to the liquid crystal alignment agent of the present invention. Specifically, the diamine which is a raw material of polylysine can be imparted with a liquid crystal alignment by using the type and combination of the diamines which are used as appropriate. The film has a better ion density and a suitable pretilt angle.
<5·本發明之液晶配向膜> / / 、, ^ 膜’為將前述本發明之液晶配向劑 中的两述聚_酸及改良劑簡狀锻燒而形成之液晶配向 ,述液晶配向膜,例如可藉由於液晶顯示元件用基 2者氣化敏聚石夕氧等測定用基板上塗佈本發明之液 :。° f,j ’且將該液晶配向劑的膜加熱至例如150〜 、較好岐⑽〜280t而形成。此處液晶配向膜的 外Γ/乂好的是10〜300 nm、更好的是30〜⑽_。另 、父好的疋,對液晶配向膜進行研磨處理。 液晶:晶配向膜的膜厚,可根據液晶配向劑的黏度及 厚,可二Α的塗佈方法進行調整。另外,液晶配向膜的膜 膜厚測偏辆(ellipsGmetef)等公知的 的成分ί衣置進行測定。進而,根據f要將液晶配向膜中 方^=解等處理,且可利用1nMS等通常的分析 106 200813158 24843pif <6·本發明之液晶顯示元件> 本發明之液晶顯示元件,包含· 基板、(2)於前述一對基板各自對向面對向配置之-對 之液晶配向膜、及(3)夾持於前述一,形成之本發明 前述對向配置的-對附電極基板, (例如玻璃基板)。 較奸的是透明基板 於前述-對基板的至少一個或兩個 據液晶顯示元件的形態設置有電極二勺表面上,根 板的一面上形成之電極則無特別限定若為於基 可舉出ΙΤΟ及金屬的基著膜等。泰 X —V电極,例如 】極:基板上’於基板表面上 發 •’於設置電極的基板上的電極二二之液曰曰配向 向膜。關於本發明之液晶配向膜之形成配 夾持於前述-對美柄严m成為如則所述。 處對於、、$曰 土 9 攻日日層包含液晶組合物。此 負白㈣正的液晶組合物以及介電常數異向性為 員的液晶組合物之任意組合物。 於日iL常韋ί異向性為正的較佳液晶組合物之例子,揭示 報、日夫」弟3086228號公報、日本專利第2635435號公 利特表平5 —5〇1735號公報、日本專利特開平 曰太蛊41就公報、日本專利特開平8 —231960號公報、 專利特開平9 —241644號公報(ΕΡ885272Α1)、日本 汗、/ 9 — 302346號公報(Ερ8〇6466Α1)、日本專利 107 200813158 24843pif 特開平- 199168 f虎公報(Ep722998A1)、日本專利特開 平9-235552號公報、日本專利特開平9一255956號公報、 =本專利特開平9 —241643號公報(E州測Μ)、日本 士利4了開平1〇-204〇16號公報㈤844229川、日本專利 t開Γ 1〇一2〇4436號公報、日才、專利特開平10一2難2<5. Liquid crystal alignment film of the present invention> / /, "The film" is a liquid crystal alignment in which the poly-acid and the modifier of the liquid crystal alignment agent of the present invention are simply calcined, and the liquid crystal is described. For the alignment film, for example, the liquid of the present invention can be applied to a substrate for measurement such as gasification of a liquid crystal display element. ° f, j ' is formed by heating the film of the liquid crystal alignment agent to, for example, 150 to 〜10 to 280 t. Here, the outer diameter of the liquid crystal alignment film is preferably 10 to 300 nm, more preferably 30 to 10 (10). In addition, the father is good, and the liquid crystal alignment film is polished. Liquid crystal: The film thickness of the crystal alignment film can be adjusted according to the viscosity and thickness of the liquid crystal alignment agent. Further, a well-known component such as a film thickness measuring device (ellipsGmetef) of the liquid crystal alignment film is measured. Further, according to f, the liquid crystal alignment film is subjected to a process such as a solution, and a general analysis such as 1 nMS can be used. 106 200813158 24843pif <6. Liquid crystal display element of the present invention> The liquid crystal display element of the present invention includes a substrate, (2) a pair of counter electrode substrates in which the pair of substrates are opposed to each other facing each other and (3) sandwiched between the ones of the present invention and formed in the opposite direction of the present invention (for example) glass substrate). The transparent substrate is a transparent substrate, and at least one or two of the substrates are provided on the surface of the liquid crystal display element, and the electrode formed on one surface of the root plate is not particularly limited. The base of the metal and the like. The X-V electrode, for example, the electrode: on the substrate, is placed on the surface of the substrate, and the electrode of the electrode on the substrate on which the electrode is disposed is aligned with the film. The formation of the liquid crystal alignment film of the present invention is carried out as described above. For the,,,,,,,,,,,,,,,,,,,,, This negative white (iv) positive liquid crystal composition and any composition of the liquid crystal composition having a dielectric anisotropy. Japanese Patent No. 3086228, Japanese Patent No. 2635435, Japanese Patent No. 2635435, Japanese Patent, Japanese Patent No. 2,635,435, Japanese Patent No. 2,635,435, Japanese Patent No. 2,635,435, Japanese Patent No. 2,635,435 Japanese Patent Laid-Open No. Hei 8-231960, Japanese Patent Laid-Open No. Hei 9-241644 (ΕΡ 885 272 Α 1), Japanese Khan, No. 9-302346 (Ερ8〇6466Α1), Japanese Patent 107 200813158 24843pif _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Shili 4 Kaiping 1〇-204〇16 Bulletin (5) 844229 Sichuan, Japanese Patent t Kaikai 1〇1〇2436 Bulletin, Japanese Talent, Patent Special Kaiping 101-2 Difficult 2
Tim 4Lt",]#F" 2〇00'087040 ^ 開2001 — 48822號公報等。 廿制贿晶顯示元件巾職狀液晶組合物,可將 其製成介電常數里向拇〜〜 J ^ ;組:::例,·:=== -罵85號3=35號公報、日本專利特開平4 本專本專特開平8 —娜3號公報、曰 16807^/^〜1〇4869號公報、日本專利特開平i0 — 本專利、日料婦解1Q—刪53號公報、日 本專利扣開平10 —236989號公 236990號公報、日本專 本專⑷開平10_ 本專利特開平t ΓΓ號公報、曰 士 Γ 日本專利特開平1〇-237〇〇〇號公報a = = 1ΰ—2_號公報、日本專利特料二 237024 *5虎公報、日太直奋|牡 i〇^2t7〇7?; I! 10~237035 a 細6號二日報、日本專_平ι〇-㈤嶋U1)、日本專平—237蝴號公報 本專利特㈣1G__287875 1G 287874 #u公報、日 287875旒公報、日本專利特開平10_ 108 200813158 24843pif 291945號公報、日本專利特開平m 本專利特料u-__號公報、日本專利報、曰 2麵號公報、日本專利特開2〇〇 = ^;^_- ==;:r726, 添加 之液顯示元件,當然亦可具有其他部件。 φ二广使用薄膜電晶體之顏色顯示TFT型访曰士技 二有薄膜電晶體、絕緣二護 膜及像素電::黑巴矩陣、彩色濾光器、平坦化 元件^外^顯示元件尤其ms液晶顯示 j *減 透基板上形成有稱為區(d_in)之微 =、政物。另外,亦可形成基板間的面板間隙調整用間隔 2由任意方法製作本發明之液晶顯示元件,例如可 ==1列步驟之方法來製作:(1)於前述二片透明基 反液晶配向劑之步驟,⑺將經塗佈的液晶 之步驟’⑺實行對將經乾燥的液晶配向 2水、_反縣碎.減歡 1 膜進行配向處理之步驟,⑸紅絲板具有特定= 口以貼合後’將液晶封人基板間的間隙中之步驟,或者 109 200813158 24843pif =液晶滴加於—片基板上後與另一片基板進行貼合之步 而言作ίίΐϊ述液晶配向劑的步驟中之塗佈方法,-般 有旋轉器法、印刷法、、、君、、主、、木 ^ 法等。這些方法亦可應用於本^明Γ貝滴法1墨 的二驟=為必要 紅外線爐中進科士為老 焱而吕,已知有於烘箱或者 之方法f 理之方法、於驗上進行加熱處理 二広寸。廷些方法亦可適周於本發明。乾丨 (5"- i5〇〜W^K^驟’—崎,較好的是於 〇CB==向膜的配向處王里,於iPS型液晶顯示元件、 -、員示元件、™型液晶顯示元件、s™型液晶 !^1兀,通常是進行研磨處理。於VA型液晶 件中,常常亦可不進行研磨處理。 域日日顯不凡 接著,將接著劑塗佈且貼合於一片基板 :合所使用的接著劑產生硬化而製作本發明之液 亦可於本發明之液晶顯示元件上安裝偏光 膜)、波長板、光散射膜、驅動電路等。 [實施例] 110 200813158 24843pif 以下,利用實施例來說明本發明,但本發明並不限定 於這些實施例。另外,於實施例中所使用的四羧酸二酐、 二胺、烯基取代納迪克酸醯亞胺化合物、雜環化合物以及 溶劑的名稱,是以下列省略號來表示。 [四羧酸二酐]Tim 4Lt",]#F" 2〇00'087040 ^ Open 2001 — 48822, etc.廿 贿 晶 显示 显示 显示 显示 显示 显示 显示 显示 显示 显示 显示 显示 显示 显示 显示 显示 显示 显示 贿 贿 贿 贿 贿 贿 贿 贿 贿 贿 贿 贿 贿 贿 液晶 液晶 液晶 液晶 液晶 液晶 液晶 液晶 液晶 液晶 液晶 液晶 液晶 液晶Japanese Patent Special Kaiping 4 This special edition special Kaiping 8 - Na 3 bulletin, 曰 16807 ^ / ^ ~ 1〇 4869 bulletin, Japanese patent special Kaiping i0 - this patent, Japanese women's solution 1Q - delete 53 bulletin, Japanese Patent Deduction No. 10-236989, No. 236990, Japanese Special Edition (4) Kaiping 10_ This patent is open to the public, and is published in the Gazette of the Japanese Patent Special Publication No. 1〇〇〇-237〇〇〇 a = = 1ΰ— 2_ bulletin, Japanese patent special 2 237024 *5 tiger bulletin, Japanese too straight fortune | oy i〇^2t7〇7?; I! 10~237035 a fine 6th second daily newspaper, Japan special _ flat 〇 - (5)嶋U1), Japanese specialization-237 butterfly publication, this patent special (four) 1G__287875 1G 287874 #u bulletin, Japanese 287875旒 bulletin, Japanese patent special Kaiping 10_108 200813158 24843pif 291945, Japanese patent special Kaiping m patent patent u- __ bulletin, Japanese Patent Report, 曰2 face number bulletin, Japanese patent special opening 2〇〇 = ^; ^_- ==;: r726, added liquid display element Of course, also have other components. φ Erguang uses the color of the thin film transistor to display the TFT type visitor. There are thin film transistors, insulating two films and pixel electrodes:: black matrix, color filter, flattening element ^ outside ^ display component especially ms A liquid crystal display j* is formed on the substrate and has a micro-representation called a region (d_in). Further, the liquid crystal display element of the present invention may be formed by any method by forming the panel gap adjusting interval 2 between the substrates, for example, by the method of =1 column steps: (1) the two transparent transparent liquid crystal alignment agents In the step of (7) the step of applying the coated liquid crystal '(7) to the step of aligning the dried liquid crystal to 2 water, _ anti-counterfeiting, and reducing the film, (5) the red silk plate has a specific = mouth to paste After the step of 'liquid crystal sealing the substrate between the substrates, or 109 200813158 24843pif = liquid crystal drop is applied to the substrate and then bonded to another substrate for the step of aligning the liquid crystal alignment agent The coating method, such as a rotator method, a printing method, a jun, a master, a wood method, and the like. These methods can also be applied to the two-step method of the ink drop method 1 ink = the necessary infrared furnace in the infra-red furnace, and the method is known in the oven or the method. Heat treatment two inches. These methods may also be suitable for the present invention. Cognac (5"-i5〇~W^K^j'--Saki, preferably in the alignment of the CB== film to the film, in the iPS type liquid crystal display element, -, member element, TM type The liquid crystal display element and the sTM type liquid crystal are usually polished. In the VA type liquid crystal device, the polishing process is often not performed. The day and day are remarkable. Then, the adhesive is applied and adhered to one piece. The substrate may be formed by curing the adhesive used to form the liquid of the present invention, or a polarizing film may be attached to the liquid crystal display element of the present invention, a wavelength plate, a light-scattering film, a driving circuit, or the like. [Embodiment] 110 200813158 24843pif Hereinafter, the present invention will be described by way of Examples, but the present invention is not limited to these Examples. Further, the names of the tetracarboxylic dianhydride, the diamine, the alkenyl substituted nadic acid ruthenium imide compound, the heterocyclic compound and the solvent used in the examples are indicated by the following ellipsis. [tetracarboxylic dianhydride]
均苯四甲酸二酐{結構式(1) } : PMDA 1,2,3,4_環丁烷四甲酸二酐{結構式(19) } : CBDAPyromellitic dianhydride {structural formula (1) } : PMDA 1,2,3,4_cyclobutane tetracarboxylic dianhydride {structural formula (19) } : CBDA
[二胺][diamine]
ί -—胺基^一本基甲丈完{結構式(V — 1) } · DDM 4,4-[1,3_丙烷雙(4,M申苯基亞甲基)]雙[苯胺]{結構式 (W-2) } : BABZP3 苯基甲基二胺基苯{結構式(!γ_ 16)> :phPDA 戊基[UL雙環己基]I基)苯基]曱基]二 胺基苯{通式(砸一5) /R23 = c5Hn} : 5ChCh- - - Amino group - a base of the base - [Structure (V - 1) } · DDM 4,4-[1,3_propane double (4, M phenylene methylene)] bis [aniline] {Structure formula (W-2) } : BABZP3 Phenylmethyldiaminobenzene {Structure formula (!γ_ 16)> :phPDA pentyl [UL biscyclohexyl]I group)phenyl]fluorenyl]diamine group Benzene {general (砸5) /R23 = c5Hn} : 5ChCh
1,1_雙[4_(4_胺基节基)苯基]_4_庚基環己烷《通式(冱一 2) /R29=C7H15} : 7ChBZ1,1_bis[4_(4-aminophenyl)phenyl]_4_heptylcyclohexane "General formula (冱2 2) /R29=C7H15} : 7ChBZ
U-雙[4-(4-胺基苯氧基)苯基](反式_4_正己基環己 基)¾ 己燒{通式(XI-4) /R30 = C5Hn} ·· 5ChChBA 4,4 -乙烯基一本胺《結構式(v _7)》:det [烯基取代納迪克酸醯亞胺化合物] 以下述結構式(lna—所表示之化合物:βΑΝΙ_ [化 52] 111 200813158 24843pifU-bis[4-(4-aminophenoxy)phenyl](trans_4_n-hexylcyclohexyl)3⁄4 hexane = General formula (XI-4) /R30 = C5Hn} ·· 5ChChBA 4, 4-vinyl-monoamine "Structure formula (v _7)": det [alkenyl-substituted nadic acid ylide imine compound] The compound represented by the following structural formula (lna-: βΑΝΙ_ [52] 111 200813158 24843pif
[環氧乙烷化合物] 4,4匕亞曱基雙(n,n-二縮水甘油基苯胺):DGA (3-縮水甘油氧基丙基)三曱氧基矽烷:tms (3·&水甘油氧基丙基)甲基二曱氧基矽烷:DMS 2^(3,‘環氧基環己基)乙基三甲氧基矽烷: [氧環丁燒(oxetane)化合物] 雙[(3-乙基I環氧丙烷基曱氧基)曱基]笨:BMMB [氮丙咬(aziridine)化合物] 2,4,6_三(1!-氮丙啶基)-1,3,5-三嗪:ΑΤΑ [噻喃(thiirane)化合物] N,N,N’,N’-四噻喃基甲基_4,4,_二胺基二苯基曱烷: TMAP ^ [^惡唾ϋ林化合物] 聚(苯乙烯-co-2-異丙烯基噁唑啉)(日本觸媒股份有限 公司製:EPOCROS RPS - 1005 ) : PSO [噁嗪化合物] 雙(3-本基-3,4-二氫-211-1,3-苯幷。惡嗪_6_基)曱烧(四國 化成工業製笨并噪嗪F-a型):B0Z ")f^( 0 [溶劑][Ethylene oxide compound] 4,4匕-indenyl bis(n,n-diglycidylaniline): DGA (3-glycidoxypropyl)trimethoxy decane: tms (3·& Glycidoxypropyl)methyldimethoxyoxydecane: DMS 2^(3, 'epoxycyclohexyl)ethyltrimethoxydecane: [oxetane compound] bis[(3- Ethyl I propylene oxide decyloxy) fluorenyl] stupid: BMMB [aziridine compound] 2,4,6_tris(1!-aziridine)-1,3,5-three Oxazine: ΑΤΑ [thiirane compound] N, N, N', N'-tetrathiopyranylmethyl 4,4,-diaminodiphenyl decane: TMAP ^ [^ ϋ ϋ ϋ 林Compound] Poly(styrene-co-2-isopropenyloxazoline) (manufactured by Nippon Shokubai Co., Ltd.: EPOCROS RPS - 1005) : PSO [oxazine compound] bis(3-propenyl-3,4- Dihydro-211-1,3-benzoquinone. Oxazine _6_yl) 曱 ((Four types of chemical industry stupid and noise azine type Fa): B0Z ") f^ (0 [solvent]
N-甲基1吡咯啶酮:NMP 丁基溶纖素(乙二醇單丁基_) : BC 112 200813158 24843pif <1·聚醯胺酸之合成> [聚醯胺酸之合成] 合成例1 於安裝有溫度計、擾拌機、原料投入口及氮氣導人口 之 100 mL 四口 燒瓶中,加入 1.6760 g 之 5〇!〇1、1.7918N-methyl 1 pyrrolidone: NMP butyl cellulolytic (ethylene glycol monobutyl _) : BC 112 200813158 24843pif <1· Synthesis of polyglycine> [Synthesis of polyaminic acid] Synthesis example 1 Add 1.6760 g of 5〇 to a 100 mL four-necked flask equipped with a thermometer, a scrambler, a raw material input port, and a nitrogen-conducting population! 〇1, 1.7918
之PhPDA、及Μ·3 g之脫水NMP,於乾操氮氣流中進^ 攪拌溶解。接著添加2.5321 g之CBDA,於室溫環境丁^ 應30小時。於反應中反應溫度上升之情形時,將反應温度 抑制於約70°C以下進行反應。於所得溶液中知入37.7 g之 ®C 5成》辰度為6重置%之聚酿胺酸溶液(pa 1 )。所得 PA1的重量平均分子量為37,〇〇〇。 此處,以由磷酸與DMF所構成的稀釋夜(磷酸/dmf 、 100 ·重里比)將所付聚·胺酸稀釋成聚酿胺酸濃度 為約1重量%,使用Chromatopac c一R7A (島津製作二 將上述稀釋液作為展開劑且藉由GPC法;行S定, =打聚笨乙烯換算,藉此求出聚醯胺酸的重量平均分子 tH,管柱是使用GF—7HQ (昭和電工 衣 吕柱溫度50°C、流速0.6 mL/min之條件進行測定。 合成例2〜6 、 除如表1所示將四叛酸二酐及二胺加以變更以外,其 餘依照合成例1來合成聚醯胺酸溶液(PA2〜PA6)。將包 含合成例1的結果集中示於表i。 [表1] 表1 113 200813158 24843pifPhPDA, and 3·3 g of dehydrated NMP were stirred and dissolved in a dry nitrogen stream. Then, 2.5321 g of CBDA was added and the mixture was allowed to stand at room temperature for 30 hours. In the case where the reaction temperature rises during the reaction, the reaction temperature is suppressed to about 70 ° C or lower to carry out the reaction. To the resulting solution, 37.7 g of ® C 5 was formed into a 6% by weight poly-aracine solution (pa 1 ). The obtained PA1 had a weight average molecular weight of 37, 〇〇〇. Here, the diluted polyamine acid is diluted to a polyaracine concentration of about 1% by weight in a diluted night (phosphoric acid/dmf, 100 · weight ratio) composed of phosphoric acid and DMF, and Chromatopac c-R7A (Shimadzu) is used. In the second production, the above-mentioned diluent is used as a developing solvent, and the weight average molecular weight tH of the polylysine is determined by the GPC method, and the polystyrene acid is converted into a polystyrene. The column is made of GF-7HQ (Showa Denko) The conditions were measured under the conditions of a temperature of 50 ° C and a flow rate of 0.6 mL/min. Synthesis Examples 2 to 6 were synthesized in accordance with Synthesis Example 1 except that four tetrahydrous dianhydrides and diamines were changed as shown in Table 1. Polylysine solution (PA2 to PA6). The results including Synthesis Example 1 are collectively shown in Table i. [Table 1] Table 1 113 200813158 24843pif
<2·液晶顯示元件之製作> [實施例1] 將合成例1中合成的濃度6重量%的聚醯胺酸溶液 (ΡΑ1)與合成例2中合成的濃度6重量%的聚驗胺酸溶液 (ΡΑ2)以重量比1/9加以混合。於所得混合物中,每1⑻ 重量份聚醯麵分縣加1()重量份作為縣取_迪克 酸醯亞胺化合物之ΒΑΝΙ —Μ、及作為環氧W化合物之 DGA,將包含這些化合物的改良劑的總量調整為2〇重量 ^隨後,加人NMP/BC=1/1 (重量比)的混合溶劑,將 劑。使用㈣ 為4重量%以製備液晶配向 件。 斤獲侍之液晶配向劑,製作如下述之液晶顯示元 液晶顯*元件之製作方法 其杯^㈣專裔將液晶配向劑塗佈於二片附1 T〇電極的玻璃 土 ,形成膜厚7〇 nm的膜。塗膜後於80。〇下加熱乾燥 114 200813158 24843pif 約5分鐘,隨後於220°C下進行40分鐘加熱處理,接著 行研磨處理,以形成液晶配向膜。 將於玻璃基板上所形成之液晶配向膜於超純水中進疒 5分鐘超音波清洗,隨後於烘箱中於i2(rc下進 〇八: 乾燥。 刀鐘 於一片玻璃基板上散布4 μηι的間隔材,將形成液曰曰 配向膜的面作為内侧,以研磨方向成為反方向平行之= 式,將形成液晶配向膜的一對玻璃基板對向配置,隨後以 環氧硬化劑蔣液晶配向膜的周圍密封7製作間隔為4 的反平行單元(anti-parallel ceil)。於該單元中,將下述所 示的液晶組合物j注入前述間隔中,以光硬化劑將液晶組 合物用注入口密封。接著,於il〇°C下進行30分鐘加熱處 理,以製作液晶顯示元件。 [化 53]<2. Preparation of liquid crystal display element> [Example 1] A polyglycine solution (ΡΑ1) having a concentration of 6 wt% synthesized in Synthesis Example 1 and a concentration of 6 wt% synthesized in Synthesis Example 2 were collected. The amine acid solution (ΡΑ2) was mixed at a weight ratio of 1/9. In the obtained mixture, 1 () part by weight per 1 part (8) parts by weight of the polythene surface is used as a DGA of the county-dick yttrium imide compound, and DGA as an epoxy W compound, and the improvement of these compounds is included. The total amount of the agent was adjusted to 2 〇 by weight ^ and then a mixed solvent of NMP/BC = 1/1 (weight ratio) was added. The liquid crystal alignment member was prepared using (4) at 4% by weight. The liquid crystal alignment agent of the liquid crystal display unit is produced by the following method. The cup is made of the following liquid crystal alignment agent, and the liquid crystal alignment agent is applied to two glass soils with 1 T electrode, forming a film thickness of 7 〇nm film. After coating the film at 80. The underarm was heated and dried 114 200813158 24843pif for about 5 minutes, followed by heat treatment at 220 ° C for 40 minutes, followed by grinding treatment to form a liquid crystal alignment film. The liquid crystal alignment film formed on the glass substrate is ultrasonically cleaned in ultrapure water for 5 minutes, and then dried in an oven at i2 (rc): drying. The knife clock spreads 4 μηι on a piece of glass substrate. The spacer is formed such that the surface on which the liquid helium alignment film is formed is the inner side, and the polishing direction is parallel in the opposite direction, and the pair of glass substrates forming the liquid crystal alignment film are opposed to each other, and then the epoxy resin is used as the liquid crystal alignment film. The surrounding seal 7 is formed with an anti-parallel ceil having a spacing of 4. In this unit, the liquid crystal composition j shown below is injected into the space, and the liquid crystal composition is used as an injection port with a light hardener. After sealing, heat treatment was performed for 30 minutes at il 〇 ° C to produce a liquid crystal display element.
液晶組合物I 115 200813158 24843pifLiquid crystal composition I 115 200813158 24843pif
H FH F
5wt% 7wt%5wt% 7wt%
Bwt% 8wt% 14wt% 14wi% 1Qwt% 10wt% 12wt% 12wt% [實施例2] 將合成例1中合成的濃度6重量%的聚醯胺酸溶液 (PA1)與合成例3中合成的濃度6重量%的聚醯胺酸溶液 116 200813158 24843pif (PA3)以重量比1/9加以混合。於所得混合物中,每 重里份聚醯胺酸分別添加10重量份作為烯基取代耐地酸 鉍亞胺化合物之BANI— ]VI、及作為噁嗪化合物之B〇z, 將包含這些化合物的改良劑的總量設為2〇重量份。 加入NMP/BC=1/1 (重量比)白勺混合溶劑,將聚酿胺酸稀 ,成相對於全體為4重量%,以製備液晶配向劑。使用所 得液晶配向劑,以與實施例1同樣之方式製作液晶顯示元 件。Bwt% 8 wt% 14 wt% 14wi% 1Q wt% 10 wt% 12 wt% 12 wt% [Example 2] A concentration of 6 wt% of polylysine solution (PA1) synthesized in Synthesis Example 1 and a concentration 6 synthesized in Synthesis Example 3 The wt% polyamine solution 116 200813158 24843pif (PA3) was mixed at a weight ratio of 1/9. In the obtained mixture, 10 parts by weight of BANI-]VI as an alkenyl-substituted dysinoid compound, and B〇z as an oxazine compound are added per part by weight of the poly-proline, and the improvement of these compounds is included. The total amount of the agent was set to 2 parts by weight. A mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polylactoic acid was diluted to 4% by weight based on the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
舲合成例1中合成的濃度6重量%的聚醯胺酸溶液 (/Μ)與合成例3中合成的濃度6重量%的聚醯胺酸溶液 亩重量比1/9加以混合。於所得混合物中,每_ «酸分別添加1Q重量份作為職取代細 酞酏亞胺化合物之ΒΑΝί —M、及 〜 化合物之BMMB,將向人一此几人^ 烷(〇Xetane ) 20重量份。隨後,广3 5物的改良劑的總量設為 一, 後 入NMP/BC== 1/1 (重m沾、日人 4«%, '1:; 液曰曰配向劑。使用所 ,以衣備 方式製作液晶顯示元件。叫卩與貫施m同樣之 [實施例4] ⑽===咖_胺酸溶液 ⑽)以重量比二::的^ 重量份聚— 117 200813158 24843pif 酸醯亞胺化合物之bani^m、 ΑΤΑ,將包含這些化合物之改:及作為氮丙啶化合物之 隨後,加入NMP/BC=l/l (重^彳的總量設為20重量份。 胺酸稀釋成相對於全體為4重比)的混合溶劑,將聚醯 使用所得液晶配向劑,以與趣里/°,以製備液晶配向劑。 顯示元件。 ί施例1同樣之方式製作液晶 [實施例5]The 6% by weight polylysine solution (/?) synthesized in Synthesis Example 1 was mixed with the 6% by weight polylysine solution synthesized in Synthesis Example 3 at a weight ratio of 1/9. In the obtained mixture, 1Q parts by weight of each of the _ «acids as a substitute for the quinone imine compound ΒΑΝ — - M, and ~ compound BMMB, will be given to a few people (〇Xetane) 20 parts by weight . Subsequently, the total amount of the modifier of the Guangwu 5 is set to one, and then NMP/BC== 1/1 (weight m, Japanese 4«%, '1:; liquid helium alignment agent. A liquid crystal display element is produced by means of clothing. The same method as in the case of the application of the same [Example 4] (10) === coffee-amino acid solution (10)) in a weight ratio of two:: part by weight of poly-117 200813158 24843pif acid bismuth The bani^m, hydrazine of the imine compound will contain the modification of these compounds: and as the aziridine compound, NMP/BC=l/l (the total amount of the hydrazine is 20 parts by weight. A liquid crystal alignment agent was prepared by using the obtained liquid crystal alignment agent in a mixed solvent of 4 weight ratio with respect to the whole to prepare a liquid crystal alignment agent. Display component. ί Embodiment 1 produces liquid crystal in the same manner as in Example 1 [Example 5]
將合成例1中合成的濃度 Θ (PA1 )與合成例3中合成的二广重量%的聚酿胺酸溶液 (PA3U:<重量比1/9加以現重量%的聚聽胺酸溶液 重量份_㈣分縣加妓合物中 ,每 100 酸醯亞胺化合物之ΒΑΝί\里份作為稀基取代納迪克 ΤΜΑΡ,將包含這些化合物之 及作為噻喃化合物之 份。隨後,加anmp/bc=i/i义劑的總量設為2〇重量 聚醯胺酸稀釋成相對於全體為重^比)的混合溶劑,將 劑。使用所得液晶配向劑,:!量%,以製備液晶配向 液晶顯示元件。^貫施例1同樣之方式製作 [實施例6] 騎合成例 ,·甲合成的濃唐&壬曰 (而)與合成例3中合成的遭乂 聚酿胺酸溶液 (PA3)以重量比1/9混合。於、曰里/〇的聚醯胺酸熔液 份聚酸胺酸分別添加1G 、=麵中,每_重量 亞胺化合物之BANI —M 基取代納迪克酸醯 將包含這些化合物之改良劑的總 118 200813158 24843pif 加入NMP/BC= 1/1 (重量比)的混合溶劑,將聚醯胺酸稀 釋成相對於全體為4重量%,以製備液晶配向劑。使用所 得液晶配向劑,以與實施例1同樣之方式製作液晶顯示元 件。 [實施例7] 將合成例1中合成的濃度5重量%的聚醯胺酸溶液 (PA1)與合成例3中合成的濃度6重量%的聚醯胺酸溶液 (PA3)以重量比1/9加以混合。於所得混合物中,每100 重量1'分聚酉篮月安酸添力口 30 重量1分作為婦基取1·戈納迪克酸^醢 亞胺化合物之BANI —Μ,另外每100重量份聚醯胺酸添 加10重量份作為噁嗪化合物之ΒΟΖ,將包含這些化合物 之改良劑的總量設為40重量份。隨後,加入NMP/BC= 1/1 (重量比)的混合溶劑,將聚醯胺酸稀釋成相對於全體為 4重量。/〇,以製備液晶配向劑。使用所得液晶配向劑,以 與實施例1同樣之方式製作液晶顯示元件。 [比較例1] 將合成例1中合成的濃度6重量%的聚酸胺酸溶液 (PA1)與合成例2中合成的濃度6重量%的聚醯胺酸溶液 (PA2 )以重量比1/9加以混合。於所得混合物中加入 NMP/BC=1/1 (重量比)的混合溶劑,將聚醯胺酸稀釋成 相對於全體為4重量%,以製備液晶配向劑。使用所得液 晶配向劑,以與實施例1同樣之方式製作液晶顯示元件。 [比較例2] 將合成例1中合成的濃度6重量%的聚醯胺酸溶液 119 200813158 24843pif (PAl)與合成中合成的濃度6重量%的聚 (PA3)以重量請加以混合。於所得混合物中= NMP/BC=1/1 (重量比)的混合溶劑,將聚醯胺酸 相對於全體為4重量%,以製備液晶配向劑。使用= 晶配向劑’以與實施例i同樣之方作液晶顯示/ [比較例3] T °The concentration Θ (PA1 ) synthesized in Synthesis Example 1 and the weight % polylactoic acid solution synthesized in Synthesis Example 3 (PA3U: < weight ratio 1/9 were added to the present weight % of the polyamine acid solution solution weight In the _(4) sub-county addition compound, the ΒΑΝί\ part of each of the 100 bismuth imidate compounds is substituted as a dilute group, and the compound is included as a thiopyran compound. Subsequently, anmp/bc is added. The total amount of the =i/i agent is set to 2% by weight, and the polyglycolic acid is diluted to a mixed solvent with respect to the whole weight. Use the resulting liquid crystal alignment agent, :! Amount % to prepare a liquid crystal alignment liquid crystal display element. The same manner as in Example 1 was carried out in the same manner as in [Example 6], riding a synthetic example, a synthetic tannin & 壬曰 (and) and a synthetic polyglycolic acid solution (PA3) synthesized in Synthesis Example 3 by weight. Mixed than 1/9. The polyamic acid melt of the yttrium/niobium is added to the 1G and = surface, respectively, and the BANI-M-substituted Nadickic acid bismuth per _ weight of the imine compound will contain the modifier of these compounds. Total 118 200813158 24843pif A mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 7] A 5% by weight poly-proline solution (PA1) synthesized in Synthesis Example 1 and a 6% by weight poly-proline solution (PA3) synthesized in Synthesis Example 3 were subjected to a weight ratio of 1/ 9 mix. In the obtained mixture, 30 parts by weight per 100 parts by weight of the 1'-concentrated sputum basket, and the BANI-Μ of the 1% Gonadic acid compound, and the weight of each 100 parts by weight 10 parts by weight of guanamine was added as a oxime compound, and the total amount of the modifier containing these compounds was 40 parts by weight. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and the polyaminic acid was diluted to 4 parts by weight with respect to the whole. /〇 to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Comparative Example 1] A 6% by weight polyamic acid solution (PA1) synthesized in Synthesis Example 1 and a 6% by weight polylysine solution (PA2) synthesized in Synthesis Example 2 were subjected to a weight ratio of 1/1. 9 mix. To the resulting mixture, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight based on the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Comparative Example 2] A 6% by weight polylysine solution 119 200813158 24843pif (PAl) synthesized in Synthesis Example 1 was mixed with 6% by weight of poly(PA3) synthesized in the synthesis. In the mixed solvent of the obtained mixture = NMP / BC = 1 / 1 (weight ratio), polyglycine was 4% by weight based on the whole to prepare a liquid crystal alignment agent. Using the = crystal alignment agent as the liquid crystal display in the same manner as in Example i / [Comparative Example 3] T °
將合成例1中合成的濃度6重量%的聚軸酸 (ΡΑ1)與合成例3中合成的濃度6重量%的聚酸胺酸溶液 (ΡΑ3)以重量比1/9混合。於所得混合物中,每1〇〇重旦 份聚醯胺酸添加10重量份作為烯基取代納迪克酸醯亞月^ 化合物之ΒΑΝΙ —Μ。隨後,加aNMP/bc=1/1 (重量比) 的混合溶劑,將聚醯胺酸稀釋成相對於全體為4重量%, 以製備液晶配向劑。使用所得液晶配向劑,以與實施^、 同樣之方式製作液晶顯示元件。 [比較例4] 將合成例1中合成的濃度6重量%的聚醯胺酸溶液 (PA1)與合成例3中合成的濃度6重量%的聚醯胺酸溶液 (PA3)以重量比1/9加以混合。於所得混合物中,每_ 重篁份聚醢胺酸添加10重量份作為之ps()。隨後, 加入NMP/BC-1/1 (重量比)的混合溶劑,將聚酿胺酸稀 釋成相對於全體為4重量%,以製備液晶配向劑。使用所 得液晶配向劑,以與實施例丨同樣之方式製作液晶顯示元 件0 [實施例8] 120 200813158 24843pif 於合成例3中合成的濃度6重量%的聚醯胺酸溶液 (PA3)中,每100重量份聚醯胺酸分別添加10重量份作 為烯基取代納迪克酸醯亞胺化合物之BANI — Μ及作為環 氧乙院(oxirane)化合物之DGA,將包含這些化合物之改 良劑的總量設為20重量份。隨後,加入NMP/BC=1/1(重 量比)的混合溶劑,將聚醯胺酸稀釋成相對於全體為4重 量%,以製備液晶配向劑。除使用所得液晶配向劑、使用 以下所示的液晶組合物Π以外,其餘以與實施例1同樣之 方式製作液晶顯示元件。 [化 54] 液晶組合物ΠThe polyhexanoic acid (ΡΑ1) having a concentration of 6% by weight synthesized in Synthesis Example 1 and the polyamic acid solution (ΡΑ3) having a concentration of 6% by weight synthesized in Synthesis Example 3 were mixed at a weight ratio of 1/9. To the resulting mixture, 10 parts by weight of an alkenyl-substituted nadic acid yttrium compound was added per 1 〇〇 of the heavy poly-polyamine. Subsequently, a mixed solvent of aNMP/bc = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in the above, using the obtained liquid crystal alignment agent. [Comparative Example 4] A 6% by weight poly-proline solution (PA1) synthesized in Synthesis Example 1 and a 6 wt% poly-proline solution (PA3) synthesized in Synthesis Example 3 were subjected to a weight ratio of 1/1. 9 mix. To the resulting mixture, 10 parts by weight of ps() was added per gram of the polyglycolic acid. Subsequently, a mixed solvent of NMP/BC-1/1 (weight ratio) was added, and polylactoic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. Using the obtained liquid crystal alignment agent, a liquid crystal display element 0 was produced in the same manner as in Example [ [Example 8] 120 200813158 24843pif In a concentration of 6% by weight poly-proline solution (PA3) synthesized in Synthesis Example 3, 100 parts by weight of polylysine is added to 10 parts by weight of BANI as an alkenyl-substituted nadic acid ylidene compound and DGA as an oxirane compound, and the total amount of the modifier containing these compounds is added. Set to 20 parts by weight. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight based on the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 except that the obtained liquid crystal alignment agent was used and the liquid crystal composition shown below was used. Liquid crystal composition
FF
C〇HC〇H
17wt.°/〇17wt.°/〇
17wt%17wt%
c3h7C3h7
16wt% 121 200813158 24843pif16wt% 121 200813158 24843pif
c2h4C2h4
FF
F tOwt.%F tOwt.%
FF
5wt%5wt%
F 10wt%F 10wt%
6wt.% /\ ίΓ"\ f/\6wt.% /\ ίΓ"\ f/\
6wt·% 13wt% [實施例9] 於合成例2中合成的濃度6重量%的聚醯胺酸溶液 (PA2)中,每100重量份聚醯胺酸分別添加10重量份作 為烯基取代納迪克酸醯亞胺化合物之BANI — Μ及作為噁 嗪化合物之ΒΟΖ,將包含這些化合物之改良劑的總量設為 20重量份。隨後,加入NMP/BC=1/1 (重量比)的混合 溶劑,將聚醯胺酸稀釋成相對於全體為4重量%,以製備 液晶配向劑。除使用所得液晶配向劑、使用液晶組合物Π 以外,其餘以與實施例1同樣之方式製作液晶顯示元件。 122 200813158 24843pif [比較例5] 於合成例3中合成的濃度6重量%的聚驢胺酸溶液 (PA3)中,每100重量份聚龜胺酸添加20重量份作為烯 基取代納迪克酸醯亞胺化合物之BANI — Μ。隨後,加入 NMP/BC=1/1 (重量比)的混合溶劑,將聚醯胺酸稀釋成 相對於全體為4重量%,以製備液晶配向劑。除使用所得 液晶配向劑、使用液晶組合物Π以外,其餘以與實施例1 同樣之方式製作液晶顯示元件。 「咸 >> 1 ΑΊ |[貝aivej丄^」 將合成例4中合成的濃度6重量%的聚醯胺酸溶液 (PA4)與合成例5中合成的濃度6重量%的聚醯胺酸溶液 (PA5)以重量比8/2混合。於所得混合物中,每100重量 份聚醯胺酸添加20重量份作為烯基取代納迪克酸醯亞胺 化合物之BANI —Μ,另外每100重量份聚醯胺酸添加20 重量份作為環氧乙烷化合物之TMS,將包含這些化合物之 改良劑的總量設為40重量份。隨後,加入NMP/BC=1/1 (重量比)的混合溶劑,將聚醯胺酸稀釋成相對於全體為 4重量%,以製備液晶配向劑。使用所得液晶配向劑,以 與實施例1同樣之方式製作液晶顯示元件。 [實施例Π] 將合成例4中合成的濃度6重量%的聚醯胺酸溶液 (PA4)與合成例5中合成的濃度6重量%的聚醯胺酸溶液 (PA5)以重量比8/2加以混合。於所得混合物中,每100 重量份聚醯胺酸添加20重量份作為烯基取代納迪克酸醯 123 200813158 24843pif6 wt·% 13 wt% [Example 9] In a 6% by weight poly-proline solution (PA2) synthesized in Synthesis Example 2, 10 parts by weight per 100 parts by weight of polyglycine was added as an alkenyl-substituted sodium. The BANI of the dick bismuth imidate compound and the oxime compound as a oxazine compound set the total amount of the modifier containing these compounds to 20 parts by weight. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 except that the obtained liquid crystal alignment agent and the liquid crystal composition were used. 122 200813158 24843pif [Comparative Example 5] In a 6% by weight poly-proline solution (PA3) synthesized in Synthesis Example 3, 20 parts by weight per 100 parts by weight of polymyric acid was added as an alkenyl-substituted naphthoic acid hydrazine. BANI of the imine compound - Μ. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 except that the obtained liquid crystal alignment agent and the liquid crystal composition were used. "salt >> 1 ΑΊ |[Bei aivej丄^" A 6% by weight polyphosphamic acid solution (PA4) synthesized in Synthesis Example 4 and a 6% by weight polyamine synthesized in Synthesis Example 5. The acid solution (PA5) was mixed at a weight ratio of 8/2. To the obtained mixture, 20 parts by weight of BANI-oxime which is an alkenyl-substituted nadic acid ruthenium imide compound per 100 parts by weight of polylysine, and 20 parts by weight per 100 parts by weight of polyglycine as epoxy B The TMS of the alkane compound, the total amount of the modifier containing these compounds was 40 parts by weight. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example Π] A 6% by weight poly-proline solution (PA4) synthesized in Synthesis Example 4 and a 6% by weight poly-proline solution (PA5) synthesized in Synthesis Example 5 were used in a weight ratio of 8/ 2 to mix. In the resulting mixture, 20 parts by weight per 100 parts by weight of polyglycolic acid is added as an alkenyl-substituted naphthoic acid 醯 123 200813158 24843pif
亞胺化合物之BANI — Μ ’另外每100重量份聚醯胺酸添 加20重量份作為環氧乙烷(oxirane)化合物之DMS,將 包含這些化合物之改良劑的總量設為40重量份。隨後,加 入NMP/BC=1/1 (重量比)的混合溶劑,將聚醯胺酸稀釋 成相對於全體為4重量% ’以製備液晶配向劑。使用所得 液晶配向劑,以與實施例1同樣之方式製作液晶顯示元件TBANI of the imine compound - Μ ' Further, 20 parts by weight of DMS as an oxirane compound was added per 100 parts by weight of the polyaminic acid, and the total amount of the modifier containing these compounds was 40 parts by weight. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4 wt% relative to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element T was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
[實施例12] 將合成例4中合成的濃度6重量%的聚醯胺酸溶液 (PA4)與合成例5中合成的濃度6重量%的聚醯胺酸溶液 (PA5)以重量比8/2加以混合。於所得混合物中,每1〇〇 重量份聚醯胺酸添加20重量份作為烯基取代納迪克酸酿 亞胺化合物之BANI — Μ ’另外每1〇〇重量份聚醯胺酸添 加20重量份作為環氧乙烷(oxirane)化合物之Ecs,將 包含這些化合物之改良劑的總量設為40重量份。隨後,加 入NMP/BC=1/1 (重量比)的混合溶劑,將聚醯胺酸稀釋 成相對於全體為4重量%以製備液晶配向劑。使用所得液 晶配向齊1] ’以與實施例1同樣之方式製作液晶顯示元件。 [實施例13] 將合成例4中合成的濃度6重量%的聚醯胺酸溶液 (PA4 )與合成例6中合成的濃度6重量%的聚酸胺酸溶液 (PA6)以重量比8/2加以混合。於所得混合物中,每IQ。 重量份聚醯胺酸添加20重量份作為烯基取代納迪克酸酿 亞胺化合物之BANI — M,另外每100重量份聚醯胺酸添 加20重量份作為環氧乙烷(oxirane)化合物之TMS,將 124 200813158 24843pif 包含這些化合物之改良劑的總量設為4〇重量份。隨後,加 入NMP/BC=1/1 (重量比)的混合溶劑,將聚醯胺酸稀釋 成相對於全體為4重量%,以製備液晶配向劑。使用所得 液晶配向劑,以與實施例1同樣之方式製作液晶顯示元件。 [實施例14] 將合成例4中合成的濃度6重量%的聚醯胺酸溶液 (PA4)與合成例6中合成的濃度6重量%的聚醯胺酸溶液 (PA6)以重量比8/2混合。於所得混合物中,每1〇〇重量 份聚醯胺酸添加20重量份作為烯基取代納迪克酸醯亞胺 化合物之BANI — Μ,另外每1〇〇重量份聚醯胺酸添加20 重量份作為環氧乙烷(oxirane)化合物之ECS,將包含這 些化合物之改良劑的總量設為40重量份。隨後,加入 NMP/BC=l/i (重量比)的混合溶劑,將聚醯胺酸稀釋成 相對於全體為4重量%,以製備液晶配向劑。使用所得液 晶配向劑,以與實施例1同樣之方式製作液晶顯示元件。 [比較例6] 將合成例4中合成的濃度6重量%的聚醯胺酸溶液 (PA4)與合成例5中合成的濃度6重量%的聚醯胺酸溶液 (PA5)以重虿比8/2混合。於所得混合物中,每1〇〇重量 U皿胺Uu 20重i份作為烯基取代納迪克酸酿亞胺 化合物之BANI-Μ。隨後,加入则膽㈤八(重量比) 的混合溶劑,將聚酿胺酸蘇雜# j U ^ ^ ^ 0/ , 久稀擇成相對於全體為4重量%以 製備液晶配向劑。使用所得、、态曰心人M t ^ ^ / ϊ 1 m 1付成晶配向劑,以與實施例1同 樣之方式製作液晶顯示元件。 〃、 125 200813158 24843pif [比較例7] 將合成例4中合成的濃度6重量%的聚醯胺酸溶液 (PA4)與合成例5中合成的濃度6重量%的聚醯胺酸溶液 (PA5)以重量比8/2混合。於所得混合物中,每100重量 份聚酸胺酸添加20重量份作為環氧乙炫(oxirane)化合 物之ECS。隨後,力口人NMP/BC=1/1 (重量比)的混合溶 劑,將聚醯胺酸稀釋成相對於全體為4重量%,以製備液 晶配向劑。使用所得液晶配向劑,以與實施例1同樣之方 '式製作液晶顯示元件。 [比較例8] 將合成例4中合成的濃度6重量%的聚醯胺酸溶液 (PA4)與合成例5中合成的濃度6重量%的聚醯胺酸溶液 (PA5 )以重量比8/2加以混合。隨後,加入NMP/BC= 1/1 (重量比)的混合溶劑,將聚醯胺酸稀釋成相對於全體為 4重量%,以製備液晶配向劑。使用所得液晶配向劑,以 與實施例1同樣之方式製作液晶顯示元件。 Γ <3.電氣特性之評價〉 [試驗例1〜22] 對於實施例1〜14、比較例1〜8中製作之液晶顯示元 件,以如下之方式進行離子密度之測定及電氣特性長期可 靠性之測定。 (1)離子密度之測定 使用TOYO Technica製液晶物性評價裝置6254型, 進行離子密度之測定。測定條件為:波形··三角波、頻率: 126 200813158 24843pif 0.01 Hz、電壓:士 10 V,測定溫度為60°c。離子密度值越 小則電氣特性越好。結果示於表2。 (2— 1)離子密度的保持特性之測定[試驗例1〜14] 對於所製作的液晶顯示元件,歷時性地求出離子密度 [pC],評價其保持特性。保持特性的試驗方法是採用以下 方法:將液晶顯示元件於溫度為60°C的環境中放置100小 時,途中歷時性地測定取出的離子密度[pC]。離子密度的 下降越小則(例如增加率小於1·5倍:增加率(倍)=1⑻ 小時後的離子密度/初期(〇小時)的離子密度)離子密度 的保持特性越好,另外電氣特性的長期可靠性越好。結果 示於表2。 127 200813158 24843pif [表2][Example 12] A 6% by weight poly-proline solution (PA4) synthesized in Synthesis Example 4 and a 6% by weight poly-proline solution (PA5) synthesized in Synthesis Example 5 were used in a weight ratio of 8/ 2 to mix. In the obtained mixture, 20 parts by weight of BANI as an alkenyl-substituted nadic acid-based imine compound is added per 1 part by weight of polyamic acid, and 20 parts by weight per 1 part by weight of polyglycine is added. As Ecs of an oxirane compound, the total amount of the modifier containing these compounds was 40 parts by weight. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment. [Example 13] A 6% by weight poly-proline solution (PA4) synthesized in Synthesis Example 4 and a 6% by weight polyamic acid solution (PA6) synthesized in Synthesis Example 6 were used in a weight ratio of 8/ 2 to mix. In the resulting mixture, every IQ. 20 parts by weight of BANI-M as an alkenyl-substituted nadic acid-based imine compound, and 20 parts by weight of TMS as an oxirane compound per 100 parts by weight of polyglycine The total amount of the modifier containing 124 200813158 24843pif containing these compounds was set to 4 parts by weight. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 14] A 6% by weight poly-proline solution (PA4) synthesized in Synthesis Example 4 and a 6% by weight poly-proline solution (PA6) synthesized in Synthesis Example 6 were used in a weight ratio of 8/ 2 mixed. To the obtained mixture, 20 parts by weight of BANI-oxime which is an alkenyl-substituted nadic acid ruthenium imide compound, and 20 parts by weight per 1 part by weight of polyglycine are added per 1 part by weight of polyglycine. As the ECS of an oxirane compound, the total amount of the modifier containing these compounds was 40 parts by weight. Subsequently, a mixed solvent of NMP/BC = l/i (weight ratio) was added, and polyamic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Comparative Example 6] A 6% by weight poly-proline solution (PA4) synthesized in Synthesis Example 4 and a 6% by weight poly-proline solution (PA5) synthesized in Synthesis Example 5 were used at a weight ratio of 8 /2 mixed. To the resulting mixture, 20 parts by weight of U-containing amine Uu was used as an alkenyl group to replace the BANI-oxime of the nadic acid-based imine compound. Subsequently, a mixed solvent of gallium (five) and eight (by weight) was added to prepare a liquid crystal alignment agent by using polystyrene sulphate # j U ^ ^ 0 / , which was selected to be 4% by weight relative to the whole. A liquid crystal display element was produced in the same manner as in Example 1 except that the obtained crystal forming agent was obtained by using Mt ^ ^ / ϊ 1 m 1 obtained. 〃, 125 200813158 24843pif [Comparative Example 7] A 6 wt% polyproline solution (PA4) synthesized in Synthesis Example 4 and a 6 wt% polyproline solution (PA5) synthesized in Synthesis Example 5 were prepared. Mix at a weight ratio of 8/2. To the resulting mixture, 20 parts by weight of ECS as an oxirane compound was added per 100 parts by weight of the polyamic acid. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was used to dilute the poly-proline to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Comparative Example 8] A 6% by weight poly-proline solution (PA4) synthesized in Synthesis Example 4 and a 6% by weight poly-proline solution (PA5) synthesized in Synthesis Example 5 were used in a weight ratio of 8/ 2 to mix. Subsequently, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polyamic acid was diluted to 4% by weight with respect to the whole to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. Γ <3. Evaluation of electrical characteristics> [Test Examples 1 to 22] The liquid crystal display elements produced in Examples 1 to 14 and Comparative Examples 1 to 8 were measured for ion density and long-term reliability in electrical properties as follows. Determination of sex. (1) Measurement of ion density Measurement of ion density was carried out using a liquid crystal physical property evaluation device 6254 manufactured by TOYO Technica. The measurement conditions were: Waveform··Triangle wave, frequency: 126 200813158 24843pif 0.01 Hz, voltage: ±10 V, and the measurement temperature was 60°C. The smaller the ion density value, the better the electrical characteristics. The results are shown in Table 2. (2-1) Measurement of retention characteristics of ion density [Test Examples 1 to 14] The ion density [pC] was determined for the liquid crystal display element produced, and the retention characteristics were evaluated. The test method for maintaining the characteristics was as follows: The liquid crystal display element was allowed to stand in an environment at a temperature of 60 ° C for 100 hours, and the extracted ion density [pC] was measured over the course of time. The smaller the decrease in ion density (for example, the increase rate is less than 1.5 times: the increase rate (times) = 1 (8) hours after the ion density / initial (〇 hour) ion density), the better the ion density retention characteristics, and the electrical characteristics The long-term reliability is better. The results are shown in Table 2. 127 200813158 24843pif [Table 2]
-〜22] =’評價其保持特性。保持特性之試驗方 二法^液晶顯示科於溫度⑽。c的環境中放置刚小 下'降==地測定取出的離子密度μ。離子密度的 度的保持特性=(小時)的離子密度)則離子密 果示於表3。子另外電氣特性的長期可靠性越好。結 128 200813158 24843pif [表3] 表3 項目 樣品 經過時間[小時] 增加率 [倍] 0 50 100 試驗例15 實施例10 11 36 44 4.0 試驗例16 實施例1] 13 26 30 2.3 試驗例17 實施例12 17 25 27 1.6 試驗例18 實施例13 10 20 24 2.4 試驗例19 實施例14 13 30 37 2.8 試驗例20 比較例6 24 58 140 5.8 試驗例21 比較例7 15 53 110 7.3 試驗例22 比較例8 28 157 198 7.1 如表2、表3所示,於使用混合入前述記載的改良劑 的液晶配向膜之液晶顯示元件之情形時,顯著抑制離子密 度保持特性的下降。 如上所述,本發明之包含聚醯胺酸及前述記載的改良 劑之液晶配向劑,於製成液晶顯示元件的液晶配向膜時, 離子密度較高,且可顯著抑制其保持特性的下降。 【圖式簡單說明】 無。 【主要元件符號說明】 無0 129-~22] =' evaluate its retention characteristics. Test method to maintain the characteristics of the two methods ^ liquid crystal display section at temperature (10). The ion density μ of the taken out was measured by placing the drop in the environment of c. The retention characteristic of the degree of ion density = ion density of (hours) is shown in Table 3. The long-term reliability of the other electrical characteristics is better.结128 200813158 24843pif [Table 3] Table 3 Project sample elapsed time [hour] Increase rate [times] 0 50 100 Test Example 15 Example 10 11 36 44 4.0 Test Example 16 Example 1] 13 26 30 2.3 Test Example 17 Implementation Example 12 17 25 27 1.6 Test Example 18 Example 13 10 20 24 2.4 Test Example 19 Example 14 13 30 37 2.8 Test Example 20 Comparative Example 6 24 58 140 5.8 Test Example 21 Comparative Example 7 15 53 110 7.3 Test Example 22 Comparison Example 8 28 157 198 7.1 As shown in Table 2 and Table 3, when a liquid crystal display element in which a liquid crystal alignment film of the above-described modifier is mixed is used, a decrease in ion density retention characteristics is remarkably suppressed. As described above, the liquid crystal alignment agent containing the polyamic acid and the above-described improver of the present invention has a high ion density when the liquid crystal alignment film of the liquid crystal display element is formed, and the retention property can be remarkably suppressed. [Simple description of the diagram] None. [Main component symbol description] None 0 129
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006238178 | 2006-09-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200813158A true TW200813158A (en) | 2008-03-16 |
| TWI427121B TWI427121B (en) | 2014-02-21 |
Family
ID=39395683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW096124476A TWI427121B (en) | 2006-09-01 | 2007-07-05 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR20080020951A (en) |
| TW (1) | TWI427121B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI391375B (en) * | 2008-08-20 | 2013-04-01 | Jnc Corp | Diamine, liquid crystal aligning agent, liquid crystal alignment layer, and liquid crystal display device |
| TWI627202B (en) * | 2011-07-12 | 2018-06-21 | Nissan Chemical Ind Ltd | Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6057070B2 (en) * | 2012-04-25 | 2017-01-11 | Jnc株式会社 | Liquid crystal aligning agent and liquid crystal display element using the same |
| CN104704421B (en) * | 2012-08-10 | 2018-01-16 | 日产化学工业株式会社 | Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells |
| CN104718492B (en) * | 2012-08-10 | 2018-09-18 | 日产化学工业株式会社 | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element |
| KR102198214B1 (en) | 2017-11-03 | 2021-01-04 | 주식회사 엘지화학 | Liquid crystal alignment composition, process for preparing liquid crystal alignment film, and liquid crystal alignment film, liquid crystal display device using the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI341863B (en) * | 2003-11-05 | 2011-05-11 | Chisso Corp | Liquid crystal alignment agent |
| JP4433150B2 (en) * | 2003-11-06 | 2010-03-17 | Jsr株式会社 | Liquid crystal aligning agent and liquid crystal display element |
| JP2005173397A (en) * | 2003-12-12 | 2005-06-30 | Jsr Corp | Liquid crystal aligning agent and liquid crystal display element |
| JP4645213B2 (en) * | 2004-03-01 | 2011-03-09 | チッソ株式会社 | Composition for liquid crystal alignment film, liquid crystal alignment film, liquid crystal sandwich substrate, and liquid crystal display element |
| JP4513950B2 (en) * | 2004-03-05 | 2010-07-28 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| JP4840137B2 (en) * | 2004-04-28 | 2011-12-21 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element using the same |
-
2007
- 2007-07-05 TW TW096124476A patent/TWI427121B/en not_active IP Right Cessation
- 2007-08-29 KR KR1020070087126A patent/KR20080020951A/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI391375B (en) * | 2008-08-20 | 2013-04-01 | Jnc Corp | Diamine, liquid crystal aligning agent, liquid crystal alignment layer, and liquid crystal display device |
| TWI627202B (en) * | 2011-07-12 | 2018-06-21 | Nissan Chemical Ind Ltd | Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI427121B (en) | 2014-02-21 |
| KR20080020951A (en) | 2008-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI375095B (en) | ||
| TW201016751A (en) | Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display device | |
| TWI406838B (en) | Diamide,liquid crystal alignment agent,liquid crystal alignment film and liquid crystal display | |
| TWI494292B (en) | Diamine, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device | |
| TW201022331A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
| JP5273035B2 (en) | Liquid crystal alignment treatment agent | |
| JP5267454B2 (en) | Diamine compound, polyamic acid, polyimide and liquid crystal alignment treatment agent | |
| TW201030095A (en) | Alignment agent and liquid crystalline polyimide used therein | |
| TW200940506A (en) | Diamine compound, liquid crystal aligning agent, and liquid crystal display device using the same | |
| JP5293943B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TW200927734A (en) | Liquid crystal alignment agent, liquid crystal alignment layer and liquid crystal display element | |
| TW201030060A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
| TW200923012A (en) | Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display device | |
| TW201100463A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
| TW201132704A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device | |
| TW200813158A (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device | |
| JP6183616B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TW200914953A (en) | Alignment material for liquid crystal display device and a preparing method of the same | |
| TWI306529B (en) | Composition for liquid crystal alignment film, liquid crystal alignment film, liquid crystal holding substrate and liquid crystal display device | |
| TW201235384A (en) | Liquid crystal alignment agent, polymer, method of producing polymer, liquid crystal alignment film and liquid crystal display element | |
| TWI387622B (en) | Liquid crystal alignment agent and liquid crystal display element | |
| TW201120099A (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display device, polyamic acid and compound | |
| TWI275630B (en) | Composition of containing polyamic acid blends and liquid crystal alignment layer and cell using them | |
| TW201012801A (en) | Diamine, liquid crystal aligning agent, liquid crystal alignment layer, and liquid crystal display device | |
| TW201221554A (en) | The liquid crystal orientation agent, the liquid crystal orientation membrane, the liquid crystal display device, compounds and polymers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |